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Abstract 
Atlantic salmon, Salmo salar, in aquaculture are susceptible to a number of 
infectious agents which cause significant economic impacts due to mortality and 
morbidity. However, the current diagnostic armamentarium available to industry 
has a number of limitations. More specifically histopathology remains the only 
way to diagnose pathological damage during disease requiring a high level of 
skill. Moreover its destructive nature makes it unsuitable for regular proactive 
health monitoring programmes. Therefore, there is significant demand for non-
destructive markers which can indicate clinical disease specific tissue damage. 
Moreover, such tests can give valued information on the effects of disease 
management strategies, such as functional feeds, in alleviating the severity of 
disease. This thesis describes, through the use of a pancreas disease (PD) 
cohabitation model the discovery of a number of potential non-destructive 
serum markers of infection and clinical disease. In addition, the reduction in 
disease severity through the use of a functional feed is also described. Initial 
investigation demonstrated the ability of functional feed to reduce disease 
severity using histopathology lesion scores of tissues affected during PD 
(pancreas, heart, and red and white skeletal muscle) and serum activities of 
creatine kinase, alanine transaminase, and aspartate transaminase. However, 
given the ubiquitous nature of these enzymes the discovery of tissue specific 
markers of damage and infection was carried out using two dimensional gel 
electrophoresis and subsequent mass spectrometry identification of protein 
spots. This analysis identified a number of potential markers of PD associated 
pathological disease. For example, enolase and aldolase were identified as 
potential markers of white muscle pathology. Validation demonstrated that 
serum increase in enolase 3 is a biomarker for pathological damage to white 
muscle. A novel diagnostic test was also discovered based on a differential 
turbidity phenomenon which occurs when diseased sera is introduced to 
optimised buffer. This assay detected pathological damage to specific tissues 
when precipitated proteins were reconstituted and subjected to electrophoresis. 
In addition, reductions in disease severity during the trial in fish fed a functional 
feed were also detectible with this test. These biomarkers may have a 
significant impact in improving the ability to diagnose pathological damage 
(clinical disease) after infection and aid in fish health monitoring programmes. 
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1. Literature Review 
1.1 Aquaculture 
Aquaculture, the rearing or cultivation of aquatic organisms for consumption is 
the fastest growing food production industry, expanding at an average annual 
rate of 8.4% since 1970 (Hall et al. 2011). This level of growth is attributed to 
not only the increasing intensity of production but also the extension of species 
within aquaculture. For example whilst worldwide production is dominated, in 
terms of tonnage, by the production of seaweed and carp species(FAO, 2012), 
extensive levels of other organisms such as salmonids, crustaceans, molluscs, 
and a number aquatic plant species are cultured. Global tonnage is dominated 
by China and the rest of Asia, attributing 61.5% and 29.5% respectively (in 2008) 
to global culture. This level of rapid growth has meant that aquaculture now 
accounts for over 50% of annual world fisheries production with expansion being 
driven by a number of factors including the reliance of an ever increasing world 
population on sustainable and reliable protein sources and dwindling wild fish 
populations due to the over exploitation of stocks (Jensen et al. 2014). Indeed 
finfish production in recent years has expanded so much that there are now over 
310 species of teleostei produced globally with an estimated 154 million tonnes 
of fish being produced in 2011, overtaking production of wild catch fisheries 
(FAO, 2012). Whilst Europe only contributes 3.6% of worldwide tonnage its 
recent growth has largely been due to the cultivation of Atlantic salmon (Salmo 
salar) in North Western Europe. 
 
1.2 Salmon Aquaculture 
1.2.1 Background and Growth 
Farming of Atlantic salmon, Salmo salar, was first successfully carried out in 
1969 where smolts which were one generation removed from wild strains were 
introduced to marine cages, grown, and harvested in 1971 by Ove and Sivert 
Grøntvedt (Gjedrem et al. 1991). This began a surge of interest in the fish as an 
economically viable livestock with culture spreading, to varying levels of 
intensities, in subsequent years to (amongst others) Scotland, Ireland, the Faroe 
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Islands, the United States of America, Chile, and Australia (FAO, 2012). 
However, arguably it was not until 1990 that the cultivation of the species 
intensified dramatically, with the next 20 years until 2010 having an average 
tonnage increase exceeding by 9.2% per annum. The ability of the industry to 
undergo such rapid expansion has been multifactorial with biological and 
engineering developments increasing productivity (Asche, 2008) and reducing 
cost to the consumer. However, salmon aquaculture faces a number of 
challenges of sustainability for such growth. Indeed recent studies, such as by 
Asche et al. (2013), have shown that productivity in Norway is actually slowing 
and as such global growth has largely been due to the acquisition of new sites in 
Chile. Therefore, a focus on further increasing productivity, thus challenging 
sustainability issues, is a massive focus area of the salmon aquaculture industry. 
 
1.2.2 Sustainability Issues 
1.2.2.1 Sustainable Growth 
Productivity and sustainability can be seen as two intrinsically linked concepts as 
without a high level of sustainability productivity cannot remain high. As such, 
there are a number of major sustainability issues that we must explore for the 
maintenance and growth of current salmon production. As mentioned previously 
one of the driving forces of recent increased production of the species by 
aquaculture has been the development of new farm sites. This is not as simple 
as simply placing nets/ cages in an area of salt water for the introduction of 
smolts for on growing and much thought must be carried out before deciding on 
a suitable site. For example, temperature has been shown to have an impact on 
the growth (Handeland et al. 2008) with optimal temperature for maximizing 
growth varying with weight. Moreover, temperature changes have been shown to 
have different effects when distinct sites are compared (Thyholdt, 2014). 
However, this study did not take into account feeding regimes, diet, or fish 
strain all of which may play a part in this complex relationship. In addition to 
temperature, other hydrographic conditions, such as salinity and currents must 
also be considered. Therefore, most production sites are located in inland 
sheltered waters (Asche et al. 2013) and while there is the possibility of 
expansion in existing areas such plans are often met with considerable 
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opposition from a number of groups, thus possibly making the availability of 
production sites, one of the most limiting factors to sustainable growth.  
 
1.2.2 Sustainable Feed 
Salmon nutrition and feed production is arguably the most complex area the 
aquaculture industry has had to face during its growth. However, it is an area 
where vast improvements have been made. Advancements in extruder 
technologies have facilitated the development of high energy diets which have 
dramatically reduced the feed conversion ratio (FCR) throughout the industry 
(Austreng, 1994; Einen and Roem, 1997; Naylor et al., 2009). In brief, FCR is the 
ratio between dry weight of feed fed to weight gain. FCR depends on specific 
diet formulations and there have been a huge improvements made throughout 
the industry with FCR ratios as low as 0.98–1.01 (Larsson et al., 2014) reported. 
Indeed salmon boast the lowest FCR of any livestock species (Naylor et al., 
2009). This has dramatically increased the productivity of salmon farming. 
However, the availability of high quality fish meal and fish oil necessary for 
salmon feed is possibly the largest issue of sustainability the industry faces short 
and long term (Tacon and Meitan, 2008; Naylor et al., 2009).  
 
In essence this concerns the amount of fish it takes to produce enough fish oil 
(FO) and fish meal (FM) to produce salmon feed and thus can be described as a 
ratio of fish in to fish out (FIFO) ratio (Tacon and Metian, 2009). Whilst this ratio 
has been significantly reduced from 7.5 to 3 between 1995 to 2011 (Bendiksen et 
al., 2011) there is considerable effort to reduce it to near to, or below, 1 due to 
the increase of economic cost of FM and FO, in addition to declining wild stock 
sources of these ingredients. The main research in reducing further this ratio has 
focused on the use of more abundantly available vegetable oil (VO) and plant 
protein (PP) (FAO, 2012), which have long been the sources of feed for 
herbivorous fish species, as partial or whole replacements for FO and FM in 
salmon feed. Indeed, recent work has shown that partial replacement, whilst 
altering gut morphology, does not appear to have any major negative effects on 
intestinal health of salmon (Moldal et al., 2014). In addition, a study by Liland et 
 Chapter 1: Literature Review  21 
 
al. (2013) demonstrated that 80% VO and 70% plant proteins resulted in a FIFO 
ratio of less than 1, with a net production of 1.3kg of Atlantic salmon per 1kg of 
FM protein. Flesh quality and growth are maintained at 75% VO without 
compromising flesh very long chain n-3 polyunsaturated fatty acid (VLCn-3 PUFA) 
content (Torstensen et al., 2005), thus indicating partial replacement of FO and 
FM may be not only be more sustainable but also have little impact on end 
product quality and productivity. However, such replacement has been shown to 
alter transcriptomic responses to infection (Tacchi et al., 2012) which may, or 
may not, have negative impacts on fish health during challenge. This is a much 
understudied area of FO and FM replacement research and it is unclear which 
replacement levels are suitable without compromising the ability of fish to 
effectively combat infection/ disease. In addition, this may prove to have a level 
of disease specific variation depending on which metabolic pathways may be 
altered. Given that disease poses one of the greatest challenges to the Atlantic 
salmon aquaculture industry (Kibenge et al., 2012) this information is 
paramount. 
 
1.3 Major Diseases of Farmed Atlantic Salmon 
1.3.1 General 
Atlantic salmon, Salmo salar, are susceptible to a number of diseases of known 
and unknown aetiology, including a number of fungal, viral, bacterial, 
ectoparasitic, and amoebic pathogens which significantly reduce productivity, 
sustainability and profitability of the industry thus limiting its growth. Whilst 
disease in aquaculture, like in all livestock industries, is a natural challenge to 
production there is evidence that the relatively short time of separation of 
domesticated species from founding wild stock may mean that high stocking 
densities cause a chronic stress which provides an opportunity for pathogens 
which are asymptomatic under normal circumstances (Kibenge et al., 2012) to 
be associated with overt disease. Stocking density has also been shown to 
increase disease severity (Bowden et al., 2002). However, this is likely to be 
infection specific and there has been little research on the topic in a farm 
setting.  
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Whilst mortality and morbidity resulting from infection and disease is highly 
variable, and dependent on a number of factors (Yousaf et al., 2013), it 
represents a major sustainability issue to the industry (Kibenge et al., 2012). 
Moreover, a serious disease outbreak may have severe repercussions for 
production not only at a given site but for the whole industry in a given 
connected area. For instance, outbreaks of infectious salmon anaemia (ISA) in 
Scotland have had serious economic impacts on the industry, with the 
eradication programmes after the 1998-1999 outbreak costing in excess of £20 
million (Hastings et al. 1999). Moreover, a more recent ISA outbreak in the 
country in Shetland (Murray et al. 2010) and that of in Chile between 2007 and 
2009 highlights the very real danger infectious disease poses to the industry 
(Ashe et al., 2010). 
1.3.2 Fungal Diseases 
Fungal infections are serious primary and secondary stressors of Atlantic salmon 
in culture and in the wild (Meyer, 1991). Whilst there are several fungal species 
which affect salmon at various life history stages (Ramaiah, 2006) the main 
threat in aquaculture is that of Saprolegnia where outbreaks affect fish in fresh 
water stages of development (Theon et al., 2011). The reason this fungal species 
remains so economically damaging is that unlike other species it has proven 
difficult to eliminate from water pumped into hatcheries (in which it is 
ubiquitous) by standard treatments available to the industry, such as filtering 
and physical treatments (Ali et al., 2014). However, fungal infections are most 
prominent after some sort of lesion has been caused due to mechanical abrasion 
or ectoparasitic damage (Huntsman, 1918). 
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1.3.3 Ectoparasitic Diseases 
Salmon are susceptible to multiple ectoparasitic infections which have a serious 
impact on productivity. Often, like in fungal infections, they are found in 
association with diseases of other aetiologies and as such can cause massive 
welfare and health issues. 
 
One of the most topical ectoparasitic infections is Neoparamoeba perurans 
which is the aetological agent of amoebic gill disease (AGD) (Crosbie et al., 
2012). Historically the disease was only a major problem to Atlantic salmon 
aquaculture in Tasmania but there has been a huge emergence of the disease in 
other geographical locations, now being present in every country where the 
species is farmed except Canada. The disease affects salmon post sea transfer 
and gross clinical signs include multifocal white patches on the gill surface and 
lamellar fusion caused by hyperplasia of epithelial and mucus cells (Nowak et 
al., 2014) thus causing reduced ability of the fish to respire. If left untreated the 
disease can become chronic causing variable levels of mortalities, therefore 
once diagnosed treatment is given using either freshwater or hydrogen peroxide 
(H2O2) baths (Adams et al., 2012). 
 
Possibly one of the most highlighted infections of cultivated salmon is that of the 
ectoparasitic sea louse species Lepeophtheirus salmonis (Krøyer) and Caligus 
elongatus Nordmann. The lice feed on the mucus and tissue of the fish causing 
sores which can cause abbresions/ lesions for secondary infections, and 
physiological problems (Heuch et al., 2011; Skiftesvik et al., 2013) costing the 
industry hundreds of millions of Euros annually (Costello, 2009). This cost 
combined with public interest and association to other infections which may 
directly transmitted, be secondary, or increase in virulence due to stress 
(Oelckers et al., 2014)  has meant that numbers of lice at a site are routinely 
assessed (Heuch et al., 2011). Indeed since 2012 in Chile a government mandate 
has meant all farms must report site numbers of lice weekly (Kristoffersen et al., 
2013), with similar reports being made in Norway and Scotland  (Heuch et al., 
2005).  Treatment of the infestation historically has been through application of 
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chemicals to delouse fish. However, these treatments have major drawbacks, 
including increasing parasite resistance (Sevatdal et al., 2005), environmental 
contamination (Davies et al., 2001; Heuch et al., 2005), detrimental effects to 
fish health (Mayor et al., 2008) and stress levels. This has led to  alternative 
means for long term lice control in aquaculture, most notably through biological 
control: studies report reductions to as low as 1 louse per fish when ballan 
wrasse  (Labrus bergylta)  are introduced at a stocking density ratio of 5% to 
salmon stock (Skiftesvik et., 2013). Such research has been so successful that 
Marine Harvest Scotland has plans for widespread introduction of the wrasse 
species into production sites after successful trials (David Cockerill, personal 
communication). 
 
1.3.4 Bacterial Diseases 
Diseases of bacterial aetiology in general terms are not a major problem in 
Atlantic salmon aquaculture compared to other pathogens and parasites 
(Johansen et al., 2011). This is possibly in part due to their comparatively short 
viability outside of their host in the marine environment, successful 
implementation of vaccines, and ever increasing levels of disease prevention 
measures taken in both fresh and sea water sites (Bornø et al., 2010; Johansen 
et al., 2013). Indeed all salmonid fish are vaccinated against vibriosis (Vibrio 
anguillarum), cold water viriosis (Vibrio salmonicida), and furunculosis 
(Aeromonas salmonicida) in Norway. However, these infections, among others, 
can still cause significant economic impacts when outbreaks occur. Indeed, 
while great strides have been made in reducing the effects of bacterial kidney 
disease (BKD) caused by R. Salmoninarumin infection in Atlantic salmon 
aquaculture in Scotland (Murray et al. 2011) it is still notifiable throughout the 
UK. Moreover, growing concern regarding pathogen exchange between wild and 
farmed salmon has highlighted the potential ecological impact of bacterial 
infections (Johansen et al., 2011). For example, bacterial kidney disease (BKD 
(Bruno, 2004), is present in both wild and farmed salmon populations, less so in 
Scotland compared to other countries (Murray et al. 2011), and despite cases 
significantly dropping in the last 15 years it still has a major economic impact in 
fresh and sea water cultivation.  
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1.3.5 Viral Diseases 
One of the biggest challenge to salmon aquaculture, in disease terms, is that of 
viral diseases (Robertsen, 2011; Kibenge et al., 2012). This is due to a number of 
factors including a lack of understanding of biology and disputed vaccine 
efficacy (Kibenge et al., 2012; Gudding and Van Muiswinkel, 2013). Moreover, 
compared with other pathogens, viruses can remain viable in the water column 
for a longer duration thus aiding their horizontal transfer and persistence within 
the marine environment. Indeed Atlantic salmon are susceptible to a number of 
viral infections causing significant economic costs due to mortality and 
morbidity. In addition, there is a growing interest in the economic and ecological 
impact of disease interactions between farmed and wild populations (Walker and 
Winton, 2010; Robertsen, 2011; Kibenge et al., 2012; Gudding and Van 
Muiswinkel, 2013; Madhun et al., 2014). The main viral diseases which challenge 
industrial profitability and the local and global scale culture of Atlantic salmon 
are detailed in table 1-1. 
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Table 1-1 Major viral diseases of Atlantic salmon. Table of the six major viral 
diseases of Atlantic salmon, salmo salar, aquaculture. 
Disease Aetological Agent Family 
Pancreas Disease (PD) Togavirus: salmonid alphavirus 
(SAV) 
Togaviridae 
Infectious salmon 
anaemia (ISA) 
Orthomyxovirus: infectious 
salmon anemia virus (ISAV) 
Orthomyxoviridae 
Infectious pancreatic 
necrosis (IPN) 
Birnavirus: infectious  
pancreatic necrosis virus 
(IPNV) 
Birnaviridae 
Infectious 
hematopoietic necrosis 
(IHN) 
 
Infectious hematopoietic 
necrosis virus (IHNV) 
 
Rhabdoviridae 
Heart and skeletal 
muscle inflammation 
(HSMI) 
 
Piscine orthoreovirus (PRV) 
 
Reoviridae  
Cardiomyopathy 
syndrome (CMS) 
Piscine Myocardiopathic Virus 
(PMCV) 
Totiviridae 
 
 
 
 
 
 
 
 
 
1.3.5.2 Infectious salmon anaemia (ISA) 
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Infectious salmon anemia (ISA) is caused by infection of the negative sense 
segmented ssRNA orthomyxovirus, infectious salmon anemia virus (ISAV) (Walker 
and Winton, 2010). This notifiable disease is characterised by anemia but other 
clinical signs and pathological damage can be variable (Aamelfot et al., 2014), 
with some affected fish exhibiting circulatory disturbances to a number of 
organs with widespread haemorrhaging in addition to changes in appearance and 
shape of the spleen, swim bladder, muscle and other tissues (Rimstad et al., 
2011). However, whilst in most cases where severe anemia is observed there are 
necrotic lesions to the liver, gut and or kidney (Rimstad et al., 2011), some 
individuals may still not have any pathological damage at all. This variability is 
thought to be due to individual variance in the ability to cope with hypoxic shock 
(Aamelfot et al., 2014). There are also significant differences in ISAV isolates 
which may also explain the degree of variation in clinical and pathological 
changes observed in infected salmon (Markussen et al., 2008). Prevalence of the 
disease, compared to others, is relatively low (Robertsen, 2011): in 2012 only 
two cases were recorded in Norway (Johansen, 2012) with Canada being the only 
other country affected by the disease (OIE, 2012). In addition, mortality rates 
during ISA are epidemic dependent with a daily mortality rate from 0.05% to 
0.1% (Aamelfot et al., 2014). Despite this, it is one of the most economically 
important diseases of Atlantic salmon in aquaculture as failure to diagnose the 
infection/ disease quickly and implement disease management strategies can 
result in mortality of  >80% at a given site (Aamelfot et al., 2014). Such high 
mortalities in a localised area become an even greater problem when poor bio-
security, such as movement of infected fish, causes an epidemic on a massive 
scale. This is typified by the ISA outbreak in Chile from 2007 to 2009 which 
caused a 60% reduction of production in the country (Kibenge et al., 2012). This 
outbreak was thought to be the result of importation of Norwegian broodstock 
which were infected with a virulent strain of ISA leading Vike et al. (2009) to 
stipulate that vertical transmission of the virus was possible. However, this 
evidence is anecdotal at best and it is just as parsimonious that these broodstock 
were infected via contamination of ovarian fluids (Aamelfot et al., 2014) which 
is also a form of horizontal transmission. The problem was almost certainly made 
worse by the introduction of more fish into the system in infected areas to try 
and offset losses. This outbreak is a classic example of how much of an impact 
poor biosecurity, and disease management can have on the industry. 
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1.3.5.2 Infectious pancreatic necrosis (IPN) 
Infectious pancreatic necrosis (IPN) is a major problem in rainbow trout 
(Oncorhynchus mykiss) and Atlantic salmon in both fresh and sea water 
environments (Kibenge et al., 2012; Johansen 2013). Its aetiological agent, 
infectious pancreatic necrosis virus (IPNV), is a non-enveloped double stranded 
RNA virus belonging to the Birnaviridae family (Crane and Hyatt, 2011) 
comprising a number of serotypes of varying virulence (Santi et al., 2004) 
belonging to two distinct serogroups (Kibenge et al., 2012). The virus has proven 
extremely difficult to eradicate, despite it being the most intensively studied of 
all fish viruses (Crane and Hyatt, 2011), due to its ability to withstand many 
treatments and tolerate high temperatures and varying pH levels (Kibenge et al., 
2012). This, coupled with the wide array of hosts the virus is able to be establish 
itself within (Hill, 1982) and shedding from individuals recovered from clinical 
disease (Smail and Munro, 1985), makes the virus extremely difficult to 
eradicate from the environment. Indeed IPNV outbreaks are more common than 
those of any other viral infection in Norway (Robertsen, 2011; Johansen et al., 
2013). However, fish possess a high level of immunity to IPNV (Robertsen, 2011) 
meaning that outbreak mortality rate is usually low. Culling and fallowing have 
been shown to be effective in reducing prevalence in Sweden and Scotland. 
However, such control measures are extremely expensive and the economic 
impact of the disease in the major Atlantic salmon producing countries is more 
usually addressed by vaccination of smolts prior to sea transfer. 
 
 
 
 
 
1.3.5.3 Cardiomyopathy syndrome (CMS) 
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Primarily a disease of large adult fish (Kibenge et al., 2012; Johansen, 2012) 
cardiomyopathy syndrome (CMS) is characterised by necrosis of the heart where 
the atrium becomes enlarged and rupturing to the atrium occurs as well as filling 
of the pericardial sac with blood (Ferguson et al., 1990). There have also been 
reports of occasional pancreas and muscle lesions being observed in some 
individuals (Johansen, 2012). Despite being first described as a disease of farmed 
salmon in 1985 it was not until 2011 when its aetiological agent piscine 
myocardiopathic virus (PMCV) was first described by Haugland et al. (2011). 
However, little is known about the pathogenesis of the disease and, despite 
some reports of PMCV in wild salmon populations, whether there are any CMS 
disease interactions between farmed and wild fish (Johansen, 2012). 
 
1.3.5.4 Heart and skeletal muscle inflammation (HSMI) 
First identified in a production site in Norway in 1999 heart and skeletal muscle 
(HSMI) is a major disease of farmed Atlantic salmon, among others, in Norway, 
Scotland, and Chile (Kongtrop et al., 2004; Ferguson et al., 2005).  Indeed HSMI 
is an emerging problem with the disease spreading to new areas causing case 
numbers to dramatically rise in number in recent years (Bornø et al., 2010; 
Robertsen, 2011; Johansen, 2012). This horizontally transmitted disease is 
caused by Piscine orthoreovirus (PRV) (Palacios et al., 2010) and usually affects 
Atlantic salmon five to nine months after sea transfer (Kongtrop et al., 2004). 
While morbidity is high with fish showing a number of histopathological changes 
to the heart, red muscle and other tissues, disease associated mortality is 
relatively low with external stressors having a major role in disease outcome. 
Interestingly despite a clear correlation in literature between PRV load and gross 
pathological damage (Johansen, 2012). It has also been shown that fish may be 
infected with PRV for a long period of time before any clinical signs are observed 
(Wiik-Nielsen et al., 2012) and that the viruses presence may not necessarily 
result in disease (Johansen, 2012). 
 
1.3.5.5 Infectious hematopoietic necrosis (IHN) 
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Traditionally thought of as a disease of salmonid species belonging to the 
Oncorhynchus genus, such as sockeye salmon, Oncorhynchus nerka, Chinook 
salmon , Oncorhynchus tshawytscha, and cultured rainbow trout, Oncorhynchus 
mykiss (Traxler et al., 1993), infectious hematopoietic necrosis is caused by 
infection by the rhabdovirus infectious hematopoietic necrosis virus (IHNV) which 
is epizootic throughout western North America. The disease is spread 
horizontally in both fresh and saltwater production causing extensive 
haemorrhage and necrosis of a number of organs due to acute viraemia (Wolf, 
1988). Infectious hematopoietic necrosis (IHN), due to a combination of factors 
has spread to a number of different species and regions (Crane and Hyatt, 2011). 
Introduction of Atlantic salmon in these regions has compromised production. 
Indeed this species (Salmo salar) has been shown to be extremely susceptible to 
the virus with high levels of mortality observed during outbreaks (Saksida, 2006). 
This increased virulence may be due to a lack of exposure historically to the 
pathogen with genetic factors cited as playing a role in disease severity (Miller 
et al., 2004). For instance, an epidemic from 2001-2003 caused a cumulative 
mortality, of direct mortality and culling for disease control, of over 12 million 
Atlantic salmon in British Columbia (Saksida, 2006) causing significant economic 
losses to the industry as a whole. Whilst IHN is not a disease problem in the 
major Atlantic salmon producing regions (Norway, Chile, Scotland, or Ireland), 
the observation of spread to European rainbow trout means that considerable 
caution is now taken. Vaccination has proved to have little or no protection 
during IHN outbreaks (Saksida, 2006) which is a growing concern not just in IHN 
but with other viral diseases. 
 
 
 
 
 
 
1.4 Pancreas Disease (PD) 
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1.4.1 General 
First discovered in 1976 and characterized by Munro et al. (1984) and McVicar et 
al. (1987), pancreas disease (PD) of Atlantic salmon, Salmo salar, is a major 
problem to the cultivation of the species in Norway, Scotland, and Ireland. In 
addition, the disease has been described in a number of other countries, such as 
North America (Kent and Elston, 1987), France, and Spain (Raynard et al., 1992). 
Moreover, whilst the disease has not yet been described in Chile given the 
previous cases of disease spreading due to fish transfer from different countries 
there is significant monitoring for PD in the country. The disease is characterized 
by a number of behavioural and histopathological changes such as reduced 
appetite (McVicar, 1987) and a tendency for infected fish to stay close to cage 
corners, along with acute necrosis of the pancreatic acinar cells, lesions in the 
heart, and skeletal lesions (depending on the time period since infection). 
Occasionally lesions in the kidney, liver and brain can also be observed (McVicar, 
1987; McLoughlin and Graham, 2007). This histopathological damage can, in 
some cases, be extremely severe causing long term morbidity effects such as 
runting and reduced fillet quality upon harvest due to the chronic effects of 
pathological damage and a reduced ability to uptake nutrients due to pancreas 
damage (Lerfall et al., 2012; Larsson et al., 2012). While direct economic effects 
of any disease are difficult to estimate with variability between years and sites 
(Johansen, 2012), PD is one of the most economically important diseases 
affecting the industry.  
 
1.4.2 Economic Costs of Pancreas Disease 
The economic losses attributed to PD are substantial. For instance, in Ireland 
during 2003-2004 around €12 million was lost due to the disease (Ruane et al., 
2008). In addition, analysis of industrial records in Scotland from 1998 to 2009 by 
Kilburn et al. (2012) indicate that despite negligible impact of PD pre 2003 it 
accounted for the greatest level of biomass losses of any infectious disease in 
aquaculture. Arguably the country most affected by the effects of pancreas 
disease is Norway where direct costs of the disease for an average farm are 
estimated to be 14M Norwegian Krone (NOK) (Aunsmo et al., 2010). Indeed the 
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virus has been shown to be spreading to new areas and is still an emerging 
problem (Rimstad, 2011) highlighting the need for a better understanding of 
disease pathogenesis and the development of diagnostic tools for quick 
implementation of disease management strategies. Case numbers of the disease 
in Norway rose from 5 in 1995 to 109 in 2008, in part due to improvement of 
screening methods post identification of the aetiological agent by Weston et al 
(2002).  
 
1.4.3 Alphaviruses 
The aetiological agent of pancreas disease, salmonid alphavirus (SAV), was first 
described by Weston et al. (2002) and has also been shown to cause sleeping 
disease (SD) in trout (Crane and Hyatt, 2011).SAV belongs to the genus 
Alphavirus (family Togaviridae), known to consist of 26 species which in turn 
consists of numerous strains or subtypes (Strauss and Strauss, 1994) which are 
closely related in terms of molecular characteristics and structure (Strauss and 
Strauss, 1994; Powers et al. 2001). All Alphaviruses share a minimum amino acid 
sequence identity of around 45% in structural proteins (which are more 
divergent) and about 60% in non-structural proteins (Strauss and Strauss, 1994). 
Within species, diversity seems to be directly linked with the dispersal potential 
of the host species, for example Venezuelan equine encephalitis (VEE) complex 
viruses which primarily use rodent hosts and Culex mosquito species as vectors 
(which themselves have limited dispersal) tend to show high levels of diversity 
(Powers et al., 2001) when compared to Alphavirus species which use birds as 
hosts (Sammels et al., 1999).  
 
Alphaviruses are small and spherical in structure with a genome consisting of a 
single strand of positive sense RNA of approximately 11.7Kb long which possesses 
multiple copies of a single species of capsid protein of approximately 30kDa in 
weight (Powers et al., 2001; Straus and Straus, 1994). The virion envelope found 
in all Alphaviruses consists of a lipid bilayer (assembled using lipids derived from 
the plasma membrane of the host cell) with multiple copies of two encoded 
glycoproteins, E1 and E2, embedded within this bilayer (Harrison, 1986). Non-
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structural protein genes are encoded in the 5’ two thirds of the genome, which 
are labelled nSP1 to nSP4 in Figure 1.1, while structural proteins are translated 
from subgenomic mRNA at the 3’ terminal third of the genome.  
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Figure 1.1: Alphavirus genes and functions. Simple diagram of Alphavirus genome with gene functions and associated functions 
indicated. Taken and altered from Powers et al., 2001. 
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Traditionally it has been thought that the genus arose around several thousand 
years ago (Weaver, 1993; Weaver et al, 1993). However, a more recent 
phylogenetic study carried out by Powers et al, (2001) has clearly shown that 
this estimate is far too recent, whilst re-demonstrating that the viruses most 
probably arose as insect borne or insect viruses. Interestingly this work has 
shown that salmonid alphavirus (SAV) and the recently discovered (La Linn et 
al., 2001) southern elephant seal alphavirus (SESV) do not fit into the widely 
accepted hypothesis that the genus that we see today originated in the New 
World from a an insect-borne plant virus (Levinson et al., 1990; Weaver et al., 
1993; Weaver, 1995) and instead neither this hypothesis nor one in which the 
genus would have originated in the Old World as it would be equally 
parsimonious for either origin for these two species.  
 
The way in which Alphaviruses replicate is also of great interest as although they 
can replicate within the cytoplasm with virions becoming mature by budding 
through the plasma membrane where the glycoproteins E1 and E2 are 
assimilated of both their arthropod vectors and their vertebrate hosts (Strauss 
and Strauss, 1994; Powers et al., 2001). Lifelong infection can be observed can 
be observed in arthropods where infected cells survive and continue to produce 
virus at low levels. In contrast cytolytic infection is produced in vertebrate cells. 
Numerous cell culture experiments have shown in great detail the conditions in 
which Alphaviruses thrive and have highlighted that in vector enucleated cells 
virus replication is extremely low (Erwin and Brown, 1983), but when vertebrate 
enucleated cells are infected virus replication is almost normal. This seems to 
demonstrate that nucleated cells are not pivotal in virus proliferation within the 
terminal host, however, surprisingly when a virus is within such a cell around 
half of nsP2 produced after infection is transported to the nucleus (Peranen et 
al., 1990). As stated previously all Alphavirus species have been shown to be 
arthropod- borne where in typical terrestrial systems various mosquito species 
are used by the viruses to reach their vertebrate host (Strauss and Strauss, 1994; 
Powers et al., 2001; Weston et al., 2002). However, to date no SAV intermediate 
host has been identified and instead its ability to remain viable in the water 
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column for long periods of time (Graham et al., 2007) is thought to aid in wide 
dispersal and horizontal transfer (Viljurgen et al., 2009). 
 
1.4.4 History of Salmonid alphavirus Taxonomy 
Before 2008 it was thought that salmonid alphavirus species consisted of three 
subtypes (Hodneland et al., 2005; Weston et al., 2005; Hodenland and Endresen, 
2006; Karlsen et al., 2006; Graham et al., 2007), SAV1, SAV2 and SAV3. SAV 
Subtype 1 (SAV1) is the causal agent of pancreas disease in Atlantic salmon, 
Salmo salar L., farmed in Scotland and Ireland and was the first SAV to be 
isolated (Nelson et al., 1995). Sleeping disease in trout species, primarily 
rainbow trout, Oncorhynchus mykiss, was shown to be caused by infection with 
subtype named SAV2 or SDV (sleeping disease virus) (Villoing et al., 2000; 
Graham et al., 2007). In contrast, Norwegian isolates belonged to a third distinct 
subtype named SAV3 or Norwegian salmonid alphavirus (Weston et al., 2005; 
Hodneland et al., 2005). It is important to note that both SAV1 and SAV3 may be 
referred to as SPDV, salmon pancreas disease virus. 
 
A short time before the isolation of the causal agent of pancreas disease or 
sleeping disease it had been demonstrated that histological lesions of the 
pancreas, muscle and heart in their respective hosts were common features 
(Boucher and Baudin-Laurencin, 1996). However, it was not until isolates had 
been taken of these aetiological agents in 1995 (Nelson et al., 1995) and 1997 
(Castric et al., 1997) respectively that further analyses could be carried out. 
Welsh et al. (2000) demonstrated in a comprehensive study, which followed on 
from initial work which identified SPDV as the first fish alphavirus found (Weston 
et al., 1999), shared many of the characteristics of animal alphaviruses in terms 
of its RNA composition and protein. Meanwhile, Villoing et al. (2000) 
characterized SDV as an alphavirus. A comparative study was then carried out 
using the complete genomes of SPDV and SDV which demonstrated that they 
shared 91.1% complete sequence identity, with 95% amino acid identities over 
their non-structural proteins and 93.6% at their structural proteins (Weston et 
al., 2002). In addition, Weston et al. (2002) also showed by viral neutralization 
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tests with sera from artificially infected salmon indicated that SPDV and SDV 
were closely related isolates of the same species and the name salmonid 
alphavirus was proposed. It was not until 2005 that a distinct SPDV strain was 
isolated from Salmo salar in Norway (Hodneland et al., 2005) and named 
Norwegian salmonid alphavirus (NSAV) or SAV3 due to its possession of 91.6 and 
92.9% nucleotide sequence identity to SAV1 and SAV2 respectively, host species 
and the pathological changes caused. However, more recently Fringuelli et al. 
(2008) demonstrated through phylogenetic and molecular epidemiological work 
on SAV which was based upon partial E2 and nsP3 gene sequences that there 
exists six distinct SAV subtypes which vary in geographical location (see Table 1-
2). Isolates were obtained for the study (Fringuelli el al. 2008) from clinical 
samples of either heart or serum (either from associates’ archived or new 
samples), except for three strains which were CHSE-214 cell culture. This was in 
order to minimize the risk of false results due to substitutions in the genomic 
sequences which has been shown to occur (Karlsen et al., 2006) during SAV 
passage through cell culture (the three strains, French strains EE37 and VF03 and 
the Scottish strain F02-85 which were developed in cell culture were examined 
after two, four and five passages to check for substitutions). Phylogenetic 
analyses were carried out by unrooted neighbour joining trees and parsimony 
methods created using nsP3 and E2 gene fragment amino acid sequences 
independently and resulted in a high degree of agreement between the two with 
the classification of each strain remaining constant within both clusters 
(Fringuelli et al., 2008). The three new identified subtypes (SAV4, SAV5, and 
SAV6) have significantly added to our understanding of salmonid alphavirus 
species. SAV4 was identified in samples from both Ireland and Scotland, and 
interestingly two isolates of this subclass (91-115 and 91-116) came from salmon 
raised in a farm in Donegal (Ireland) where SAV1 was also isolated (from 1993 
samples) showing the presence of two subclasses in one farm in as many years 
suggesting two separate introductions of infection. SAV5 was described as 
endemic to Scotland as only samples from Scottish farms contained the subclass, 
whilst only one isolate (F/1045/96) fell into the SAV6 subclass which came from 
a PD outbreak in Connemara (Ireland), 1996.  
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1.4.5 SAV Subtypes: Geographical Location and Differences 
These six identified SAV isoforms differ not only in their genetic sequence but 
also in their geographical location, the species which they infect and disease 
they cause (McLoughlin and Graham, 2007; Graham et al., 2011; Hjortaas et al., 
2012). Table 1-2 shows this information of all isotypes which affect Atlantic 
salmon and trout. It is important to note that SAV 2 has also been shown to 
infect freshwater brown trout, Salmo trutta, causing sleeping disease (SD) but 
the main species affected, in economic terms, is rainbow trout (McLoughlin and 
Graham, 2007). 
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Table 1-2: The six subtypes of SAV. Table showing the six distinct isoforms of 
salmonid alphavirus (SAV) that affect farmed salmonids with the environment 
and location in which they occur as well as the species affected and the disease 
caused in these. 
Isotype Environment Species 
Affected 
Disease Geographical Location 
SAV1 Sea Water Atlantic 
Salmon 
PD Ireland, Scotland 
 Fresh Water Rainbow 
trout 
PD Scotland 
SAV2 Sea Water Atlantic 
Salmon 
PD Scotland, Norway 
 Fresh Water Trout SD UK, France, Spain, France 
Italy, Germany, Croatia 
SAV3 Sea Water Atlantic 
Salmon 
PD Norway 
 Sea Water Rainbow 
trout 
PD Norway 
SAV4 Sea Water Atlantic 
Salmon 
PD Ireland, Scotland 
SAV5 Sea Water Atlantic 
Salmon 
PD Scotland 
SAV6 Sea Water Atlantic 
Salmon 
PD Ireland 
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The distribution of the different SAV strains is interesting in that they not only 
differ in the countries in which they are distributed but also there is 
considerable separation between regions within a country. For instance, in a 
comprehensive study of historical data of PD and SD infections in Scotland and 
Ireland by Graham et al. (2012) there was shown to be a regional separation in 
the most prominent subtype. This was most apparent in Scottish data with SAV1 
being the most prevalent isotype in Argyll and Bute, SAV2 the main aetiological 
agent of PD in Shetland and Orkney, and SAV4 and SAV5 prevailing in the 
southern and northern Western Isles respectively.  
 
For a long time SAV3 had thought to be the only SAV strain present in Norway 
causing PD in marine reared Atlantic salmon and rainbow trout, being endemic 
to the country. However, SAV2 was recently identified in the north-western part 
of the country (Hjortaas et al., 2013) and, despite being initially thought not to 
be widespread in  Norwegian aquaculture, has now been identified at a number 
of new sites in the past year leading to the establishment of an SAV2 endemic 
zone (Jansen et al., 2014). This zone is just north of the long established SAV3 
endemic region and interestingly there appears to be a clear separation in 
geographical location of observations of marine SAV2 and SAV3 with SAV3 
occurring more in the South, although there does appear to be a spreading of 
SAV2 and given that many sites in the SAV3 endemic region do not subtype 
isolates it is possible SAV2 is becoming ever more prevalent. This analysis also 
demonstrated temporal differences in prevalence, with marine SAV2 being most 
prominent in October and November in contrast to SAV3 which is routinely 
identified between February and July, where its identification peaks, but is 
almost absent later in the year, thus indicating some variation in the properties 
of SAV subtypes. 
 
Indeed, Jensen et al. (2014) identified lower associated mortality and lower 
severity of clinical signs when PD was caused by SAV2 infection when compared 
to SAV3. This finding is supported by a previous experimental trial by Weston et 
al. (2002) reported that, Atlantic salmon were infected with SDV (now known to 
be SAV2), they had less severe lesions in a number of tissues compared to when 
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they were infected with SPDV (it is unclear which specific subtypes were used). 
Moreover, in a comprehensive infection challenge trial carried out by Graham et 
al. (2011) the effects of infection with the six known SAV subtypes were 
recorded. This study identified differing levels of PD associated pathological 
damage to tissues with SAV1 and SAV3 causing the most severe, followed by 
subtypes 4 and 5, but SAV2 and SAV6 causing mild histopathological changes. 
Similarly, viral loads in the heart tissue, determined by RT-PCR, found that 
subtypes 1 and 3 had the highest load, SAV4 and SAV5 had possessed 
intermediate levels with SAV2 and SAV6 the lowest. These results indicate 
carrying levels of virulence in SAV strains and also found varying rates of 
horizontal transfer within treatment groups. 
 
1.4.6 Virus Transmission and Biophysical Properties 
The salmonid alphavirus species is a typical alphavirus in terms of its structure 
and genome (see figure 1-1) (Powers et al., 2001; Weston et al., 2002), 
however, subtle differences have been highlighted between SAV and other 
described alphaviruses. The study in which the species name was proposed 
(Weston et al., 2002) discovered that subtypes SAV1 (SPDV) and SAV2 (SDV) when 
compared to other alphaviruses share only 41.7 to 43.6% sequence identity 
within their non-structural polyprotein and just 31.3 to 33.7% in their structural 
polyprotein. These values are much less than those observed when amino acid 
identities between the mammalian alphaviruses are compared. Despite this, SAV 
sequences do possess most or all of the conserved sequence elements which are 
believed to play an important role in virus replication and life cycle (Weston et 
al., 2002). Possibly the most significant difference between the salmonid 
alphavirus species (and its subclasses) and other alphaviruses is that, until now, 
the intermediate host which it uses has not been agreed (Powers et al., 2001; 
Snow et al., 2010). 
 
Two invertebrate species which have been studied in order to identify the 
intermediate host the bivalve mollusc mytilus edulis (mussel) and the arthropod 
Lepidophthirus salmonis (sea louse). Experimental infection of mussels was 
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carried out in the University College of Cork (Graham et al., 2008) and tissue 
samples taken from individuals over a 20 day period for RT-PCR SAV screening to 
test if the mussels were virus positive. The results from this study showed that 
whilst 40% of gills and 60% of hepatopancreas samples were positive at day zero 
(immediately after infection); by day five post infection no tissue samples were 
positive. Such a short duration of positivity of SAV in mussel tissues shows that 
the alphavirus is unable to establish an infection within the host to proliferate, 
thus positive results at days zero, two and three were due to bioaccumulation 
and contamination meaning that they pose no threat to salmonoids in terms of 
harbouring the virus. It is also plausible sea lice are an intermediate host of the 
virus as Atlantic salmon that show the clinical/ behavioural signs of pancreas 
disease often have a higher than average sea lice burden (Rodger and Mitchell, 
2007). In addition, another recently discovered aquatic alphavirus SESV 
(Southern Elephant Seal Virus) has been shown to be transmitted to the seal via 
the seal louse Lepidophthirus macrohini (Linn et al., 2001). Despite this, the 
literature is not fully in agreement on whether sea lice are the intermediate 
host of SAV or even if an intermediate host is involved in SAV transmission. For 
instance, in Norway SAV3 has been reported in lice using the RT-PCR method of 
identification (Petterson et al., 2009), whilst Weston et al. (2005) and Karlsen et 
al. (2006) have also described sea lice as a possible vector. Rodger and Mitchell 
(2007) studied the link between PD and sea lice infestation in Ireland in which 
they found a significant link from data collected in 2003, which may suggest lice 
are a vector of SAV. However, the study also used data from 2004 in which no 
significance was found. Therefore, given that evidence for a sea lice vector of 
SAV transmission is minimal it is not generally thought to be the major 
transmission route, if at all.  
  
The possibility of vertical transmission, from broodstock and eggs and fry has 
also been studied in response to the reporting of SAV2 vertical transmission 
(cited as personal communication by J. Castric in McLoughlin and Graham, 2007; 
Kongtorp et al., 2010) and SAV3 infection discovered at a smolt producing site in 
Norway (Nylund et al., 2003). However, natural outbreaks of PD have only been 
reported in the seawater phase (McLoughlin and Graham, 2007) and information 
regarding vertical transmission of freshwater SAV2 in rainbow trout has not been 
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published. In light of this, it would seem that if vertical transmission does occur 
its impact would be negligible with horizontal transmission being by far the most 
important cause of viruses spread (Rodger & Mitchell, 2007; Fringuelli et al., 
2008; Kristoffersen et al., 2009; Bratland and Nylund, 2009). It has recently been 
shown that shedding of SAV into the environment is directly linked with viraemia 
(Andersen et al., 2010). Moreover, natural outbreaks of PD in Atlantic salmon 
have only been reported in the seawater phase of production. In light of this, it 
would seem that if vertical transmission does occur its impact would be 
negligible, with horizontal transmission being by far the most important means 
of virus spread with shedding of mucus and faeces being recently described as 
transmission routes for SAV. 
 
It has been shown that SAV can be spread directly from fish to fish (primary host 
to primary host) through shedding and in faeces (McLoughlin et al., 1996; 
Andersen et al., 2010). Furthermore, it has recently been shown that virus is still 
present in organ tissues many months after an individual is infected with SAV 
(Graham et al., 2010) which could hypothetically be transmitted. This may not 
only explain why susceptibility to and severity of PD increases with higher 
stocking densities of cages and farms (Tri Nations Report, 2005) but may also 
point to wild fish stocks acting as a reservoir. This hypothesis of a wild reservoir 
has also been concluded from evidence that SPDV tends to recur in successive 
generations of Oncorhynchus mykiss when they are introduced into areas where 
SAV has previously been discovered, even if thorough management practices 
have been implemented, such as fallowing (McLoughlin and Graham, 2007). It is 
of course the possible that SAV-like species are naturally found in marine and 
freshwater environments (which is the recent ancestor of the species described 
in aquaculture), but is also possible that fish farms have led to the establishment 
of potential reservoirs of re-infection, with wild infected fish passing the virus 
on to farmed stock via shedding and in faeces. However, despite SAV not yet 
being isolated from wild salmonids (Graham, 2005) Snow et al. (2010) has 
recently detected alphavirus RNA in wild marine fish. In this study screened fish 
were caught close to the Shetland Isles (Scotland), with screening carried out 
using RT-PCR assay targeting a region of the SAV nsP1 gene. Screening of SAV 
presence in tissues by qPCR has shown that the virus is able to persist for long 
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periods of time in kidney and heart tissue of Atlantic salmon (Graham et al., 
2010). Positive SAV presence was also found in flatfish species; long rough dab 
Hippoglossoides platessoides, common dab Limanda limanda, and plaice 
Pleuronectes platessa. Following these results sampling was extended to 
Stonehaven bay (Scotland) where heart tissue samples tested positive from 
common dab. Analysis of the nucleotide sequences obtained (from further 
sequencing of the E2 gene region) has revealed minor differences between the 
strains found in the study and previously sequenced subclasses of SAV found in 
farmed salmon and trout, with SAV isolates found in wild fish most closely 
related to SAV subtype 5. However, it is at present unclear if there are any PD or 
SD disease interactions between a wild fish reservoir and farmed salmonids. 
 
Interestingly Graham et al. (2007) has shown that SAV1 is able to survive in 
sterile sea water for up to two months at lower temperatures. This information 
suggests that in favourable conditions the virus could spread between cages or 
even farm to farm without any animal host. In light of this the first statistical 
model on the spread of PD in salmon farming to incorporate hydrodynamics as a 
causal agent (by carrying the virus) was developed by Voljurgein et al. (2009). 
Despite the possession of a limited dataset, it was demonstrated that SAV in the 
marine environment is transmitted via water currents by passive drift and thus 
could be used, with knowledge of local water contact relationships, to predict 
and thus implement targeted control measures to limit the impact caused. More 
recent analysis of hydrodynamics and transmission dynamics cites water 
movement as the largest contributor to transmission of the virus over contact 
networks (i.e. distance and sharing of equipment) (Stene et al., 2014). 
Therefore, while little can be done to prevent spread from farm to farm, which 
are connected in terms of water movement, elevating the detrimental effects of 
PD, and indeed any other disease, is reliant on both rapid detection of the virus/ 
disease and the implementation of  disease management strategies. 
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1.5 Diagnostic tools and Disease Management Strategies 
1.5.1 General 
The armamentarium for diagnosing infection and disease in finfish aquaculture 
has grown significantly in recent years (Adams and Thompson, 2014). However, 
many novel methodologies are not implemented widely for a number of reasons 
such as being too expensive and the need for a high level of skill. Therefore, the 
industry, in the main, relies on a select few diagnostic tools to diagnose 
infection and disease. In terms of salmonid aquaculture the industry relies on 
virus isolation, PCR, serology, gross pathology, and histopathology for diagnosing 
viral disease and infection (McLoughlin and Graham, 2007; Jansen et al., 2010; 
Adams and Thompson, 2011; Adams and Thompson, 2014). These diagnostic tools 
have increased in use as the salmon aquaculture industry moves away from 
reliance on behavioural signs of disease to a more proactive approach. However, 
despite all of their advantages each of these approaches has limitations, out 
with technical drawbacks such as sensitivities and risk of false positives, which 
shall be discussed. 
 
1.5.2 Virus Isolation 
Virus isolation in cell culture is a well-established tool for identifying viral 
infection in salmonids where the aetiological agent is isolated traditionally from 
tissues (Christie at al., 1998; Graham et al., 2003). Following initial isolation a 
number of downstream applications can be used for identifying viral particles 
such as immunostaining techniques with virus specific monoclonal antibodies 
(mAbs) (Todd et al., 2001) for visualization of the virus in culture. However, 
such immunostaining is qualitative or at best semi-quantitative for viral load and 
relies on the aetiological agent being well defined. Moreover, it relies on the 
availability of specific mAbs to the virus which if not commercially available are 
both expensive and time consuming to produce. Viral load can be determined at 
a quantitative level by viral titre tests which are common place using most 
commonly cytopathic effect (CPE) (Knüsel et al., 2007) or alternatives such as 
heterologous interface (Desvignes et al., 2002). However, during cell culture 
there can be a number of contamination factors and relies on standardized 
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procedures between labs for trusted industrial data. Moreover, virus isolation 
from tissues is destructive, meaning that the nature of sampling causes a 
reduction in benefit of early diagnosis due to economic costs of the technique. 
This limitation is somewhat overcome by the use of non-destructive virus 
isolation through the use of blood derived sera (Jewhurst et al., 2004). Despite 
this, there is a comparatively short time window when viruses can be detected 
in the humoral system (viremic stage) requiring early sampling after an infection 
event. Furthermore, tests such as virus isolation from either tissue or sera can 
only indicate infection which may or may not necessarily result in clinical 
disease (Johansen, 2012). 
 
1.5.3 Polymerase Chain Reaction (PCR) 
By far the most common molecular method for determining the presence of a 
given virus is polymerase reaction (PCR) (Adams, 2009; Adams and Thompson, 
2011; Adams and Thompson; 2012). Reverse transcription-polymerase chain 
reaction (RT-PCR) is well established as a diagnostic tool for a number of 
infections in salmonids demonstrating a higher sensitivity than direct virus 
isolation (Knüsel et al., 2007). There have, for example, been numerous 
conventional RT-PCR tests used to detect SAV which amplify various regions of 
virus RNA (McLoughlin and Graham, 2007) with conventional methods being 
qualitative (Villoing et al., 2000) whilst more recently developed methods allow 
for quantitative results of viral load in an individual (Christie et al., 2007). RNA 
extraction for this methodology is most commonly carried out using tissues with 
the heart the best source of this when testing for presence of SAV as it can 
remain positive for the longest period of time, at least until 140 days post 
infection (Christie et al., 2007). Such sampling is of course destructive and thus 
other sampling methods have been investigated. Successful SAV RNA isolation is 
possible from serum, although similarly to virus isolation can only be detected 
for a short period of time post-infection. Interestingly another non-destructive 
source of viral RNA can be found in faeces and mucus (Graham et al., 2011). 
Despite the study only testing for a positive signal in these fluids in groups 
infected with isotypes 1, 3 and 6 it would be expected in infections with the 
others as these are thought to be transfer routes. However, persistence did not 
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seem to be longer than in previous studies which tested serum (Christie et al., 
2007). The use of specific probes for amplification also has positive aspects in 
that specific typing can be carried out (subtype specific) but is limited by the 
need for aetiological agent being clearly defined, thus for diseases of unknown 
aetiology may not be applicable. 
 
1.5.4 Serology 
While virus isolation and PCR tests are diagnostic tools for direct pathogen 
detection, serology is an alternative methodology of identifying infection by 
identifying specific antibodies in serum (Adams and Thompson, 2011). This 
methodology is not well established in finfish aquaculture except for in PD 
where the presence or absence of specific virus neutralizing (VN) antibodies is 
tested (McLoughlin et al., 1996) and has advantages over virus isolation and 
molecular methods as immunoglobulins persist in the humoral system much 
longer. However, there appears to be variation in the time taken for 
seroconversion (presence of VN antibodies) depending on the infectious isotype 
(Graham et al., 2011), thus meaning that clinical disease may already have 
occurred before identifying a sample positive for antibody. In addition, 
serological tests cannot distinguish presence of antibody between infected and 
vaccinated fish (Adams and Thompson, 2011). Given that vaccination against PD 
is commonplace in Atlantic salmon aquaculture means this is a potential 
problem. Moreover, as with virus isolation and PCR tests previously discussed, 
serology requires aetiology to be well defined and presence of VN antibodies due 
to infection may not necessarily indicate clinical disease. 
 
1.5.5 Gross Pathology 
Gross pathological signs of disease are those that can be identified through 
macroscopic assessment of a tissue or body cavity. Such assessment is an 
important on site means of assessing general fish health and is carried out 
routinely. Possibly one of the best examples of this is the non-destructive 
assessment of gill health for the diagnosis and monitoring of AGD. This approach 
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has been shown to be reasonably accurate and consistent with histopathological 
changes which are occurring at the time (Adams et al., 2004) with a number of 
semi quantitative scoring systems being used throughout the industry. However, 
while some non-destructive gross pathological signs for viral diseases are 
identifiable most significant manifestations of the disease occur in internal 
organs and tissues (see sections 1.3 and 1.4) meaning that pathology 
identification is destructive. Moreover, it has been shown that these are highly 
varied between individual and may or may not present themselves at a given 
stage of disease. Therefore, histopathology is the gold standard in diagnosing 
clinical disease. 
 
1.5.5 Histopathology  
By far the most well established methodology for disease diagnosis in salmon 
aquaculture is histopathology, where sectioned tissue samples (after fixation, 
waxing, cutting, and staining) are examined under a microscope for clinical 
manifestations of disease. In this way damage to specific tissues can be 
determined in both a qualitative and semi-quantitative manner thus describing 
the nature of clinical disease and also is an important tool for investigating 
diseases of unknown aetiology. In addition, when the pathogen is suspected, 
immunohistochemistry (IHC) can also be carried out on sections to stain, using 
specific antibodies, as in virus isolation, virus in the tissue. Despite this, 
histopathology is a laborious and time consuming process which takes a high 
level of skill for proper assessment. In addition, direct costs are added to 
significantly, as with all destructive diagnostic tools, by the effect of fish being 
removed from the population therefore not going to harvest. Therefore, it is not 
economically viable for proactive monitoring of health at a population level in 
this way and it is usually not until a problem is suspected by another means it is 
used. In addition, due to the sequential pathology of many diseases, such as PD, 
all disease indicators may not be visible at the same time point (McLoughlin et 
al., 2002) meaning that repeat sampling may be needed over a period of time 
again adding to cost. Thus there is a significant demand within the industry for 
non-destructive means of health assessment which are capable of diagnosing 
clinical disease. 
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1.6.1 Disease Prevention and Management 
For the limitation of the negative effects of infectious disease to the industry 
there are a number of general and specific preventative measures which are 
carried out. For example, general bio-security is becoming more rigorous in all 
stages of production from hatchery to slaughter (Munro et al., 2003; Delabbio et 
al., 2004) with disinfection procedures, quick removal of dead fish, pre-entry 
disease testing of new stock, and record keeping of a number of analytes all 
being highly important in preventing outbreaks (Delabbio et al., 2004). By far 
one of the most successful preventative measures against infectious disease to 
date has been vaccination with considerable success in giving protection against 
a number of infectious agents (Sommerset et al., 2005; Hølvold et al., 2014). 
However, there remain a number of issues of vaccine efficacy (Kibenge et al., 
2012; Gudding and Van Muiswinkel, 2013), with many vaccines available in 
salmon aquaculture against viral infections, e.g. SAV, which may lessen disease 
severity but do not fully protect fish (Hølvold et al., 2014). Therefore, it is 
paramount that a high level of biosecurity and regular monitoring of fish stocks 
is implemented. Moreover, when infection and or disease is identified, disease 
management strategies are put in place not only to lower the effects of the 
specific outbreak but also to lessen future impacts in new cycles. 
    
Disease management strategies are numerous and to an extent similar to 
preventative steps as they aim not only to reduce morbidity and mortality of the 
given outbreak but also to prevent the spread of disease to other sites/ 
populations. Moreover, they are not, except for in cases where specific 
treatments can be utilized, necessarily disease specific. For instance, there are 
currently no antiviral treatments available for treatment of salmon when 
infected with a viral pathogen. Therefore, many of the management/ prevention 
tools set out in PD literature may be extremely useful in dealing with other viral 
disease outbreaks: avoidance of movement of equipment or livestock between 
infected and uninfected areas; separate diving staff for each site; sites which 
have had a history of PD when using S0 should consider switching to S1 stock; 
reducing stocking numbers in cages when PD is present; smolts entering a site 
where there has been a history of PD should be injected with PD vaccine; sites 
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or bays with a history of smolt strain susceptibility should consider not using 
certain genetic lineages; and farm sites with a history of severe PD should 
consider both reducing or completely ceasing livestock exportation to other 
sites, and fallowing of the water body (mandatory in Norway) (McLoughlin et al., 
2003; Jansen et al., 2010). Despite this, a combination of factors including 
horizontal transmission, the biophysical properties of viruses, and the role of 
hydrodynamics in viral spread we do not seem to be suppressing the effects of 
viral diseases in Atlantic salmon (Robertsen, 2011) at present. Therefore, a 
number of advanced techniques are being investigated to try and lower the 
impacts of infectious disease, for example, breeding for resistance to varying 
levels of success. However, one of the most promising disease management tools 
for lowering the negative impacts of infectious disease is the use of functional/ 
protective feeds. 
 
1.6.2 Functional Feeds 
Nutrition is pivotal to the production of all livestock where specific nutritional 
requirements must be met at specific points in time for the production of 
adequate product for the consumer. Indeed it is paramount for the health and 
welfare of fish in aquaculture, where great strides have been made improving 
productivity and the product itself (Trichet, 2010; Tacchi et al., 20012). 
Moreover, there has in recent years been a realisation that altering the diet 
composition of feed during infection and disease can have major benefits to 
health, reducing morbidity during disease or even preventing it (Trichet, 2010). 
The usefulness in this form of clinical nutrition is well established and is 
achieved either by supplementation or reduction in specific compounds to 
supplement or modulate the immune system to give a favourable outcome 
(Tacchi et al., 2012). A number of different compounds have been shown to have 
such effect in aquaculture including among others numerous fatty acids, free 
amino acids, free nucleotides, antioxidants, carotenoids, minerals, 
carbohydrates, and β-glucans (reviewed in Trichet, 2010). Moreover, the 
application of these functional feeds is becoming ever more common in Atlantic 
salmon disease. For example, their use has been shown to reduce sea lice 
burden in an experimental challenge trial by Provan et al. (2013), where 
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epidermal mucus proteome was found to be significantly altered thus indicating 
an increase in synthesis of proteins important in lice detachment. In addition, 
the severity of inflammation during both CMS and HSMI has been shown to be 
reduced significantly when fish were fed diets with lower, compared to standard 
core diet, dietary lipid and fatty acid composition which were shown to have 
significant modulation effects on the immune system (Martinez-Rubio et al., 
2012; Martinez-Rubio et al., 2014). However, while the severity of pancreas 
disease in Atlantic salmon has been shown to be linked to dietary levels of 
vitamin E and polyunsaturated fatty acids (Raynard et al. 1991) there is little 
recent published evidence of how nutrition can aid in reducing morbidity of the 
disease. 
 
1.7 Aims of Study 
Despite the clear advancements in Atlantic salmonaquaculture since its 
inception it is clear that the industry still faces a number of challenges which 
threaten its expansion and sustainability. For instance, infectious disease has 
serious economic impacts through resulting mortality and morbidity. Such 
impact can be limited through identification of any issue as quickly as 
possible for the implementation of any disease management strategies or 
treatment available. However, while current non-destructive means of health 
monitoring they rely on the identification of aetological agents. This, from a 
disease monitoring standpoint, can cause problems for the industry as 
infection may or may not result in clinical manifestations of disease which is 
a crucial consideration for disease management tools, such as administering 
functional feeds. Therefore, this study aims to identify serum markers of 
disease for the non-destructive assessment of fish health. 
Using a pancreas disease (PD) cohabitation disease trial fish are exposed to 
salmonid alphavirus subtype 3 with serum and tissue samples for 
histopathological assessment taken at a number of time points. Moroever, the 
effects of nutrition on disease severity will be examined with two treatment 
groups with one receiving a commercial diet and another enriched with 
Vitamin C, vitamin E, schort chain fructooligosaccharide, mono 
oligosaccharides, and nucleotides. Inital investigation of markers of 
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pathological damage shall be through the use of established and novel (to 
Atlantic salmon aquaculture) biochemical assays of analytes. Subsequently 
the study aims to examine the changing serum proteome during the disease 
using a gel based proteomics approach to identify both markers of the 
immune response to infection and markers of specific tissue pathologies. 
Validation of results will be carried out for targets using other techniques 
such as western blotting and assays. The development of such assays also 
aims to make novel tools of assessing pathological damage for use in industry. 
 Chapter 2: Disease Trial 53 
 
 
 
 
 
 
 
 
Chapter 2 
 Disease Trial, Histopathology and Blood 
Biochemistries 
 Chapter 2: Disease Trial 54 
 
 
2.1 Introduction 
2.1.1 Infectious Disease Trials 
Horizontally transmitted diseases in Atlantic salmon, salmo salar, aquaculture 
are some of the most common and economically significant problems we face in 
striving for higher sustainability. While we can increase our understanding of 
these diseases through investigation of natural outbreaks, there are a number of 
limiting factors in doing so. Namely these include, but are not limited to, 
occurrence of multiple infections and or diseases, and the lack of control over 
other potentially mitigating factors, such as age and size of fish, and 
epidemiology at a given site between outbreaks. Therefore, the development of 
experimental infection/ disease challenge models has enabled for the control of 
these factors. Within this methodology there exist a number of different 
challenge methods (Nordmo and Ramstad, 1997) such as intra-peritoneal (i.p.) 
and muscular (i.m.) injection, bath treatment, and cohabitation protocols. 
Arguably the most readily standardized methodology of investigating disease is 
by either via intra-peritoneal or intra-muscular injection, where a titre of 
aetiological agent is injected into each fish for the investigation of a given 
outcome(s). This protocol not only allows for the standardization of magnitude 
of exposure each individual but also benefits in terms of comparison of different 
groups and individual variance as all individuals are exposed at the same time. 
However, this does not replicate true infection of infectious disease in salmon 
thus omitting initial defences of salmon to bacterial and viral particles, such as 
mucosa in the gills and body surface, which not only act as a physical barrier to 
pathogens but comprise a number of anti-infectious components (Sansonetti et 
al, 2004). Bath treatments, where fish are exposed to pathogens suspended in 
water for a given time, and cohabitation models, where naive population is 
exposed to diseased/ infected individuals, by definition allow for a simulation of 
natural outbreaks. However, bath treatments have proven difficult to administer 
as dosage must be high to ensure the successful infection of fish (Nordmo et al, 
1997). Indeed the number of particles needed for bath protocols far exceeds the 
actual exposure dosage as one must ensure contact between pathogen and host 
which not only makes the methodology difficult to standardise and control 
‘infectious dosage’ but also may exceed the culture capacity of a laboratory.  In 
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addition, where the aetiology is not clearly defined or agent not easily cultured 
this methodology is unsuitable. Therefore, cohabitation disease trials have 
become an increasingly popular means of investigating infectious disease. This 
protocol has been carried out, when aetiology was not defined, for both CMS 
(Bruno and Noguero, 2009) and HSMI (Kongtrop et al, 2004) using tissue 
homogenates from farmed salmon diagnosed with the given disease to 
successfully establish the disease, not only in those fish subjected to i.p. 
injection but also cohabitation fish. However, when aetiology is defined it is 
possible to culture viral particles using cells for the downstream administering of 
a given titre of the agent. For instance, Chinook salmon embryo (CHSE-214) 
monolayers are widely used for the cultivation of SAV (Hjortaas et al, 2013), and 
as such have been utilized in cohabitation PD cohabitation trials previously. For 
example, Graham et al. (2011) have previously carried out a comparative study 
of all six known SAV (SAV 1-6) subtypes using a cohabitation trial where Trojan 
fish, were exposed to 103 TCID50 of SAV (one out of the six) were introduced to 
naïve individuals. This procedure successfully simulated what is observed in 
aquaculture sites thus validating the methodology in investigating PD. 
 
2.1.2 Application of Clinical Serum Biochemistry 
The protein content of blood sera or plasma can give valued information on the 
disease state of an individual at a specific point in time and in a non-destructive 
manner. Biochemical analysis of sera (serum biochemistry) exploits the 
characteristics or function of proteins to infer a given proteins concentration. 
Such an approach is termed clinical pathology and has the ability to aid in the 
identification of a number of conditions such as pathological damage when a 
targets level is above or below homeostatic levels. Moreover, certain enzymes, 
with variable sensitivity and specificity, are linked with specific pathologies and 
conditions. 
Indeed clinical pathology is routine in domesticated animals (Kaneko et al, 2008) 
and is used in conjunction with other methodologies to diagnose a multitude of 
diseases. Often in terms of livestock this form of investigating pathological 
diseases due to the economic worth of the animal at an individual level is 
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advantageous as it avoids unnecessary slaughter which also has an animal 
welfare advantage. Despite this, the application of clinical pathology has been 
severely limited in aquaculture potentially due to a number of factors such as, 
the sheer number of stock on a site and comparative worth (to other livestock). 
Despite this, some investigations have used serum activities of enzymes to 
investigate disease severity and progression with creatine kinase (CK) activity 
being the most common. For instance, Rodger et al (1991) and McLoughlin et al 
(1994) showed that during pancreas disease CK levels in the sera were 
significantly raised due to associated pathological damage. In addition, more 
recently Yousaff and Powell (2012) showed significant increases in CK activities 
during HSMI and PD. Moreover, there has been a surge of interest in the use of 
CK as a non-destructive marker of pathological damage to tissues within the 
industry with a number of institutions and companies now offering this as a 
service. Despite this, the usefulness of this enzyme and others (such as alanine 
aminotransferase and aspirate transaminase) has not been fully established and 
requires further investigation and validation. 
 
2.1.3 Aims of Study  
• Simulate natural pancreas disease outbreak through the use of a pancreas 
disease challenge model 
• Assess its efficiency by standard diagnostic tools including histopathology, 
serology, RT-PCR, and virus isolation 
• Investigate the usefulness of serum biochemistry in identifying 
pathological damage by non-destructive means 
• Compare disease severity, using histopathology and serum biochemistry 
data, in fish fed different diets 
N.B. Results of RT-PCR, serology, histopathology, and virus isolation in this 
chapter are published in Braceland et al. (2013). 
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2.2 Methods  
2.2.1 Cohabitation Disease Trial  
The following experimental procedure was approved by the Norwegian National 
Animal Research Authority (NARA) prior to the trial commencing and was carried 
out at Veso Vikan (Norway). The trial was carried out in 2010 prior to this PhD 
project starting. 
 
Atlantic salmon (Salmo salar) parr of mean weight 30g (<15% CV) were randomly 
distributed into duplicate 1m3 tanks (=1400 total fish). Following a six week 
acclimatisation period, the fish were fed to a target of 1.5% body weight per 
day.  A commercial formulated feed (CPK 2mm; 3mm, with oil/ protein at 
22/48, BioMar AS, Denmark) was used as the base diet for enrichment and was 
offered to fish throughout the experiment as a control diet. See Table 2.1 for 
information on diet enrichment compounds used. Water temperature was 
maintained at 12-14 ±1ºC, water flow 0.8l/kg min, and light / dark regime 12:12 
hr.  After 42 days, 60 fish from each duplicate tank were transferred into 
triplicate (three tanks fed one diet ie diet triplicates)0.6 m3 tanks and water 
temperature was increased to 14±1ºC.  Additional fish from the duplicate tanks 
were maintained separately to be used as Trojan shedders i.e. challenge tanks 
all containing 120 fish (with Trojan fish to be added later). Naïve fish to be used 
as Trojans were marked by clipping their adipose fin and injected with SAV 3 
infected CHSE cell culture supernatant at ca. 105 TCID/fish into their 
intraperitoneal cavity. Thirty inoculated Trojans were added to each of the 
challenge tanks 6 days after their assembly. The challenge and time course of 
sampling was staggered between replicate tanks over three consecutive days and 
kept constant at each sampling. Cohabitant fish were sampled at 0, 2, 3, 4, 5, 6, 
8, 10 and 12 weeks post challenge (wpc). At each time point 9 fish per tank were 
killed by lethal overdose of anaesthetic benzocaine chloride (Apotekproduksjon 
AS, Oslo, Norway), 1g/10L water for 5 minutes being used and blood collected in 
non-heparinised vacutainers for analysis of serum biochemistry and serological 
and virological analysis. From 6 of these fish, pyloric caecae and pancreas 
(hereafter referred to as pancreas), heart and skeletal muscle tissue were 
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processed from standardised locations for histology. RT-PCR was also carried out 
using heart samples for SAV3 detection. In addition, a small section of liver from 
each fish was placed in RNA later for genomic analysis. Fish sampled at time 
point 0 were removed from the tanks before the addition of Trojan shedders. 
Figure 2.1 shows a simplified schematic diagram of this disease trial.  
 
Table 2-1: Diet enrichment information. 
Diet Enrichment 
A N/A (control) 
B  Vitamin C (1000ppm), Vitamin E 
(400ppm), scFOS, MOS, neucleotides 
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Figure 2.1: Simplified schematic diagram of cohabitation pancreas disease trial, sampling information, and initial analysis of both 
tissues and sera that were carried out and contained in this chapter.
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2.2.2 Virological, Serological and RT-PCR Testing 
The following tests were carried out at Agri-Food and Biosciences Institute (AFBI) 
by staff of the Fish Diseases Unit as described in Graham et al. (2011).  
Detection of SAV3 infection was carried out by attempting to isolate SAV and 
detection of virus neutralizing antibodies from the sera of fish at 0, 4, and 5 
Wpc. To confirm that fish were SAV free at the start of the experiment the 
viraemia of the serum was investigated. Reverse transcriptase polymerase chain 
reaction (RT-PCR) was carried out with heart tissue from sacrificed fish from 
W2pc to W5pc to investigate the horizontal spread of infection. 
 
2.2.3 Histopathology 
Histopathological scoring of tissues was carried out by Marian McLoughlin 
(Aquatic Vet Services, Belfast, UK).  
 
Tissues for histology from the salmon were immediately fixed in 3.5% v/v 
formaldehyde in buffered saline pH 7.0 (4.0g NaH2PO4.2H2O, 6.5g 
Na2HPO4.2H2O) prior to further processing by standard paraffin wax techniques, 
sectioned and stained with haematoxylin and eosin (H & E). The tissue sections 
were examined by an experienced pathologist and a scoring system was used to 
semi-quantify the distribution and severity of the tissue lesions in the pancreas, 
heart and skeletal muscle as used in previous studies (McLoughlin et al., 2006; 
Christie et al., 2007). Table 2-2 illustrates the differential scoring system used in 
more detail.
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Table 2-2: Semi-quantitative scoring system for histopathological assessment 
of tissue lesions. 
Tissue Score Description   
Pancreas 0 Normal  
 1 Focal pancreatic acinar cell necrosis 
 2 Multifocal necrosis/atrophy of pancreatic acinar tissue, 
some remaining 
 3 Total absence of pancreatic acinar tissue 
Heart 0 Normal  
 1 Focal myocardial degeneration and inflammation <50 fibres 
affected 
 2 Multifocal myocardial degeneration and inflammation 50-
100 fibres affected  
 3 Severe diffuse myocardial degeneration and inflammation 
>100 fibres affected 
Skeletal 
muscle 
0 Normal  
 1 Focal myocytic degeneration and inflammation 
 2 Multifocal myocytic degeneration and inflammation 
 3 Severe diffuse myocytic degeneration  
   
 R Repair 
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2.2.4 Serum Biochemistries 
The serum concentrations of creatine kinase (CK), ALT and AST were assayed by 
AFBI (Belfast, UK) using an Olympus (model au640) auto-analyzer (Middlesex, 
UK).  
 
Total serum CK activity was assayed using a standardised methodology in which 
the colour change of reaction mix was monitored at an absorbance of 340/660 
nm using Olympus reagent to manufacturer instructions (OSR6279). Increase of 
absorbance is due to the formation of NADPH which directly proportional to the 
activity of CK in the sample. Activity of ALT of serum samples from this 
cohabitation disease trial were assayed using Olympus reagent number OSR6507. 
In short, consumption of NADH was monitored by a decreasing absorbance at a 
wavelength of 340nm; this is proportional to ALT abundance. The consumption 
of NADH was measured at a wavelength of 340nm, with a reduction of 
absorbance being correlated to AST activity. Reagents were purchased from 
Olympus (cat # OSR6509). 
 
2.2.5 Statistical Analyses 
Statistical analysis of the data provided by the cohabitational trial was 
undertaken as part of this thesis.  A mixed model analysis of variance was used 
to analyse the data using the mixed procedure of SAS (SAS Institute, Cary, N. 
Carolina). Due to the repeated measurements, a first order anti-dependence 
covariance structure was specified for the residuals. The model fitted the 
effects of diet and time of sampling. The dependent variables were serum 
activity of the analytes or histopathological scores of tissues (separately). This 
was carried out to investigate the relationship of histopathology and serum 
biochemistry results against the diet fed to fish. In this way any significant 
correlations between results of the trial could be identified, for example 
between histopathology and analyte activity or diet and histopathology or 
analyte activity etc. In addition, any significant dietry difference was given 
according to time point and also overall effect. 
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3. Results 
2.3.1 Virology, Serology and RT-PCR 
Cohabitant fish were SAV free before introduction of Trojan shedders, as 
determined by virus isolation, virus neutralization and RT-PCR (Table 2-3). Post 
introduction there was a subsequent horizontal spread of the viral infection with 
the majority of sampled fish being infected by week 4. 
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Table 2-3: Percentage of positive RT-PCR, SAV isolation and virus 
neutralization samples throughout trial. The percentage of samples from 
salmon sampled at each time point that gave positive results for SAV infection 
detected by reverse transcriptase polymerase chain reaction (RT-PCR), virus 
identification (SAV) and virus neutralisation (VN) are detailed. ‘–’ indicates that 
testing was not carried out 
 
Sampling time point Percent of Positive Samples (%) 
  
RT-PCR 
 
SAV 
 
VN 
 
W0 
 
- 
 
0 
 
0 
 
W2 
 
75 
 
- 
 
- 
 
W3 
 
87 
 
- 
 
- 
 
W4 
 
97 
 
13 
 
27 
 
W5 
 
88 
 
2 
 
67 
 
W6 
 
- 
 
- 
 
- 
 
W8 
 
- 
 
- 
 
- 
 
W10 
 
- 
 
- 
 
- 
 
W12 
 
- 
 
- 
 
- 
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2.3.2 Histopathology of Pancreas Disease  
Negligible mortality was observed during or pre-and post-trial. The development 
of lesions over time is illustrated in Figure 2.3 which shows mean lesion scores 
for each tissue at each sampling point (See appendices for individual fish 
information).  Since this study was based upon a cohabitation model individuals 
were likely to be at different stages in the disease process at each sampling 
point due to variation in the time of infection. The pancreas was the first tissue 
to develop lesions at week 2 and was also the slowest to recover, with a 
minority of samples still not fully recovered by week 12. Conversely, the heart 
demonstrates an extremely quick recovery, with a peak in lesion severity in fish 
sampled in week 4 and then a rapid recovery. The histopathological damage to 
red and white muscle was more delayed with the peak damage occurring at 6 
and 8 weeks respectively.  
 
Histopathological assessment scores from each tissue (heart, pancreas, white 
muscle, and red muscle) from fish fed both diet A and B were compared 
statistically at each time point by mixed procedure GLM. Fish fed diet B had 
significantly lower lesion scores at specific time points during the trial (figure 
2.3), as follows, in heart, pancreas and red muscle at W4pc (p = 0.073; p = 
0.0206; p = 0.0006 respectively) and W6pc (p = 0.0288; p = 0.014; p = 0.049). 
There was also a significant reduction in lesion severity of the white muscle at 
W6pc (p = 0.0331). No other significant differences were observed between 
diets. 
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Figure 2.2: Mean histopathological scores of tissues during trial. 
Histopathological scoring of mean lesion scores in relation to week post 
challenge, of all samples irrespective of diet fed, with SAV in pancreas (Pan), 
heart (HT), red muscle (RM) and white muscle (WM) of salmon (n=72 per time 
point).  
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Figure 2.3: Dietary differences in histopathological damage to tissues. Dietary difference in mean histopathological score for each 
sampled tissue, from top left clockwise, heart, pancreas, white muscle, and red muscle at each sampling time point (weeks post 
challenge). Error bars indicate the standard error of the mean(SEM).
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2.3.3 Serum Biochemistries 
The serum activities of three analytes, creatine kinase (CK), aspartate 
transaminase (AST), and alanine transaminase (ALT), were assayed and their 
respective activities compared with; wpc, histopathological scores of fish, and 
diet effect investigated by sampling time point. As previously mentioned diets C 
and D were omitted from this analysis. 
 
The mean serum activity values of fish fed diet A and diet B at each sampling 
time point (or wpc) with SE of the mean (in international activity units per litre: 
U/L) for CK, AST and ALT can be seen in FiguresFigures 2.4, 2.5 and 2.6 
respectively. There was significantly lower serum activities in fish fed diet B at: 
W4pc and W6pc for both CK (p = 0.011; p = 0.0076 respectively) and ALT (p = 
0.0013; p = 0.0017 respectively) (see Figures 2.4 and 2.6). In addition, 
significantly lower AST activities were observed in fish fed diet B at W6pc (p = 
<0.001) (Figure 2.5).  
 
All three of the analytes correlated significantly with the histopathology results 
of lesions scores to skeletal muscle (white muscle correlation: p = 0.027; red 
muscle correlation p = 0.009) and heart (p = 0.038). However, analyte activities 
did not correlate with pancreas lesion scores therefore indicating that changes in 
serum activities of CK, ALT, and AST are not in due to a single tissue specific 
pathology rather appear to be influenced by pathological damage to skeletal 
muscle and the heart. 
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Figure 2.4: Serum creatine kinase (CK) activities. Mean serum activity of 
creatine kinase (CK) at sampling time points week 0 to week 12 of fish fed diet A 
and B separately. SE error of the mean is indicated by error bars. 
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Figure 2.5: Serum Aspartate transaminase (AST) activities.  Mean serum 
activity of aspartate transaminase (AST) at sampling time points week 0 to week 
12 of fish fed diet A and B separately. SE error of the mean is indicated by error 
bars. 
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Figure 2.6: Serum alanine transaminase (ALT) activities. Mean serum activity 
of alanine transaminase (ALT) at sampling time points week 0 to week 12 of fish 
fed diet A and B separately. SE error of the mean is indicated by error bars.
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2.3.4 Discussion 
Creatine kinase, aspartate transaminase and alanine transaminase serum 
activities were assayed to establish their usefulness as markers of pathogenesis 
during PD. All three of these analytes (irrespective of diet) rose to a peak at 
W6pc. CK and ALT mean concentrations then fell to near basal levels by W12pc. 
However, whilst AST activities fell after W6 this decline was much less 
pronounced and levels remained relatively high even at W12pc. These profiles 
did not correlate with a specific tissue’s pathology; rather activities appeared to 
be influenced by heart, red and white muscle damage. Conversely there was no 
significant correlation with pancreas histopathology scores. Thus indicating that 
these analytes may be useful as general health markers as a prognostic tool but 
would not be suitable in terms of diagnosing a specific infection, disease, or 
pathogenesis. In addition, it was found from statistical analysis of raw data 
provided that there was a significant overall reduction in ALT activity in fish fed 
a functional feed (B). Whilst no significant reduction in overall CK and AST serum 
activities was observed it is interesting to note that fish fed diet B had 
significantly lower values of CK at W4pc and W6pc (which is the same time 
points where there was a significant difference in ALT values) and lower AST 
activities at W6pc. This is supported by the observation of lower severity in 
pathological damage to tissues at these time points (W4 and W6pc) in fish fed 
diet B which is no doubt the cause for these lower analyte activities at these 
time points. In addition, it is possible that the lack of no significant overall 
reduction of severity is an artefact of the nature of statistical analysis of such 
data, where healthy scores are included as fish fed the control diet are also in 
good health at the beginning of the trial, but we observe that when pathological 
damage is at its worst functional feed reduces severity. 
 
The functional feed in this study was enriched with a number of components, 
with levels of vitamin C, vitamin E, MOS, scFOS, and nucleotides increased 
compared to their dosage given in the control diet. All of these ingredients have 
in some way been shown to have an effect on fish in a positive way and as such 
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must be discussed in further detail. For example, increasing dietary levels of 
ascorbic acid in the form of vitamin C has been shown to stimulate growth and 
give protection against Aeromonas hydrophila in Asain catfish, Clarias batrachus 
(Kumari and Sahoo, 2005). Similarly enrichment of the vitamin to high levels has 
been shown to increase the resistance of channel catfish, Ictalurus punctatus, to 
Edwardsiella ictaluri infection (Liu et al., 1989). In addition, increased vitamin C 
has been shown in the salmonid species rainbow trout, O. mykiss, to stimulate 
the alternative complement pathway, and when used in conjunction with yeast 
derived glucans, to increase specific immune response following vaccination 
against enteric redmouth disease (Verlhac et al., 1996). Moreover, the vitamin 
has been shown in Atlantic salmon to have an effect on lysozyme, complement 
components and iron levels during bacterial challenge (WaagbØ et al., 1993). 
Therefore, enrichment of the vitamin is thought to be beneficial in fighting 
infection and disease having some sort of immune stimulant function. Vitamin E 
levels in feed have also been shown to have a major influence during disease of 
fish with deficiency in the vitamin shown to lower survival and lower stress 
tolerance, which is an important consideration in aquaculture, in gilthead 
seabreem, sparus aurata, juveniles (Montero et al., 2001). Raynard et al. (1991) 
also found that during challenge with pancreas disease fish that were fed 
inadequate amounts of vitamin E had more severe pathological damage than 
those who were fed adequate levels. One of the most rapidly growing areas of 
fish nutrition is the use of prebiotic and probiotics (Merrifield et al., 2010; 
Mohapatra et al., 2012; Song et al., 2014). This form of intervention is where 
microbes (probiotics) or stimulants for bacterial growth (prebiotics) are used to 
manipulate gut microbiota to give a health benefit to the fish, with a multitude 
of these being shown to give beneficial effects under a number of conditions. 
This study used a functional feed which was also enriched with the prebiotics 
mannoligosaccharide (MOS) and short chain fructooligosaccharide (scFOS) which 
are the two main compounds currently used as prebiotics in salmonid 
aquaculture (Tacchi et al., 2012). Mannoligosaccharide (MOS) have a profound 
effect on the immune system through the action of binding mannose receptor on 
the endothelium, which is a receptor for antigen receptor and presenting cells, 
and mannose binding lectins which activate the complement pathway (Tsutsui et 
al, 2006; Russell et al., 2009). Moreover, its use has been shown to have positive 
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effects on innate immune parameters of rainbow trout (Staykov et al., 2007) 
indicating its use may aid in fighting infection. Short chain 
fructooligosaccharides (scFOS) is well established in human and terrestrial 
species promoting growth and immunoregulation but is by comparison 
understudied in important aquaculture species with conflicting evidence of its 
effects (Song et al., 2014). Despite this, it has recently been shown to induce a 
number of innate immune responses in red swamp crayfish, Procambarus clarkii, 
(Dong and Wang, 2013). The addition of supplementary nucleotides has also 
been shown to have a range of effects in aquaculture species such as increasing 
total gut area (Burrels et al., 2001a) presumably aiding in the uptake of 
nutrients which would aid FCR and growth. Moreover, the inclusion of free 
nucleotides has been shown to increase resistance to bacterial, viral, and 
ectoparasitic infections (Burrels et al., 2001b). While it is not possible to explain 
the precise mechanisms by which the functional feed has given this reduced 
severity of tissue lesions and resulting serum enzyme activities it has added to 
our understanding of how pivotal nutrition can be in this capacity. Moreover 
whilst this formulation has previously been shown, by Tacchi et al. (2012), to 
alter the transcriptome of Atlantic salmon compared to those fed the control 
diet, this is the first evidence of its protective effects during a disease 
challenge. 
 
It is important to note that whilst serum ALT and AST activity have not been 
widely investigated as a marker of pathogenesis in salmon disease, a number of 
studies have investigated CK in this manner. Ferguson et al. (1986) and Rodger 
at al. (1991) showed that levels in fish affected with PD to be higher than in 
healthy fish. However, these studies did not investigate the relationship 
between histopathology and the sera analyte levels. In addition, in a study by 
Yousaff and Powell (2012) on the effect of heart and skeletal muscle 
inflammation and cardiomyopathy syndrome (CMS) CK and lactate 
dehydrogenase (LDH) activities, it was shown that CK correlated with 
histopathological damage during HSMI (but not CMS). Despite this, there are a 
number of issues with using CK (and from this study it would also indicate the 
same issues may be apparent in using ALT and AST), as a diagnostic/ prognostic 
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tool in the field. First, the range of concentrations in healthy sera (W0 fish in 
this study) (due to a high and variable activity) is large as described in the 
literature (Ferguson et al., 1986; Roger et al., 1991; Yousaff & Powell 2012) thus 
making it hard to identify subtle changes in concentrations on which  to base 
health management decisions  at a given time point. This is especially a problem 
when a fish farm site has an outbreak of HSMI where changes may be quite small 
and fall within this range. Indeed, it would appear that values (U/L) of CK are 
extremely high when fish are affected with PD compared to HSMI. In addition, to 
this the literature has only investigated total CK concentrations, which is 
ubiquitous, thus not indicating a specific pathology. These two issues are much 
more of an issue given the nature of sampling at an aquaculture site, where 
there is a low probability that a fish will be sampled multiple times over a given 
period, meaning that individual variability can be easily accounted for. 
Therefore, it would be useful in terms of diagnostics to have other non-
destructive targets that may add to information attained from serum analysis 
and may be more sensitive, accurate, and reliable in diagnosing pathogenesis.  
 
Despite this, as aquaculture strives to become more sustainable through 
maximizing output, non-destructive means of health assessment and disease 
identification must be further developed. Without doubt interest in this area is 
growing with potential targets of specific pathologies beginning to be identified. 
In addition, they offer an interesting application of quantitative pathological 
assessment of fish where we can examine the fish’s relative health or disease 
severity as a whole rather than at a given place in a tissue with histopathological 
assessment. In addition, the reduction in histopathological lesion scores and 
serum activities at certain points in this trial has shown the protective nature of 
this functional feed’s formulation. Moreover, these tools may have further utility 
as supportive evidence for the benefits of the utilization of other functional feed 
formulations.
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Chapter 3 
Proteomic investigation of changing proteome 
during pancreas disease
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3.1 Introduction 
3.1.1 Proteomics 
Proteomics is a well-established post-genomic tool which allows investigation of 
biological systems through the study of protein composition. Essentially, it is the 
study of the entire or part of the protein content (proteome) of a given cell, 
organ, or organism (or its humoral system) at a given moment in time. Such 
investigation has a number of applications such as biomarker detection of 
infection and disease, and the study of protein-protein interactions, protein 
expression, protein turnover, alternative splicing, and post translational 
modifications, applied to the understanding of conditions in an extensive range 
of species, from primates to the single celled organisms. 
 
Livestock production has also benefited greatly from the use of proteomics 
which is increasingly being used to understand the biology of infection and 
markers of quality. For instance our understanding of meat and milk quality, gut 
health, infection and disease, neurodegenerative disorders, reproductive 
biology, and even obesity have all benefited from proteomics (reviewed in 
Bendixen et al. 2011). Interestingly despite proteomics being a relatively old 
‘omics’ approach recently the use of the approach has grown rapidly due to 
improvements in sensitivity and reliability of technical approaches, mass 
spectrometry (MS), and advances in analytical software (Abdallah et al. 2012). 
 
3.1.2 Proteomic Methodologies 
Proteomic methodologies rely on the separation of peptides according to 
physiochemical properties (such as molecular weight and isoelectric point) and/ 
or affinity interactions for identifying proteome components of a complex 
sample. Many recent developments in proteomics have been in gel free 
approaches which unlike gel based proteomics do not utilize gel electrophoresis 
to separate proteins prior to MS analysis (Abdallah et al. 2012). Despite this most 
studies apply some sort of protein separation such as liquid chromatography, 
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centrifugal filtration, or OFFGEL electrophoreses (OGE) utilized for the reduction 
of complexity of sample where proteins of at a given size or isoelectric point (pI) 
range are investigated. In addition, gel free approaches have also proven useful 
in quantifying a given peptide/ proteins concentration in a sample. This ‘MS-
based quantitation’ is a bottom up process where specific peptides are 
quantified in a sample by either prior labelling or by the somewhat cheaper 
methodologies of quantification of the relationship of ion peaks and thus its 
abundance.  
 
Currently, gel based separation remains the most established approach prior to 
MS protein identification. One dimensional separation (1-DE) by either molecular 
weight (Mw) or isoelectric focusing (IEF) to separate proteins by isoelectric point 
(pI) is the simplest method of proteomic investigation where bands are visualised 
by staining and then excised for MS identification. A greater level of separation 
is gained by two dimensional electrophoresis (2-DE) where proteins are 
separated by both pI and Mw. Since the first description of this procedure by 
O’Farell (1975) significant improvements have been made in the resolution and 
broad and narrow pH ranges for pI focusing are commonly used. Such separation 
means that each protein spot usually but not always consist of one protein but 
multiple spots may consist of modified forms of the same protein (O’Donnel et 
al. 2004). After separation in ‘classical’ 2-DE studies proteins are stained before 
analysis with one of a number of possible dyes that bind protein for visualization 
of proteome. One of the main criticisms of this methodology has in the past 
been poor reproducibility of gels (Lilley et al. 2002). This led to the 
development of another 2-DE technique to be developed called difference gel 
electrophoresis (DiGE) (Ünlü et al. 1997) which uses three fluorescent cyanine 
(Cy) dyes (Cy2, Cy3, Cy5) to investigate directly the difference in proteome 
between two given samples. However, this significantly limits the number of 
samples that can be directly compared thus making it not ideal for investigating 
the changing proteome over a long period of time or with many conditions. 
Alternatively and with correct technical care and the use of multiple replicates 
one can minimize variability. Through the use of advancing gel image analytical 
software it is possible to ensure that a given spot’s profile is significant and 
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reproducible by power and analysis of variance (ANOVA) analysis. In addition a 
gel based proteomics approach can be favoured over a gel free approach in 
order to visualize isoforms of proteins which may give valuable information on 
possible tissue specific forms of an enzyme or alternate splicing during disease.  
 
3.1.3 Proteomics in Fin Fish 
The application of proteomics in teleostei species has been relatively limited (in 
comparison with other livestock). However; its use is growing year on year 
(Rodrigues et al. 2012) with recent studies investigating a number of biological 
questions in many species, from model organisms such as zebra fish (De Wit et 
al. 2010) to leopard sharks (Dowd et al. 2010). However, it is in species used in 
aquaculture that much recent emphasis has been placed as an increase in 
efficiency in livestock production through a better understanding of biological 
processes. For instance, Kolditz et al. (2008) used transcriptomics and 
proteomics to investigate the role of liver metabolism on fat allocation and its 
effect on flesh quality of rainbow trout (Oncorhynchus mykiss) and the effect of 
variable fat content diets fed to the fish. The liver proteome has been examined 
to investigate the impact of using genetically modified (GM) soy in Atlantic 
salmon, Salmo salar, feed identifying minor differences in liver protein 
composition in fish fed GM soy compared to non-GM (Sissner et al. 2009). The 
effect of nutrition has also been studied using proteomics in relation to infection 
and disease by a number of groups (Rodrigues et al. 2012). For instance, a 
recent study by Provan et al. (2013) identified a significant effect on the protein 
composition of Atlantic salmon mucus between control and diets enriched with 
immunostimulants during sea lice infection. The proteome of humoral systems, 
such as blood derived serum and plasma, has also been investigated as a means 
of assessing fish health and welfare. One example of this is Russell et al. (2006) 
who identified through the use of 2D-PAGE a number of potential markers of 
health during the acute phase response (APR) of rainbow trout to Aeromonas 
salmonicida lipopolysaccharide infection. However, only one study has directly 
investigated the effects of pathology during disease on the serum proteome. 
Stentiford et al. (2005) in a multidisciplinary study investigated the proteomic 
and metabolomic change in relation to the pathogenesis of liver tumours in wild 
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dab (Limanda limanda). However, to date little proteomic investigation has been 
carried out to discover humoral markers of infection and pathogenesis during 
disease in Atlantic salmon. 
 
3.1.4 Aims of Study 
• To discover potential serum markers of infection and pathogenesis of PD 
in Atlantic salmon by 2D-PAGE 
• MS/MS fingerprinting to identify proteins found to alter in abundance 
through the twelve weeks of sampling.  
• Determine association between histopathological data of pathological 
damage to tissues during the disease and the serum proteome. 
N.B. The findings of this chapter have been published in Braceland et al (2013). 
 
3.2 Materials and methods 
3.2.1 Sample Preparation and Two-Dimensional Electrophoresis (2-DE) 
In order to keep the 2-DE investigation to a manageable size, 1 μl of each serum 
sample collected from each fish sampled at a particular time point was pooled 
according to week to create samples for the analysis of changing protein 
composition throughout the time course. Total protein concentration of the 
pooled samples was determined by Bradford assay, using Bradford Reagent 
(Sigma-Aldrich, Poole UK), in accordance with the manufacturer’s protocol. 
Samples were dilutef in loading buffer (BioRad Hemel Hempstead, UK), to an 
equal protein loading (of 208 µg) for 2-DE  protein separation by isoelectric 
focusing based on isoelectric point (pI) and sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) based on molecular weight (Mw). 
Three replicate 2-DE gels were run of the serum pool of samples from each time 
point to allow for technical replication.  Separation by pI was carried out using 
11cm immobilized pH Gradient (IPG) strip with a pH range of 3 to 10 (BioRad, 
Hemel Hempstead, UK). After protein loading of the IPG strips, with serum 
diluted in a rehydration buffer (8M Urea, 2% CHAPS, 50 mM DTT, 0.2% Bio-Lyte®) 
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(BioRad, Hemel Hempstead, UK) and covered in 500µl of mineral oil, a combined 
rehydration and focusing step was carried out over 17 h with a total of 35000 V-
hr. The IPG strips were removed, oil drained and then treated with two 
equilibration buffers both made from a stock solution comprised of 6M urea, 
0.375 M Tris-HCl, pH 8.8, 2% (w/v) SDS, 20% (v/v) glycerol, the first of these 
containing 2% (w/v) dithiothreitol (Sigma-Aldrich, Poole, UK) to reduce the 
proteins and subsequently the alkylating agent iodoacetamide at 2.5% (w/v) 
(Sigma-Aldrich, Poole, UK). IPG strips were then placed onto Criterion SDS-PAGE 
gels and submerged in XT Mops running buffer and subjected to electrophoresis 
at 200V for one hour. (Bio-Rad, Hemel Hempstead UK)  Subsequently gels were 
stained in Coomassie brilliant blue G-250 dye 0.1% (w/v) in de-stain solution for 
1 hour and then de-stained using a solution of methanol: water: acetic acid, 
(4:5:1) overnight, scanned and saved in 16-bit grey TIFF format images for gel 
image analysis. 
 
3.2.2 Gel Image Analysis 
Images were uploaded onto ‘Nonlinear Progenesis SameSpots 2D gel image 
analysis software (Nonlinear Dynamics, Newcastle, UK) which was used to 
identify protein spots that were differentially expressed through time (inferred 
by the programme by normalised spot intensities). Initial results were filtered 
using the programme’s statistical analysis function, with only those with a power 
value of >80% and ANOVA significance score of <0.05 between groups of replicate 
gels, being chosen for protein identification.  Samespots analysis was performed 
in the laboratory of Dr P Cash, University of Aberdeen.  To investigate the 
relationship among different time-points and different proteins with respect to 
spot intensity and the dataset was analysed using cluster analysis. ArrayStar 
software (DNASTAR, Madison, WI, USA) was the programme used to perform 
Hierarchical Cluster Analysis based on Euclidean distance with the results being 
illustrated in the form of a heat map. 
Spot information (profiles) were also used in a general linear model procedure in 
SAS version 9.3 (SAS Institute, Cary, N. Carolina) for regression analysis. Each 
spot was regressed on the mean value of each tissue’s histopathological score at 
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each sampling time point in a separate model.  Therefore, the probability that a 
protein spot increased or decreased in intensity in association with tissue 
damage as determined by histopathology was assessed. 
 
3.2.3 Spot Preparation and Mass-Spectrometry 
Chosen protein spots were excised manually by scalpel and placed in individual 
vials to be subjected to in-gel digestion for protein extraction prior to 
identification via mass spectrometry analysis. Gel pieces were washed with 
100mM NH4HCO3 for 30 minutes and then for a further hour with 100 mM 
NH4HCO3 in 50% (v/v) acetonitrile. After each wash all solvent was discarded. 
Gel plugs were then dehydrated with 100% acetonitrile for 10 minutes prior to 
solvent being removed and dried completely by vacuum centrifugation. Dry gel 
pieces were then rehydrated with 10 µl trypsin at a concentration of 20 ng/µl in 
25 mM NH4HCO3 (Cat No. V5111, Promega, Madison, WI, USA) and proteins 
allowed to digest overnight at 37˚C. This liquid was transferred to a fresh tube, 
and gel pieces washed for 10 min with 10 µl of 50% acetonitrile. This wash was 
pooled with the first extract, and the tryptic peptides dried to completion. 
Tryptic peptides were solubilized in 0.5 % (v/v) formic acid and fractionated on 
a nanoflow uHPLC system (Thermo RSLCnano) before analysis by electrospray 
ionisation (ESI) mass spectrometry on an Amazon ion trap MS/MS (Bruker 
Daltonics). Peptide separation was performed on a Pepmap C18 reversed phase 
column (LC Packings), using a 5 - 85% v/v acetonitrile gradient (in 0.5% v/v 
formic acid) run over 45 min. at a flow rate of 0.2 ml / min. Mass spectrometric 
(MS) analysis was performed using a continuous duty cycle of survey MS scan 
followed by up to five MS/MS analyses of the most abundant peptides, choosing 
the most intense multiply-charged ions with dynamic exclusion for 120s. MS data 
were processed using Data Analysis software (Bruker) and the automated Matrix 
Science Mascot Daemon server (v2.1.06). Protein identifications were assigned 
using the Mascot search engine to interrogate protein sequences in the NCBI 
databases restricting the search to teleostei, allowing a mass tolerance of 0.4 Da 
for both MS and MS/MS analyses. In addition, the search consisted of a 
carbamidomethyl fixed modification and a variable oxidation. 
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3.2.4 Statistical Analysis 
The relationship between disease pathology and protein abundance, given by 
spot intensities, was examined by multilinear regression general linear model 
(GLM) analysis to investigate the statistical correlation between individual spots 
intensities against tissue specific pathologies. For this every spots intensity 
profile from W0pc to W12pc was regressed against individual (ie white muscle, 
red muscle, heart, and pancreas individually) mean tissue histopathology scores 
over the same period. 
 
3.3 Results 
3.3.1 Profiling Changes in The Serum Proteome  
There were a number of clearly visible differences in the serum proteome over 
the 12 week period of the trial, illustrated in Figure 3.1 where representative 
gels from each of the nine sampling time points are shown. To quantify and 
identify changes, scanned 2D-PAGE gel images from each sampling time point 
were compared using ‘SameSpots’ software to identify protein spots which were 
differentially expressed in the serum as a result of PD. In total, 894 spots were 
identified by the SameSpot software of which 72 spots were found to differ 
significantly over the course of infection (Figure 3.2).  These were excised for 
peptide mass fingerprinting from the gel where they showed greatest intensity.  
Protein identification following DEAMON /MASCOT searching is given in Table 
3.1.  Spot intensities at each time-point were analysed using Hierarchical Cluster 
Analysis to more clearly identify whether an association with disease progression 
over time could be identified (Figure 3.3) and to group proteins which possessed 
similar expression profiles. Figure 3.3 also lists spot numbers and their 
corresponding identities obtained by ion trap mass spectrometry analysis of 
excised spots. 
 
The dendrogram at the top of Figure 3.3 shows the relationship of the spot 
intensities at the nine time points illustrating progression of the infection.  
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There was a clear separation between those recorded from 0 – 4 wpc and those 
recorded from 5 wpc onwards. Comparison of the proteome at 12 wpc with those 
prior to 4 wpc indicated a return to homeostasis. The overall fold increase or 
decrease in spot intensities from basal level (week 0) for up regulated and down 
regulated proteins respectively is shown in Table 3.1. Whilst most proteins and 
enzymes increased in their abundance there were also a number of proteins that 
declined in abundance (e.g. albumin).  
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Figure 3.1 Two dimensional electrophoresis separation of serum. Sample images of 2-dimension electrophoresis gels, after coomassie 
staining and subsequent de-staining, from all sampling time points from week 0 to 12 post challenge. From left to right: Top row = Week 0, 
2 and 3 images. Middle row = Week 4, 5 and 6 images. Bottom row = Week 8, 10 and 12 images. Molecular weight (Mw) and isolectric point 
(pI) range are indicated on the gel at the top left (week 0).
W0 W2 W3 
W4 W5 W6 
W8 W10 W12 
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Figure 3.2: Protein spots subjected to mass spectrometry. Protein spots identified as being differentially expressed following infection 
on a 2-dimension electrophoresis 
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Table 3-1 Protein spot identifications. Protein spots (n=72) showing significant  change in spot intensity during the 12 weeks post 
infection, where negative symbol (-) indicates a fold decrease in spot intensity, compared to pre-infection on week 0. 
Spot 
Number 
Identification (Uniprot Reference) Max. 
Fold 
Change 
Estimated 
pI 
Estimated 
MW (kD) 
MOWSE 
Score 
Peptide 
Matches 
% 
coverage 
19 Serotransferrin II + Ig heavy chain C region (TRF2SALSA + 
A46533) 
3.1 6.91 112 821,  65 43,  2 38,  5 
32 C1 inhibitor (Q70W32) 5.4 5.21 97 137 6 14 
43 Serotransferrin II (TRF2SALSA) 4.5 7.36 91 527 14 19 
45 Complement factor H (Q2L4Q6) 10.4 8.37 91 79 2 3 
47 Alpha-2 enolase-1 + Complement factor H (Q9DDG6 + 
Q2L4Q6) 
3.2 7.52 90 111,  94 3,  3 9,  3 
74 No significant identification 4.4 4.33 81    
98 Apolipoprotein A-I precursor (JH0472) 2.6 4.96 76 113 5 23 
146 Complement component C9 (Q4QZ25) 2.2 5.2 70 226 7 17 
150 Hemopexin-like protein (P79825) 9.6 4.22 68 64 3 9 
151 Transferrin + Ig heavy chain C region (T11749 + A46533) 1.5 7.27 68 967,  
139 
32,  4 35,  12 
201 Antithrombin + Complement C9( Q9PTA8+ Q4QZ25) -2.8 5.43 59 156,196   8,  6 14,  21 
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Spot 
Number 
Identification (Uniprot Reference) Max. 
Fold 
Change 
Estimated 
pI 
Estimated 
MW (kD) 
MOWSE 
Score 
Peptide 
Matches 
% 
coverage 
220 Hemopexin-like protein + Beta-actin (P79825 + Q4U1U5) 2.5 6.57 57 166,  
107 
3,  3 8,  12 
224 Hemopexin-like protein (P79825) 2.2 7.5 56 150 7 16 
227 Hemopexin-like protein (P79825) 1.5 6.06 56 128 11 14 
249 Serotransferrin II (TRF2SALSA) 5.4 8.36 51 101 3 7 
260 Serum albumin 2 + Serum albumin 1 (ABONS2 + ABONS1) -1.7 4.77 50 364,  
320 
14,  13 24,  20 
299 Enolase (Q7ZZM5) 5 8.03 47 308 14 25 
313 Pyruvatekinase (Q8QGU8) 3.5 7.58 46 155 6 11 
317 Alpha-2 enolase-1 (Q9DDG6) 7.6 7.94 45 648 37 53 
326 Alpha-2 enolase-1 (Q9DDG6) 5.6 7.78 45 560 23 42 
328 Alpha-2 enolase-1 (Q9DDG6) 5.2 7.27 44 292 15 39 
342 Serum albumin 2 (ABONS2) -11.1 5.54 44 666 32 31 
357 Serum albumin 2 + Complement factorB/C2-B (ABONS2 + 
Q9DEC8) 
2.4 5.2 41 302,  49 13,  3 18,  3 
360 Alpha-2 enolase-1 (Q9DDG6) 15.3 7.77 41 624 28 44 
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Spot 
Number 
Identification (Uniprot Reference) Max. 
Fold 
Change 
Estimated 
pI 
Estimated 
MW (kD) 
MOWSE 
Score 
Peptide 
Matches 
% 
coverage 
368 Serum albumin 2 + Serum albumin 1(ABONS2 + ABONS1) -2.8 4.88 40 318,  
295 
15,  13 19,  16 
381 Alpha-2 enolase-1 + Creatine kinase (Q9DDG6 + Q8JH38) 2.8 7.28 38 704,  
101 
30,  5 28,  14 
386 Aldolase (Q804Y1) 13.8 8.72 38 108 3 23 
388 Aldolase (Q804Y1) 8.1 8.62 38 94 1 9 
391 Muscle-type creatine kinase CKM1 (Q8JH39) 5.1 7.35 38 252 9 17 
393 Glyceraldehyde3-phosphate dehydrogenase (O42259) 15.7 8.79 38 102 9 36 
394 Aldolase A (Q8JH72) 11.8 8.82 38 231 11 20 
395 Serotransferrin II (TRF2SALSA) 2.2 6.56 38 210 5 9 
440 Alpha-2 enolase-1(ABONS1) 4.5 6.64 36 164 3 9 
442 Creatine kinase (Q98SS7) 3 7.61 36 218 6 17 
444 Complement C3-1 + Cystein proteinase inhibitor protein 
(P98093 + Q70SU8) 
-3.1 5.4 36 156,  36 10,  2 6,  12 
450 Serotransferrin II precursor (TRF2SALSA) -2.6 6.79 36 444 15 23 
463 Glyceraldehyde3-phosphate dehydrogenase (Q90ZF1) 10.6 8.98 34 247 18 41 
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Spot 
Number 
Identification (Uniprot Reference) Max. 
Fold 
Change 
Estimated 
pI 
Estimated 
MW (kD) 
MOWSE 
Score 
Peptide 
Matches 
% 
coverage 
472 Serum albumin 2 (Q98SS7) -3.7 4.79 34 323 12 19 
473 Fructose-bisphosphate aldolase (Q4RVI9) 16.9 8.81 34 98 1 3 
477 Aldolase A (Q8JH72) 10.1 8.7 33 130 5 18 
479 Glyceraldehyde 3-phosphate dehydrogenase (O42259) 7.1 8.43 33 190 20 34 
493 Glyceraldehyde 3-phosphate dehydrogenase (O42259) 11.6 8.18 33 147 13 12 
494 Glyceraldehyde 3-phosphate dehydrogenase (Q90ZF1) 15.3 8.2 33 280 13 45 
499 Proteasome (Q7ZVP5) 8.2 8 32 35 1 1 
500 Aldolase A (Q8JH72) 15.4 8.58 32 110 4 17 
509 Serotransferrin II (TRF2SALSA) -2.6 6.78 31 250 11 18 
529 Alpha-2 enolase-1 (Q9DDG6) 5 7.07 30 80 3 11 
545 Serotransferrin II (TRF2SALSA) -5.7 6.57 28 64 3 5 
548 Serum albumin 1 (P21848) -7 6.29 27 122 3 7 
556 Serotransferrin 2 + Immunoglobulin light chain (TRF2 + 
AAG18369) 
-5.3 6.36 27 404, 
150 
18,  7 16,  33 
565 Hemopexin-like protein (P79825) 7.8 6.26 26 51 4 8 
568 Transferrin (Q8AYG2) -3.6 7.36 26 285 12 36 
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Spot 
Number 
Identification (Uniprot Reference) Max. 
Fold 
Change 
Estimated 
pI 
Estimated 
MW (kD) 
MOWSE 
Score 
Peptide 
Matches 
% 
coverage 
575 Apolipoprotein A-I + Ig light chain precursor (JH0472 + 
AAG18369) 
1.8 6.62 26 188,  76 8,  4 28,  24 
584 Malatedehydrogenase1a (B8JMZ0) 5.8 8.88 25 70 1 4 
586 Apolipoprotein A-I (JH0472) 1.9 4.76 25 262 8 27 
598 Apolipoprotein A-I (JH0472) 1.5 5.15 24 257 19 42 
602 No significant identification. 3.6 8.63 24    
608 Triosephosphate isomerase (Q70I40) 2.8 8.5 24 170 6 22 
613 Serum albumin 2 (ABONS2) 2.4 8.1 24 488 19 23 
623 Triosephosphate isomerase + Ig light chain (Q70I40 + 
AAG18369) 
3.4 8.57 23 305,  
109 
10,  5 49,  19 
624 Triosephosphate isomerase (Q70I40) 2.4 8.1 23 194 11 50 
626 Ig light chain (AAG18369) 2.4 7.26 23 190 8 24 
627 Triosephosphate isomerase + Ig light chain constant region 
(Q70I40 + AAN40739) 
2.6 7.53 23 131,  87 5,  4 22,  25 
628 Triosephosphate isomerase (Q70I40) 3.9 7.85 23 432 19 65 
642 Apolipoprotein A-I (JH0472) 3.8 5.57 21 435 27 37 
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Spot 
Number 
Identification (Uniprot Reference) Max. 
Fold 
Change 
Estimated 
pI 
Estimated 
MW (kD) 
MOWSE 
Score 
Peptide 
Matches 
% 
coverage 
656 Serotransferrin II (TRF2SALSA) -5.3 8.63 20 251 6 10 
668 Apolipoprotein A-I (JH0472) -4.8 5.17 19 325 19 34 
669 Apolipoprotein A-1 (JH0472) -4.1 5.42 19 221 14 32 
687 Serotransferrin II (TRF2SALSA) 4.6 7.93 18 199 7 12 
702 Prostaglandin D synthase (Q9DFD7) -3.3 8.16 17 82 1 9 
738 Putative oncoprotein nm 23 (Q2L4Q6) 7.2 7.3 14 58 11 22 
741 Nucleoside diphosphate kinase (Q7ZZQ7) 4.6 6.9 14 58 8 22 
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Figure 3.3: Arraystar heat map representing the results of Hierarchical 
clustering of spot intensities. The relationships among different sampling time-
points are illustrated as a dendrogram at the top of the diagram. The right-hand 
side gives spot number and corresponding identity from MS/MS which are 
grouped by profile similarity with a dendrogram showing the relationships on 
left-hand side. The heat map is on a colour scale where low protein abundance 
is represented in blue and high abundance in red. 
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3.3.4 The Relationship Between Tissue Pathology and The Serum 
Proteome  
The relationship between disease pathology and protein abundance, given by 
spot intensities, was examined by multilinear regression general linear model 
(GLM) analysis of mean pathological scoring and all mean spot intensities at each 
sampling time point. Table 3.2, which lists spot numbers and their corresponding 
protein identity, also indicates the probability (Pr > F) that a given spot 
expression profile is linked with a particular tissue pathology, with values <0.05 
being regarded as significant. However, it is important to note that significance 
in this case is approached with cautrion due to the high number of comparisons 
and the use of a p = 0.05 threshold. Moreover, this demonstrates the merits of 
validating any perceived significance correlation by other methods (chapter 3) 
for promising results. In addition, the comparison of a continuos measurement 
such as spot intensity against a semi quantitative histopathological scoring 
system may increase false positives/ untrue correlation thus again increasing the 
need for further validation of said results. 
 
In addition, expression profiles were plotted on a graph for each protein against 
the mean pathology pattern of each tissue sampled. As an example Figure 3.4 
illustrates the relationship between mean white muscle histopathology results 
and the spot intensity of protein spot 313, identified as pyruvate kinase between 
weeks 2 and 12. Week 0 was removed from this analysis as white muscle showed 
no lesions at this time point. Graphs for other proteins are given as extra 
material in the Appendix. 
 
The alterations in serum proteins as a result of PD fell into two categories. The 
first category included proteins which demonstrated a change in serum 
abundance (spot intensity) associated with damage to a particular tissue or 
tissues where an increase in intensity was significantly related to the damage 
(p<0.05).  In contrast there were proteins for which the abundance change was 
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not associated with tissue damage and were possibly present in serum as 
humoral components of host defence (Table 3-2). Among the group of proteins, 
the concentration of which was associated with tissue pathology, were a number 
of enzymes described by ontology as being involved in intracellular pathways.  
These include creatine kinase, enolases, triosephosphate isomerase, and malate 
dehydrogenase 1a. The second group of proteins, alteration of which were not 
related to tissue damage , included a number of well defined (in other systems) 
humoral constituents of the immune response such as a number of complement 
components, hemopexin, transferrin, and apolipoprotein.  
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Figure 3.4: Spot profile v histopathological score. Plotting spot 313 (pyruvate 
kinase) mean intensity and mean histopathological scoring of white muscle 
against sampling time points. Open circles plot histopathology scores and filled 
circles plot spot intensity at a given time point.  
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Table 3-2 Significant correlation analysis of spot profiles and tissue lesion scores. Probability (P) of relation between change in protein 
spot intensity and histopathology of tissues in salmon infected with SAV. Significant correlations (p < 0.05) are in bold. 
  Probability (P)  
Spot 
Number 
Identification Pancreas  Heart Red 
Muscle 
White 
Muscle 
19 Serotransferrin II + Igheavy chain C region (TRF2SALSA+A46533) 0.4775 0.7044 0.642 0.8544 
32 C1 inhibitor(Q70W32) 0.542 0.3536 0.9656 0.3992 
43 Serotransferrin II (TRF2SALSA) 0.0904 0.8329 0.204 0.0166 
45 Complement factor H (Q2L4Q6) 0.3102 0.5645 0.1132 0.0061 
47 Alpha-2 enolase-1 + Complement factor H (Q9DDG6+Q2L4Q6) 0.0241 0.7643 0.0663 0.0059 
74 No significant identification 0.2794 0.5719 0.4255 0.1125 
98 Apolipoprotein A-1 Iprecursor(JH0472) 0.2179 0.5856 0.474 0.1619 
146 Complement component C9(Q4QZ25) 0.1032 0.6175 0.8862 0.9013 
150 Hemopexin-like protein(P79825) 0.872 0.3269 0.7833 0.804 
151 Transferrin + Ig heavy chain C region(T11749+A46533) 0.0786 0.8847 0.5434 0.3814 
201 Antithrombin + Complement component C9 (Q9PTA8+Q4QZ25) 0.5868 0.5314 0.5774 0.9455 
220 Hemopexin-like protein + Beta-actin (P79825+Q4U1U5) 0.2798 0.4227 0.5775 0.1481 
224 Hemopexin-like protein(P79825) 0.2104 0.9728 0.857 0.7601 
227 Hemopexin-like protein (P79825) 0.077 0.8458 0.5829 0.4513 
249 Serotransferrin II(TRF2SALSA) 0.2894 0.5577 0.1483 0.0339 
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  Probability 
(P)  
Spot 
Number 
Identification Pancreas  Heart Red 
Muscle 
White 
Muscle 
299 Enolase(Q7ZZM5) 0.1996 0.5102 0.1088 0.0032 
313 Pyruvatekinase(Q8QGU8) 0.0806 0.8639 0.0559 0.0039 
317 Enolase1,(Alpha)(Q6GMI7) 0.1688 0.6918 0.0963 0.0042 
326 Alpha-2enolase-1(Q9DDG6) 0.1489 0.6904 0.0853 0.0061 
328 Alpha-2enolase-1(Q9DDG6) 0.2178 0.5131 0.1028 0.0013 
342 Serum albumin 2 (ABONS2) 0.371 0.1541 0.8433 0.3281 
357 Serum albumin 2 + Complement factorB/C2-B (ABONS2+Q9DEC8) 0.1225 0.1539 0.71 0.6958 
360 Alpha-2enolase-1(Q9DDG6) 0.1997 0.7136 0.047 0.0002 
368 Serum albumin 2 + Serum albumin 1(ABONS2+ABONS1) 0.0766 0.0806 0.7414 0.6659 
381 Alpha-2 enolase-1 + Creatine kinase (Q9DDG6+Q8JH38) 0.0618 0.9464 0.0272 0.0041 
386 Aldolase(Q804Y1) 0.1753 0.911 0.0229 0.0204 
388 Aldolase(Q804Y1) 0.153 0.7466 0.0532 0.0752 
391 Muscle-typecreatinekinaseCKM1(Q8JH39) 0.0462 0.7088 0.004 0.0009 
393 Glyceraldehyde3-phosphate dehydrogenase(O42259) 0.1131 0.9435 0.0028 0.0002 
394 AldolaseA(Q8JH72) 0.1324 0.9747 0.0067 0.0003 
395 Serotransferrin II (TRF2SALSA) 0.0732 0.7892 0.4174 0.1811 
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  Probability 
(P)  
Spot 
Number 
Identification Pancreas  Heart Red 
Muscle 
White 
Muscle 
440 Alpha-2enolase-1(ABONS1) 0.0534 0.8544 0.0097 0.0006 
444 Complement C3-1 + Cysteinproteinase inhibitor protein (P98093 
+Q70SU8) 0.3808 0.3852 0.8427 0.4569 
450 Serotransferrinv II precursor(TRF2SALSA) 0.0744 0.1147 0.8475 0.8393 
463 Glyceraldehyde3-phosphatedehydrogenase(Q90ZF1) 0.1712 0.8982 0.0287 0.0277 
472 Serum albumin 2 + Creatine kinase(ABONS2+Q98SS7) 0.2774 0.2544 0.7464 0.3222 
473 Fructose-bisphosphate aldolase(Q4RVI9) 0.1771 0.8644 0.0292 0.0336 
477 Aldolase A (Q8JH72) 0.1181 0.7005 0.0143 0.0255 
479 Glyceraldehyde-3-phosphatedehydrogenase(O42259) 0.0972 0.4788 0.0307 0.1032 
493 Glyceraldehyde3-phosphatedehydrogenase(O42259) 0.2358 0.7868 0.0975 0.1501 
494 Glyceraldehyde3-phosphate dehydrogenase(Q90ZF1) 0.271 0.8078 0.132 0.2332 
499 Proteasome (Q7ZVP5) 0.1454 0.6439 0.0706 0.1262 
500 AldolaseA(Q8JH72) 0.1836 0.7625 0.039 0.0693 
509 Serotransferrin II (TRF2SALSA) 0.1302 0.1569 0.9378 0.5525 
529 Alpha-2enolase-1(Q9DDG6) 0.0105 0.1837 0.0004 0.0232 
545 SerotransferrinII(TRF2SALSA) 0.01 0.1764 0.0002 0.0215 
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  Probability 
(P)  
   
Spot 
Number 
Identification 
Pancreas 
Heart Red 
Muscle 
White 
Muscle 
548 serumalbumin1(P21848) 0.381 0.1562 0.7586 0.2887 
556 Transferrin+Immunoglobulinlightchain(Q8AUU0+AAG18369) 0.1617 0.063 0.7479 0.5452 
565 Hemopexin-likeprotein(P79825) 0.1514 0.0657 0.7578 0.6317 
575 Apolipoprotein A-I + Ig lightchain precursor (JH0472+AAG18369) 0.0124 0.115 0.3685 0.7495 
584 Malatedehydrogenase1a(B8JMZ0) 0.0555 0.7354 0.0006 0.0001 
586 ApolipoproteinA-I (JH0472) 0.1272 0.781 0.3957 0.1807 
598 Apolipoprotein A-I (JH0472) 0.018 0.3991 0.3503 0.4654 
602 No significant identification 0.0931 0.8462 0.0318 0.0005 
608 Triosephosphate isomerase(Q70I40) 0.0134 0.6271 0.0079 0.0029 
613 Serum albumin 2 (ABONS2) 0.1367 0.6988 0.1639 0.0516 
623 Triosephosphateisomerase+ Ig light chain(Q70I40+AAG18369) 0.1508 0.5987 0.0971 0.0068 
624 Triosephosphate isomerase(Q70I40) 0.0893 0.8886 0.1385 0.0628 
626 Ig light chain (AAG18369) 0.1144 0.7554 0.1929 0.0606 
627 Triosephosphate isomerase + Ig light chain constant 
region(Q70I40+AAN40739) 0.0396 0.6455 0.0066 0.0115 
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  Probability 
(P)     
Spot 
Number 
Identification Pancreas  Heart Red 
Muscle 
White 
Muscle 
628 Triosephosphateisomerase(Q70I40) 0.0082 0.3003 0.0001 0.0047 
642 ApolipoproteinA-I(JH0472) 0.4075 0.7725 0.675 0.6736 
656 SerotransferrinII(TRF2SALSA) 0.0929 0.0296 0.7203 0.6526 
668 ApolipoproteinA-I(JH0472) 0.2306 0.1865 0.8973 0.4736 
669 Apolipoprotein A-1 (JH0472) 0.5808 0.4595 0.5278 0.3262 
687 SerotransferrinII(TRF2SALSA) 0.1577 0.0552 0.8437 0.5952 
702 Prostaglandin D synthase(Q9DFD7) 0.1102 0.356 0.2959 0.4512 
738 Putative oncoprotein nm 23 (Q2L4Q6) 0.1136 0.9017 0.0695 0.0056 
741 Nucleoside diphosphate kinase(Q7ZZQ7) 0.0736 0.8809 0.0467 0.007 
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3.4 Discussion 
3.4.1 Monitoring Pancreas Disease Via Proteomics 
The analysis of spot profiles at sampling points demonstrated that the serum 
proteome of salmon was altered markedly in response to SAV3. The heat map of 
proteome responses following the 2-DE showed a distinct change in the serum 
proteome between pre and post week 4 (Figure 3.3), with the exception of week 
12, which clustered with samples collected between weeks 1 and 4; thus, 
indicating the near return of homeostasis. These results corresponded with the 
histopathological results (see chapter 2 Figure 2.3) indicating that 2-DE could be 
used as a useful investigative approach to monitor PD. Furthermore, using both 
histopathology and proteomic approaches allowed proteomic results to be 
separated into proteins which rise or fall in association with tissue damage and 
those which were likely to be part of the host response to SAV3 (Table 3.2) as 
their alteration in intensity was unrelated to the histopathology score.  The use 
of hierarchical clustering to analyse spot intensities effectively highlighted the 
common responses within groups of protein spots and clearly illustrated a 
temporal trend in the dataset. It is important to note that this analysis was 
carried out using pooled samples, determined by time point. Whilst, there is an 
argument for using biological replicates using individual fish it was considered 
that pooling samples prior to electrophoresis was the optimal approach as 
resource constraints limited the study to 3 gels per time point. As this study was 
a cohabitation trial there are, due to infection dynamics, fish at various disease 
stages which would, when using an individual fish approach, potentially require 
many replicates and pooling of samples was thus required to make the study 
feasible. Moreover, as this experimental methodology simulates conditions 
during an outbreak of PD at an aquaculture site it was decided that pooling 
would allow for the analysis of changes at a site as a whole. 
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3.4.2 Biomarkers of Tissue Pathologies 
The use of histopathology in conjunction with a 2-DE proteomic approach 
allowed statistical analysis to be carried out to test the hypothesis that the 
expression profile of specific proteins was correlated with the pathology of 
examined tissues. Analysis of this relationship allowed the identification of the 
tissue source of the identified serum proteins. 
 
The abundance of only one spot significantly correlated to the histopathology 
results of heart damage. This was spot 656 and was identified by MS as the 
Serotransferrin II. The expression profile of this protein was significantly related 
to the pathological damage to the heart. The lack of additional biomarkers of 
heart damage was most likely because the abundances of other potential 
specific protein biomarkers were not raised sufficiently in the serum to be 
detected by the proteomic methodology used in this study 
 
The pathological damage to the pancreas as well as the white and red skeletal 
muscle was much more pronounced and longer lasting than that observed in the 
heart (chapter 2 Figure 2.3), and there were more protein spots correlated with 
histopathology lesion scores of this tissue (Table 3.2). Six spots were found to be 
correlated with damage to pancreas as well as correlating to damage to white 
and red muscle. Three of the spots were identified as triosephosphate isomerase 
(spots 608, 627, and 628) and were in close proximity on 2-DE gels, whilst the 
remaining three spots were identified as creatine kinase, alpha-2 enolase-1, and 
serotransferrin (spots 391, 529 and 545 respectively). Enolase and creatine 
kinase are enzymes of glycolysis and were presumably derived from the damage 
to muscle. Transferrins are found in the fibroblasts of the pancreas and skeletal 
muscles thus it was possible that this serotransferrin was membrane bound/ 
intracellular transferrin isoform that leaked into the circulation due to tissue 
damage. Only three spots were exclusively correlated with damage to the 
pancreas (Table 3.2).  One was identified as albumin (spot 260) while the other 
two spots contained apolipoprotein (spots 575 and 598). However, as the 
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apolipoprotein spot intensities during PD infection only increased by <2 fold they 
were unlikely candidates as biomarkers of pancreas damage.  
 
The two types of skeletal muscle studied in this investigation were white and red 
muscle. These muscle fibres are differentiated by two functional characteristics, 
specifically contractile speed and metabolic activity. White fibres (fast) possess 
a higher action potential due to the quicker generation of ATP by glycolysis 
compared to red (slow) fibres which in general terms generate ATP by oxidative 
(aerobic) processes. However, glycolysis does occur in red muscle fibres, which 
explains the finding that many glycolytic enzymes were found to rise in serum 
spot intensities at the peak of PD pathological damage to both muscle types 
(Table 3.2). Many of these glycolytic enzymes have been observed and studied in 
both muscle types in salmon, and have been found to possess higher activity 
levels in white muscles than in red (Johnston 1977; Martinez et al. 2004). Only 
two spots, identified as Glyceraldehyde-3-phosphatedehydrogenase and aldolase 
A (479 and 500 respectively), were exclusively identified as related to red 
muscle pathology. Rather than highlighting the metabolic differences between 
these two types of Salmo salar skeletal muscle these differences may indicate 
that red and white muscle fibres display a differential expression of multiple 
isozymes of these enzymes.  
 
Conversely this study identified a number of possible unique biomarkers of white 
muscle damage due to SAV3 as spots 43, 45, 249, 299, 313, 326, 328, and 738 
(for protein identification see Table 3.1 or Table 3.2) were related to 
histopathological change in white muscle. An explanation of this observation is 
that in Atlantic salmon the white muscle mass is much greater than red. 
Complement factor H (CFH) was one of the proteins found in this study to be a 
possible biomarker of white muscle damage; in fact all three spots identified as 
this protein (45, 47 and 738) possess expression profiles that correlated 
significantly with white muscle pathology. This glycoprotein is an important 
component of the innate immune system with a number of known functions 
related to it being a regulator of the complement system alternative pathway 
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(Meri and Pangburn, 1990) and acting to reduce local concentrations of toxic 
products of inflammation (Jozsi et al. 2004). The expression profile of all three 
spots which contained CFH was that of a continuous rise in intensity until a peak 
at week 8wpc and then a sharp fall to near basal intensities in week 12.  
 
3.4.3 Humoral Components of The Serum Response During 
Pancreas Disease 
Complement is a vital component of the immune system of all animals. 
However, fish are unique in that their complement components exhibit a greater 
diversity than that of those observed in the mammalian system (Holland and 
Lambris 2002). In addition to complement Factor H described above, other 
Complement components were identified by 2-DE and found to change following 
SAV3 challenge in salmon but without a correlation to histopathology.  Thus 
complement components C3, C9, complement factor B, and the complement 
inhibitor C1 (spots 444, 146, 357 and 32 respectively), which have been 
previously characterised as part of the fish innate immune system, were 
identified in protein spots on 2-DE. Interestingly the complement membrane 
attack complex (MAC), of which C9 is a pivotal component, damages the 
envelope of enveloped viruses (Nakao et al. 2011). Moreover, it has been shown 
that salmonid antibodies are dependent on the presence of complement to 
neutralize (VHSV) and infectious hematopoietic necrosis virus (IHNV) both of 
which are enveloped rhabdoviruses (Holland and Lambris 2002).  Given that SAV 
is also an enveloped virus it is possible that complement also plays a role in its 
neutralization by Atlantic salmon antibodies in vivo. The expression profiles of 
C3 and complement factor B fell significantly at 5wpc whilst at the same time 
fractions of immunoglobulins rose sharply, (for example spot 626), which may 
have indicated that as immunoglobulins were synthesised to combat SAV, 
complement components declined in their serum concentration.  In contrast, the 
expression profile of C1 inhibitor was substantially different from these 
previously discussed complement components. The late peak in serum 
abundance of this protein at 10wpc may indicate that in the latter stages of 
disease recovery it becomes advantageous to inhibit complement activation due 
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to the harmful effects of the alternative pathway and MAC can have on host 
tissues (Lorenzen and Lapatra 1999).   
 
Hemopexin-like protein (spots 150, 220, 224, 227 and 565) was found to be 
significantly altered during SAV3 infection.   In mammalian species hemopexin is 
an acute phase protein (APP), synthesised in hepatocytes and extra-hepatocytic 
sites to be secreted into circulation, and possesses a high affinity for free 
circulating haem thus facilitating its clearance (Wicher and Fries 2010). 
Hemopexin in teleostei is usually referred to as hemopexin-like protein and has 
been studied at a genetic level by a number of groups. Its expression is highly up 
regulated during bacterial infections of Atlantic salmon (Tsoi et al. 2004) and 
rainbow trout (Bayne et al. 2001) with the proposal that hemopexin-like protein 
is up regulated in order to clear free haem from the circulation which would be 
detrimental to the proliferation of bacteria. In this study the expression profiles 
of the hemopexin-like protein spots was also found to change following 
infection. The first four of these spots were in close proximity and exhibited 
very similar expression profiles remaining near basal week 0 levels until at 5wpc 
they increased sharply and reached their peak intensity at 10wpc and started to 
fall again by 12wpc. This may have indicated an increase in serum haem 
concentration during PD with higher levels of hemopexin being synthesised to aid 
its clearance. In other teleost species two isoforms of hemopexin-like protein 
have been identified. For instance, medaka (Oryzias latipes) possesses two 
hemopexin-like proteins which differ not only in their tissue expression locations 
but also in their ability to bind haem (Hirayama et al. 2004). Interestingly, spot 
565 showed the opposite from these previously discussed spots in terms of 
expression profile. Despite also displaying early stable expression levels it fell 
sharply in intensity at 5wpc and continued to fall until 10wpc before starting to 
rise. Therefore, it is possible that Atlantic salmon also possess two isoforms of 
hemopexin-like protein with the first contained in spots 150, 220, 224 and 227 
and the second located in spot 565.  However it is possible that alterations in 
the hemopexin-like protein spots, especially for the lower molecular weight spot 
565, could be due to unspecific degradation of proteins of higher molecular 
weight.  It was notable that the matched peptides profiles were similar between 
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the hemopexin-like spots so that the differences in these protein spots could be 
due to post translational modification or degradation.  However it is possible 
that there could be two homologous isoforms thus more work is required to 
ascertain if, as in other fish (Hirayama et al. 2004), salmon possess multiple 
hemopexin isoforms. 
 
A total of 13 protein spots, differentially expressed during PD, were identified as 
transferrin (Tf). This glycoprotein is one of several humoral proteins with an 
affinity to iron. Iron binding by Tf facilitates the transport of iron from the 
circulation to cells (Bayne and Gerwick 2001) thus preventing a potentially toxic 
iron build up, although other functions are known (Stafford and Belosevic 2003). 
The intensities of 4 of the 13 Tf spots had a significant relationship with tissue 
damage (pancreas and skeletal muscle) and have been previously discussed. 
However, the change in expression of nine Tf spots did not exhibit such a 
relationship to tissue damage, and were thus deemed components of the 
immune system response to SAV infection. Of these Tf spots number 151 was by 
far the largest (in terms of area), migrated with the highest Mr (~68kD) and 
remained at a relatively constant expression level until between 8 and 10wpc at 
which point its expression increased sharply only to fall slightly by 12wpc. This 
spot was presumably the main protein constituent of Tf in the serum and is the 
full length isoform. Other spots identified as Tf were smaller in size with lower 
Mr than spot 151. These could have been degradation products, although 
Stafford et al (2001) has shown that certain transferrin fragments may not be 
just simply degradation products to be eliminated from the circulation, but play 
a significant role in the innate immune system of fish.  These studies 
demonstrated the ability of transferrin fragments (but not full length transferrin) 
of goldfish (Carassius auratus) to induce nitric oxide (NO) activation of 
macrophages which is vital in viral disease recovery since NO is a potent 
antiviral-agent and immune system modulator (Akaike and Maeda 2000). This 
observation of multiple transferrin fragments with different expression profiles 
may also help explain the considerable variability in the reporting of transferrin 
as either a positive or negative APP (Bayne and Gerwick 2001) in the fish 
immune system as certain approaches in studies may or may not detect these 
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fragments in terms of total transferrin. However, given the large number of 
spots (13 in total) which contained the protein it cannot be overlooked that, as 
with other proteins, many of these changes in concentration could be due to 
unspecific degradation. 
 
Interestingly the S-nitrosylation of glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) within cells can initiate a cascade ultimately ending in apotosis of cells 
(Hara et al. 2005). However, this study not only found GAPDH spots associated 
with tissue pathologies, but also two spots (493 and 494) which rose dramatically 
in intensity at 5wpc reaching their peak expression at 6wpc before falling to 
near basal intensities at 8wpc independently of tissue damage. Since GADPH is 
regarded as an intracellular enzyme involved in glycolysis this at first may be 
regarded as a surprising observation. However, endogenous authentic GADPH has 
previously been shown to be secreted outside of cells without causing cell lysis 
by Yamaji et al (2005) leading to the hypothesis that it may possess a role in 
defence against pathogens. Therefore, GADPH may be classed as an example of 
a moonlight protein where a primarily intracellular protein is secreted by cells 
and exhibits very different functions extracellularly. Another intracellular 
enzyme found by 2-DE that may possess ‘moonlighting’ functions extracellularly 
was the cytoplasmic glycolytic enzyme aldolase. This study found two spots of 
aldolase that showed no relationship with histopathology (Table 3.2) though 
whether there is a moonlighting function of this enzyme is currently unknown. 
 
Other proteins found in this study which increased in serum concentration were 
the apolipoproteins. Apolipoprotein A-1 together with apolipoprotein A-II 
constitute the most abundant circulating protein observed in teleosts. Its 
primary function is the binding and transportation of lipids. However, other 
antiviral, antimicrobial and anti-inflammatory defensive functions are known 
(Villaroel et al. 2007; Whyte 2007). This study identified four protein spots 
containing apolipoprotein which did not exhibit a relationship between 
expression profile and histology. Interestingly, despite apolipoprotein A-I being 
widely defined as negative acute phase proteins in mammals all, except spot 
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668, exhibited a steady increase in intensity with a peak at approximately 6 or 
8wpc confirming previous results which found apolipoprotein to be up regulated 
during fish disease (Magnadottir 2006; Russell et al. 2006). This finding 
demonstrated a major difference in the expression of this protein during disease 
in fish and may indicate additional functions of the protein in fish that do not 
exist in mammalian apolipoprotein. Despite this, as with transferrin, the 
possibility of this expression profile being due to nonspecific degradation of 
protein cannot be overlooked. 
 
Protein synthesis can also fall during disease as a shift due to a preferential 
synthesis of specific proteins. This is the widely accepted hypothesis of why 
albumin (an extremely abundant serum protein in all animals) is observed to act 
as a negative acute phase protein in most instances. This study also observed 
albumin to be down regulated following SAV3 challenge with the protein spots 
containing it showing a steady decline in expression. Albumin hepatic expression 
has also been shown to be reduced in other fish species during a number of 
diseases (Gerwick et al. 2006). Whilst albumin is a well-known negative acute 
phase protein, two other proteins which declined in serum abundance during PD 
are not as well documented. These are antithrombin (spot 201) and 
prostaglandin-D synthase (spot 702). Antithrombin inactivates several enzymes 
involved in the coagulation system and thus down regulation may allow the 
benefits of coagulation during disease. Prostaglandin-D synthase in serum has 
not been studied to any extent in fish or other species immunity, although 
inhibition of the protein has been shown to correlate with muscular necrosis 
(Mohri et al. 2009) which may have significance in PD and other viral diseases 
that cause necrosis of muscle fibres. It is therefore probable that these proteins 
are being down regulated for sufficient nucleotides to be available for the 
synthesis of afore up regulated proteins previously discussed. Moreover, giving us 
an insight into the pathways and components of the immune system which are 
pivotal for fighting SAV infection, for example, complement system and acute 
phase proteins.  
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This histopathological and proteomic study of PD in Atlantic salmon, Salmo salar, 
has identified numerous serum proteins which are altered in abundance during 
the disease.  Giving an insight, at the protein level into pathways and 
components of the immune system which are pivotal for fighting SAV infection, 
for example, complement system and acute phase proteins as well as potential 
markers of pathological damage during PD. A correlation between pathology and 
changes in spot intensity of intracellular proteins and enzymes was established, 
including variations in a number of tissue specific isozymes. Furthermore 
alterations, not associated with histopathology, were identified for components 
of humoral immunity which were presumably involved in both limiting the 
establishment of PD and aiding the return to homeostasis. A number of proteins, 
including complement components, apolipoprotein, hemopexin, and transferrin 
were identified as increasing in serum concentration, whilst albumin and 
antithrombin levels appeared to decrease during PD.  Prior to their use as 
biomarkers of either tissue damage or humoral response in PD, the diagnostic 
value of these proteins should be validated by complementary approaches,such 
as western blotting, immunohistochemistry and ELISA. The proteomics approach 
described here could be used to investigate other disease challenge models to 
look for points of similarity and difference between diseases of importance in 
aquaculture. This would help identify protein changes most associated with 
morbidity and death, and to deliver insights into disease aetiology and identify 
mitigation strategies. 
 
 Chapter 4: Validation 111 
 
 
 
 
 
 
 
 
 
Chapter 4 
Validation and Development of Potential Markers of 
Pathology
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4. Introduction 
4.1.1 The Biomarker Pipeline 
Post genomic tools such as proteomics have had great success in identifying 
novel biological markers of a number of diseases and traits in many species 
(Moore et al., 2007). For an identified potential target to have an impact on the 
armamentarium available for clinicians in both human and animal health there 
are a number of steps which must be carried out from identification to field use. 
Rifai et al. (2006) describe this process as a biomarker pipeline where potential 
targets are identified from a small number of samples before qualification, 
verification, and validation by clinical assay development with ever increasing 
sample numbers. However, to date the impact of many ‘omic’ studies in general 
terms to real world application has been poor. This lack of impact has been due 
to a number of failings and remains one of the greatest challenges in animal 
health. Indeed this transition from potential marker identification to assay 
development is more challenging in understudied species, such as salmon due to 
a lack of suitable tools such as suitable antibodies. 
 
In brief, for a biomarker to be a useful tool in diagnostics it must be accurate 
and sensitive for disease state, have low variation within a population 
undergoing the same stimuli and be reproducible and consistent over time and 
circumstance (Moore et al., 2007). If normally present in biological fluid or 
tissue under homeostatic conditions a ‘healthy range’ of analyte concentration 
must be established so a problem may be identified swiftly when out with this 
range. In addition, any diagnostic test target must also be consistent and 
accurate with robustness to biological and analytical variation.  
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4.1.2 Biomarkers of Pathological Damage 
Biological markers to assess fish health fall into a number of categories. For 
instance, markers of infection such as acute phase proteins (Eckersall and Bell, 
2010) can be used to give an indication that there is an infectious agent present 
at a given time. These can be extremely useful as non-destructive health 
monitoring tools and have advantages over specific tests of virus presence and 
antibody presence commonly used in salmon aquaculture (Adams and Thompson, 
2011). Acute phase proteins are detected in fish serum much earlier than 
antibody and can also be used as markers when the aetiological agent is not 
known. However, it is widely established that aetiological agents can be present 
at a given site for a period of time before, if any, clinical disease is observed 
(Kristofferson et al., 2009; Jansen et al., 2010). This, in terms of disease 
management strategies, creates a massive problem as one cannot be certain 
when a clinical outbreak occurs, using the current armamentarium available, 
unless histopathological analysis is routinely carried out thus further reducing 
output of fish to harvest and at significant sampling cost. Whilst creatine kinase 
(CK) is being used ever more routinely in salmon aquaculture as a prognostic tool 
and a general biomarker of pathological damage this assay has a number of 
limitations with more sensitive and tissue specific markers in high industrial 
demand for accurate diagnosis of clinical disease. 
 
4.1.3 Skeletal Muscle Damage 
Atlantic salmon aquaculture, like any industry, relies on the production of an 
end product which is profitable. In fish culture the main aim, therefore, is to 
produce flesh, comprised of skeletal muscle and fat, which is desirable in the 
market place. Quality of flesh is assessed in a number of ways (Larsson et al., 
2012) and is the result of a number of complex genetic and nutritional 
processes. Upon harvest of fish the quality of flesh is the major determinant of 
price and thus profitability of the cycle. Whilst downgrading of fillet can be 
caused by nutritional factors, toxic myopathies, and muscle breakdown due to 
excessive exertion (Larsson et al., 2012), one of the most important causes is 
infectious diseases which cause skeletal muscle myopathy.  
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Pancreas disease (PD) has been shown to have significant effects on fillet quality 
even in fish clinically healthy following recovery from disease, most probably 
due to chronic effects of pathological damage to skeletal muscle, and pancreas 
damage resulting in reduced ability to uptake nutrients (Lerfall et al., 2011; 
Larsson et al., 2012). However, whilst there are a number of non-destructive 
tools to detect the aetiological agent SAV and presence of antibody to the virus, 
there are not any tissue specific biomarkers currently available to diagnose 
associated pathologies. Therefore, a biomarker which could be used as a 
diagnostic tool for skeletal muscle myopathy would have great application in the 
field not only in diagnosing PD associated muscle myopathy but pathological 
damage due to other stressors.  
 
4.1.4 Validating Proteomic Results 
Given that the major constituent of skeletal muscle in salmon is white muscle 
any biomarker of pathological damage to this tissue would have potential at not 
only diagnosing the pathology in terms of disease but also as a marker of flesh 
quality. Therefore leading on from proteomic analysis of serum proteome 
changes during PD, enolase and aldolase were selected for further evaluation of 
their potential as markers of white muscle myopathy (section 3.4.2).  In addition 
to this, glyceraldehyde 3-phosphate dehydrogenase was chosen due to its 
surprising spot profiles in proteomic work. This ubiquitous enzyme has been 
previously shown to increase in serum abundance in other systems due to tissue 
pathology although it did not correlate with pathological damage during PD. 
Therefore, it was investigated to demonstrate if this apparent lack of correlation 
(between serum abundance and tissue pathology) was due to limitations of the 
gel based proteomic approach used. 
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4.1.5 Enolase  
Classically this enzyme is defined as a glycolytic enzyme catalyzing the 
conversion of 2-phosphoglycerate (2-PG) to phosphoenolpyruvate (PEP) in the 
ninth and penultimate step of glycolysis (Pancholi, 2001). However, it has been 
shown in numerous studies to have a number of other functions leading to it 
being regarded as a “moonlighting” enzyme (Avilan et al., 2011). Enolase 
distribution and isoform status in mammalian species is clearly defined with 
three paralogs being enolase 1 (α enolase), 2 (γ enolase) and 3 (β enolase) 
(Tracy and Hedges, 2000). Whilst these can form heterodimers, in the main they 
are separated by their tissue distribution with enolase 2 being expressed in 
neurons, enolase 3 in the muscle, and enolase 1 in all other tissue types. Indeed 
these isoforms have previously been shown to be biomarkers of a number of 
conditions in human medicine: enolase 1 serum concentrations are significantly 
higher in patients with hepatic fibrosis compared to healthy individuals (Zhang 
et al., 2013), raised enolase 2 levels have been shown to indicate ischemic 
stroke (Singh et al., 2013), and the presence of enolase 3 has been shown to 
correlate with progressive muscular dystrophy status (Mokuno et al., 1984). 
 
Enolase enzyme and its distribution is poorly defined in teleost species and little 
is known of its pathophysiology in salmonids. Landrey et al. (1978) investigated 
the enzyme in coho salmon, Oncorhynchus kisutch, examining both enolase 
activity in different tissues by enzymatic activity and isoforms distribution by 
cellulose acetate strip electrophoresis. In this study he stipulates there to be at 
least six isoenzymes with clear tissue separation of some of these forms 
stipulating that polyploidy may contribute to complexity and non-allelic forms 
arising through gene duplication. In some way this is supported by more recent 
work with two enolase 1 gene homologs in brown trout, Salmo trutta, being 
identified by Tracy and Hedges (2000) thus indicating there may be an added 
complexity in salmonid enolase due to gene duplication. Moreover, increased 
enolase gene family complexity may be found in other teleost species with a 
novel gene homologue being observed in sea bream, Sparus aurata, which was 
found to increase in expression 48 hours post bacterial lipopolysaccharide (LPS) 
infection thus indicating this isoform has some acute phase reaction (APR) 
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function (Ribas et al., 2004). Nakagawa and Nakagawa (1991) demonstrated 
differential enzyme activity in muscle enolase in red sea bream (Pagellus 
bogaraveo), Pacific mackerel (Scomber australasicus), and carp (Cyprinus 
carpio). However, serum concentrations of the enzyme have never been assayed 
in any fish species and thus its use as a non-destructive marker of muscle 
damage remains unknown /undetermined. 
 
4.1.6 Aldolase 
Aldolase is a ubiquitous enzyme involved in glycolysis which catalyses the 
reversible cleavage of fructose 1,6-bisphospahate to glyceraldehydes 3-
phosphate and dihydroxyacetone phosphate (Meyerhof and Lohman, 1934). 
However, like enolase and several other glycolytic enzymes, aldolase has been 
shown to possess numerous non glycolytic functions (Lorenzatto et al., 2012) 
thus being categorised as a moonlighting protein. Three genetically distinct 
isoforms of the enzyme exist in mammalian species (Lebherz and Rutter, 1969) 
of which expression is tissue and life stage dependent (Numazaki et al., 1984; 
Llewellyn et al., 1998). Aldolase A is expressed in the muscle and most other 
tissue types, aldolase B is the predominant isotype in the liver and kidney, and 
aldolase C expressed in the central nervous system (Haimoto et al., 1989) but 
has been found in other tissue types (Haimoto and Kato, 1986). Serum presence 
of these isoforms has been reported numerous times in association with 
pathological disorders in humans.  
Teleost aldolase, by comparison, is much understudied. However, enzyme 
activities have been shown to alter in tissues of the green sunfish (Lepomis 
cyanellus) and walking catfish (Clarias batrachus) in response to temperature 
changes and pesticides respectively (Shaklee et al., 1977; Tandon and Dubey, 
1983). Aldolase B has also been cloned and expression levels during 
smoltification studied in Atlantic salmon (Llewellyn et al., 1998). Despite this, as 
with enolase, its potential as a serum marker of pathological damage has not 
been investigated. 
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4.1.7 Glyceraldehyde 3-phosphate (GAPDH) 
Another glycolytic enzyme which has been shown to possess moonlighting 
functions is glyceraldehyde 3-phosphate (GAPDH) (Tristan et al., 2011). The 
enzyme’s diagnostic potential has previously been shown in human sera as a 
marker of myocardial infarction (Karliner et al., 1971) and liver cirrhosis 
(Shibuya and Ikewaki, 2002). In fish little is known about the enzyme but two 
isoforms have been identified in gilthead sea bream (Sparus aurata) and the 
European sea bass (Dicentrarchus labrax) (Sarropoulou et al., 2011).   
 
4.1.6 Aims of Study 
• To investigate the suitability of enolase, alsolase A, and GAPDH as 
biomarkers of skeletal muscle damage 
• Validate proteomic results and subsequent statistical analysis by other 
means 
• To develop an ELISA for the most suitable candidate for quantification and 
establish suitability as a diagnostic tool. 
 
N.B. Work presented in this chapter is published in Braceland et al. (2014). 
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4.2 Materials and methods 
4.2.1 Fish husbandry and challenge and histopathology 
Fish serum samples (unless otherwise stated) and histopathological data were 
derived from the disease trial explained in section 2.2.1. 
 
 
4.2.2 Histopathology 
Tissue sections were examined by an experienced pathologist and a scoring 
system was used to semi-quantify the distribution and severity of the tissue 
lesions in the pancreas, heart and skeletal muscle as shown in section 2.2.3. 
 
 
4.2.3 Preparation of tissue lysates From Healthy Fish 
Whole skeletal muscle was collected from healthy adult fish, independent of the 
trial described above, with an average weight of 3kg from a commercial fish 
farm (Scotland, UK). Fish were killed using a lethal overdose of anaesthetic (MS-
222, Pharmaq), tissues removed and frozen in dry ice and then stored until use 
at -80°C. Protein was extracted into lysate from tissue samples by grinding one 
gram of tissue with a mortar and pestle kept frozen by the periodic addition of 
liquid nitrogen. Once a fine powder was formed it was transferred to another 
mortar and 10ml of cell lysis buffer (20mM Tris-HCL, pH 7.5) added and the 
tissue buffer mix ground for a further five minutes. The resulting extract was 
then transferred into a 15ml universal tube and centrifuged at 10,000xg at 4°C 
for ten minutes and the supernatant removed, transferred into another tube and 
the centrifugation repeated. The solid residue was discarded after each 
centrifugation. Finally the supernatant was passed through a 0.45µm syringe 
driven filter and stored at -80°C.  
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4.2.4 Protein Concentration Determination 
Protein concentrations were determined for tissue lysates and serum samples via 
the Bradford assay (Sigma-Aldrich, Poole, UK) with protein concentrations being 
determined using a bovine serum albumin (BSA) protein standard. Serum samples 
were pooled according to week post challenge (Wpc).  
 
 
4.2.5 Western Blotting 
The suitability of enolase, aldolase and GAPDH as markers of PD associated 
pathologies was initially investigated by western blotting. Aldolase (aldolase A) 
was probed using a rabbit anti N-terminal region sequence polyclonal (Aviva 
systems biology, San Diego, USA) at an optimized concentration of 1:2000 
(diluted in 5% skimmed milk TTBS). A mouse glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) monoclonal antibody (Millipore, Darmstadt, Germany) 
raised against GAPDH immunogen from rabbit muscle was used at a dilution of 
1:500. 
Three separate commercially available rabbit polyclonal primary antibodies were 
used to investigate serum enolase in Atlantic salmon sera by western blot 
analysis. The first of these was produced against a peptide sequence designed 
using human enolase 1 sequence (Aviva systems biology, San Diego, USA) and is 
referred to as ENO1a herein. The others were purchased from GeneTex (Hsinchu 
City, Taiwan) and were produced using peptides based on zebrafish enolase 1 
and enolase 3 sequences, and are herein referred to as ENO1b and ENO3 
antibodies respectively. These were found to cross react with salmon enolase 
through western blotting using optimized concentrations of: 1:2000 (in 5% 
skimmed milk TTBS) for ENO1a and ENO1b antibodies and 1:5000 for ENO3 
antibody. Samples for Western blotting were pools of sera derived by pooling 1µl 
aliquots from each fish (n = 108) from the same week post challenge, thus 
resulting in nine pools being created from week 0 to week 12 post challenge.  
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Samples were prepared in sample buffer (Biorad, Hemel Hempstead, UK) and XT 
reducing agent (Biorad, Hemel Hempstead, UK) and then diluted in water until 
the final protein loading was 8 µg per sample. The samples were then heated on 
a heating block for 5 minutes at 95°C. Proteins were separated by one 
dimensional electrophoresis (1-DE) using Criterion XT precast gels 4-12% Bis-Tris 
(Biorad, Hemel Hempstead, UK). Gels were run at 200V in a 3-(N-morpholino) 
propanesulfonic acid (MOPS) running buffer (Biorad, Hemel Hempstead, UK) for 
one hour, with one well containing 8µl of the protein molecular weight standard 
‘all blue’ (Biorad, Hemel Hempstead, UK). Gels were then removed and protein 
transferred to a 0.2 µm pore size nitrocellulose membrane using the iBlot® dry 
blotting system (Novex life technologies, Paisley, UK). Nitrocellulose was then 
placed into Ponceau S stain for ten minutes to ensure the transfer of protein to 
the membrane was successful and the global protein profile intensity was 
comparable for each sample. The stain was subsequently washed off using TTBS 
buffer which comprised of 50 mM Tris, 150 mM NaCl, and 1% Polyethylene glycol 
sorbitan monolaurate. The membrane was then blocked for one hour in 10% w/v 
powdered skimmed milk (dissolved into TTBS) and washed three times in TTBS. 
Primary antibody was diluted in TTBS containing 5% w/v powdered milk and left 
rocking overnight at 4°C. Antibody was then removed and the membrane washed 
three times before treatment with HRP linked donkey polyclonal secondary 
antibody to rabbit IgG (Abcam, Cambridge, UK) at a 1:10,000 dilution (in TTBS 
containing 5% w/v powdered milk) for one hour at room temperature. After 
washing the blot was then developed using Pierce enhanced chemiluminescence 
(ECL) Western Blotting Substrate (Thermo scientific, Rockford, IL USA). This ECL 
substrate binds HRP on the membrane facilitating band detection after exposure 
to a photographic emulsion coated film, in this case Hyperfilm™ Film 
(GE Healthcare, Buckinghamshire, UK) and development with a X-ray film 
developer. Exposure times were optimized and films scanned (Umax Poerlook III, 
Umax, Taiwan) and saved in TIFF format for analysis of band intensities was 
carried out using Image J (http://rsbweb.nih.gov/ij/) as described in Gassmann 
et al (2009).  
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Western blots of the same samples were run and separately stained with a rabbit 
polyclonal antisera to aldolase at 1:2000 dilution (Aviva systems biology, San 
Diego, USA) and a monoclonal antibody to 3-phosphoglyceraldyhyde 
dehydrogenase at a 1:250 dilution (Millipore, Massachusetts, USA). Donkey 
polyclonal secondary antibody (HRP linked) at a 1:10,000 dilution and a donkey 
polyclonal antibody to mouse IgG (Abcam, Cambridge, UK) at 1:5000 were used 
to detect antigen bound aldolase and GAPDH antbodies respectively. 
 
Western blots were also carried out using anti enolase 3antibody (ENO3) 
following two dimensional electrophoresis (2D-E) and subsequent transfer, to 
examine the specificity of the antibody. In brief, 2-DE was carried out as in 
Braceland et al. (2013) with pooled W0pc and W8pc serum to see if binding of 
antibody was consistent with previous proteomic discovery of the enzyme in 
terms of molecular weight and isolectric point (pI) and changed in serum 
abundance as indicated by 1-DE western blots and previous proteomic 
information. 
 
 
4.2.6 Enzyme-linked Immunosorbent Assay for Enolase (ELISA) 
For ELISA determination of enolase concentrations the primary antibodies used 
were ENO1a and ENO3 at dilutions (in TTBS) of 1:500 and 1:1000 respectively, 
chosen on the basis of western blot results and optimised for ELISA. 
 
Purified salmon enolase was not available to use as a calibrator, therefore, a 
pool of whole muscle lysate, known to possess a high concentration of the 
enzyme, was used as a standard by serial dilution.  Arbitary units (AU) were 
given to this standard using serial dilutions from 100AU down to 10AU in ELISA 
coating buffer (0.2M sodium bicarbonate pH9.4). Accuracy was determined by 
parallel curves of dilutions of serum sample with a high enolase content versus 
the calibrator. Precision was established by calculating the intra and inter 
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coefficients of variance by calculating variation of optical density within and 
between runs respectively. The limit of detection was assessed as the amount in 
AU of enolase detectable at 3SD from the mean of blank. Specificity was 
demonstrated bythe antibody cross reactivity on western blot. 
  
To each well 100µl of either diluted sample, standard or blank (buffer alone, 
unless otherwise stated) was added and the plate left overnight at 4°C. Wells 
were emptied then washed 3 times using 250 µl TTBS, then blocked with 10% 
w/v (in TTBS) powdered skimmed milk and left on a shaker for one hour at room 
temperature. The plate was washed again three times and then 100µl of primary 
antibody at appropriate dilution in TTBS added to each well and the plate left on 
a shaker for one hour. Another series of washes were carried out and then 100µl 
of a HRP linked donkey polyclonal secondary antibody to rabbit IgG (Abcam, 
Cambridge, UK) at a 1:10,000 dilution added for one hour with the plate on a 
shaker. Finally wells were washed with TTBS three times and then developed 
using 100µl (per well) of a 3, 3’, 5, 5’ - tetramethylbenzidine (TMB) Microwell 
Peroxidase Substrate Kit (Insight biotechnology, Middlesex, UK) which by 
peroxidase reaction catalysed by HRP forms a blue byproduct. After incubation, 
on a shaker, of 10 minutes the reaction was stopped by the addition of 50µl of 
1M hydrochloric acid. The addition of HCl causes the colour of solution to change 
to yellow thus enabling accurate measurement of the intensity at 450 nm using a 
plate reader (FLUOstar OPTIMA, BMG Labtech, Ortenberg, Germany ). The ELISA 
was validated by assessment of performance characteristics.  
 
Two sample sets were analysed by ELISA. First, enolase content of the pooled 
samples used as for western blots was determined. Second, sera from fifty 
individual fish (see Table 1) from the PD trial were selected on the basis of 
skeletal muscle pathology due to the significant correlation of enolase 
abundance with skeletal muscle myopathy (see results). This was carried out to 
investigate the relation of the histopathological scoring system to this non 
destructive biomarker and by examining serum concentrations from fish with a 
range of spectrum of muscle pathology severity. 
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4.2.7 Statistical analysis 
Any correlation between enolase concentrations and histopathological lesion 
scores was examined through statistical analysis applying a general linear model 
procedure in SAS version 9.3 (SAS Institute, Cary, N. Carolina). 
 
 
4.2.8 Immunohistochemistry 
Tissues for histology, from healthy salmon independent of the trial (4.2.3), were 
immediately fixed in 3.5% v/v formaldehyde in buffered saline pH 7.0 (4.0g 
NaH2PO4.2H2O, 6.5g Na2HPO4.2H2O) prior to further processing by standard 
paraffin wax techniques and then sectioned in preparation for IHC. In the first 
instance sections were stained with haematoxylin and eosin (H & E). IHC was 
carried out using muscle sections which were subjected Heat-induced epitope 
retrieval (HIER) using Menarini Access Retrieval Unit using in a sodium citrate 
(pH 6) buffer at 125ºC with full pressure for 1 minute and 40 seconds. Slides 
were then loaded on to a Dako autostainer and rinsed with a tris-tween (pH 7.5) 
buffer (herein buffer A) and then treated with Dako RealTM peroxidase blocking 
solution for five minutes before being rinsed twice with buffer A for a further 
five minutes. Primary antibodies were diluted to 1:1000 (a number of 
concentrations were initially tested for optimization) using Dako universal 
diluent and incubated for 30 minutes. Sections were then rinsed again with 
buffer A twice for five minutes before treatment with an anti-rabbit IgG HRP 
labelled polymer (Dako, Cambridgeshire, UK) secondary antibody at a dilution of 
1:10,000 for 30 minutes. Post washing (buffer A 5 minutes twice) development 
was carried out using Dako K5007 DAB and then rinsed with distilled water, 
counterstained with Gills Haematoxylin for 30 seconds, and washed in water 
again. Finally sections were dehydrated by treatment with 70% meth spirits then 
absolute alcohol, cleared with xylene and then mounted in DPx mounting media 
(Cell Path cat # SEA-0302-00A) 
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4.3 Results  
4.3.1 Histopathology 
The mean histopathological pathology scores, using the semi-quantitative scoring 
system previously described (Table 2-2) can be seen in Figure 4-1. The scores 
were used for statistical comparison between pathology and enolase levels 
determined by ELISA (see section 4.3.4). 
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Figure 4.1: Mean tissue histopathology lesion scores for analysis. Mean histopathological score (using a semi quantitative scoring system) 
of each tissue at the nine sampling time points from week 0 to week 12 post challenge. (n per time point = 108)
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4.3.2 1-DE Western blotting  
Western blots were carried out using all three commercially available antibodies 
to enolase: anti ENO1a (Figure 4-2a), anti ENO1b (Figure 4-2b) and anti ENO3 
(Figure 4-2c). All of these antisera detected a dominant protein with a molecular 
weight (Mw) of just under 50KDa with some lesser abundant proteins apparent 
with ENO1b and ENO3.  These could be due to nonspecific cross reactions or in 
the case of protein with low Mw, could be degradation product. Semi 
quantification of band intensities of the Western blots with antibody to enolase 
was carried out using image J (Figures 4-1a, 42b and 4-2c) with similar band 
profiles being seen in all three blots. Some variation in the specificity and 
reactivity was observed between these antibodies which may account for a 
failure to detect enolase in W3 with ENO3 (at a concentration above the 
sensitivity of the test). Strong signals were detected in weeks 4-10pc samples 
with weaker signals detected in weeks 3 and 12. These profiles agreed, in the 
main, with pathology scores of white muscle (Figure 4-1) with a higher band 
intensity being observed where there is an increase in lesion severity. In 
addition, the observation of a band at the same Mw and of high intensity when 
using muscle lysate indicated further that pathogenesis of PD may be influencing 
sera concentrations. Blots using all three antibodies gave a higher intensity in 
band when using W6 serum compared to W8 serum at which time point mean 
white muscle pathology was at its highest. 
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Figure 4.2: Western blots using enolase antibodies. Western blots using: (a) anti ENO1a (Aviva systems biology) antibody at 1:2000 
concentration.  (b) ENO1b (GeneTex) antibody at 1:2000 (c) anti ENO3 (GeneTex) antibody at 1:5000. Sample identifications for each lane 
can be found at the top of each with ‘W’ indicating week post introduction and ‘Muscle’ indicating which lane a muscle lysate was used. 
Band intensities from image J analysis of western blot are given below respected blots. 
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Therefore, an immunological assay in the form of an ELISA was developed out 
using ENO1a and ENO3 antibodies (ENO1b omitted due to previously discussed 
background staining) to investigate in a more quantitative manner the 
relationship between serum enolase concentrations and the pathogenesis of PD. 
 
Western blot with antiserum to aldolase (Figure 4-3a) and to GAPDH (Figure 4-
3b) confirmed that these enzymes were also raised in serum during the PD 
infection.  In comparison to the western blot with antibody to enolase, the 
aldolase blot showed more background staining suggestive of some non-specific 
interaction while the blot with antibody to GAPDH revealed a shorter time 
window in the infection where the protein could be detected. 
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Figure 4.3: Western blots probing for aldolase A and GAPDH. Western blot 
using: (a) anti Aldolase (Aviva systems biology) antibody at 1:2000 
concentration. (b) anti GAPDH antibody at 1:250 concentration. Sample 
identifications for each lane can be found at the top of each with ‘W’ indicating 
week post introduction.
 Chapter 4: Validation 130 
 
 
 
 
 
 
4.3.3 2-DE Western Blotting 
Figure 4-4 shows the specificity of ENO3 with major binding at the appropriate 
Mw (~48kD) and pI (7 to 8). Whilst there is some binding in other areas this is 
most likely to be albumin and apolipoprotein which are, based on previous 
investigations, the most abundant proteins in the salmon serum proterome. This 
non-specific binding does not appear to alter depending on disease state, having 
similar intensity in both W0pc and W8pc blots. In addition, there appears to be 
an absence of any specific ENO3 binding in W0pc with high intensity with W8pc, 
thus in agreement with 1-DE western blots.   
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Figure 4.4: Two dimensional western blot probing for enolase. Two 
dimensional western blot using anti ENO3 (GeneTex) antibody at 1:5000. The top 
image shows the staining post development when week 0 post challenge pool 
was used and the bottom shows week 8 post challenge. A black box is around the 
area we hypothesise to be specific ENO3 staining at the correct Mw and pI.
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4.3.4 ELISA 
Discordance between band intensities and proteomic and histopathology data 
could be due to the higher sensitivity of western blots compared to the gel 
based proteomic investigation or possible image J saturation effects of high 
sample concentration of enolase. Therefore, an ELISA was developed to quantify 
serum concentrations of enolase with the use of ENO1a and ENO3 antibodies 
being compared to more accurately determine levels of target. 
 
Average intra assay %CV using ENO1a antibody was 3.4% and ENO3 3.5% (n= 98). 
Inter assay %CV of low standard (W4pc pool) was 10.8%, and high standard 
(W8pc) = 6% when using antibody ENO1a, whilst ENO3 antibody gave inter assay 
%CV results of 12.4% and 4.3% for low and high standards respectively (n= 30). 
Limit of detection was found to be 2AU (arbitrary units) for ENO1a and 2.1AU 
when the ELISA was carried out using ENO3 antibody.  When using W0pc sera as a 
blank the limit of detection was found to be 4.5 AU (ENO1a) and 4.7 AU (ENO3). 
The same pooled sera used in western blots were used in an indirect ELISA which 
used a whole muscle lysate ‘standard’ to give a sample concentration in 
arbitrary units. Optical density (OD) values were corrected against a fetal calf 
serum (FCS) blank. Quantification of serum enolase using both ENO1a and ENO3 
antibodies by ELISA resulted in a similar profile of change after infection and 
validated western blot results (Figure 4-6). In addition, the concentration of 
enolase 1 and enolase 3 concentrations significantly correlated with mean white 
muscle histopathology scores (Table 1) with pearson coefficient values of 0.9639 
and 0.945 respectively. Moreover, concentrations of enolase did not correlate 
significantly with the pathology of any other tissue (red muscle, heart, and 
pancreas) in salmon with PD.
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Figure 4.5: Standard curve of ELISA. Standard curve of skeletal muscle standard with arbitrary units on x axis and optical densities on the 
y axis.
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Figure 4.6: Enolase concentrations. Enolase concentrations of pooled sera from the nine sampling time points (x axis) post challenge. 
Arbitrary units are given as sera optical densities (ODs) were read against the OD of whole skeletal muscle lysate using varying dilutions. 
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Table 4-1 Mean white muscle pathology against enolase 1 and enolase 3 
concentrations. Mean white muscle histopathological score for each time point of 
sampling and corresponding enolase 1 and enolase 3 concentrations. 
Week Average White Muscle 
Histopathology Scores 
Enolase 1 
Conc. (Au) 
Enolase 3 
Conc. (Au) 
0 0 18.325 0 
2 0 16.915 0 
3 0.0139 24.967 9.062 
4 0.3194 30.258 25.051 
5 1.0278 43.966 41.763 
6 1.6389 52.093 49.6 
8 2.0972 55.499 60.905 
10 1.0833 37.024 47.042 
12 0.0833 27.42 20.607 
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Fifty fish from the trial were selected to give a range of histopathological scores 
(Table 4-2) and their enolase 3 concentrations assayed.  In a modification the 
ELISA pooled W0 sera was used as the blank so concentrations could be 
corrected against those of a ‘healthy fish’ thus giving more actual relevance. 
These concentrations were then compared to all tissue pathological scores by 
linear regression procedure GLM. Results verified those previously with the only 
significant correlation being found with white muscle pathology p = <0.0001 and 
38% variation explained. Figure 4-7 illustrates this relationship with the enolase 
3 concentrations of specific fish plotted against their corresponding 
histopathological score of white muscle damage. A clear trend of higher sera 
enolase concentrations can be seen in fish with more severe histopathological 
damage.
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Figure 4.7: Plot of white muscle pathology v enolase concentration. SAS output of Individual fish enolase 3 concentrations plotted 
against corresponding white muscle histopathological score.
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Table 4-2 Enolase concentrations of 50 fish against tissue lesion scores. Samples used 
with their identification (ID), histopathological damage scores of all tissues examined 
(heart, pancreas, red and white muscle) and enolase concentration in arbitrary units 
(AU). 
ID Heart Pancreas Red 
Muscle 
White 
Muscle 
ENO 3 
CONC. 
(AU) 
(tank.fish.week) 
1.1.0 0 0 0 0 5 
8.6.12 0 2 0 0 0 
3.3.0 0  0 0 0 0 
4.4.5 2 3 0 0 12 
12.1.12 0 3 0 0 0 
2.3.3 2 3 1 0 0 
1.5.3 3 3 1 0 0 
4.2.6 2 3 1 0 25 
6.6.3 2 3 1 0 1 
11.6.3 2 3 1 0 12 
4.3.4 1 3 2 0 8 
2.1.4 3 3 2 0 1 
2.2.4 2 3 2 0 6 
7.4.5 3 3 2 0 20 
1.3.4 3 3 2 0 0 
1.6.4 2 3 3 0 9 
10.2.5 1 3 3 1 18 
4.5.5 3 3 3 1 12 
8.2.6 1 3 3 1 26 
1.6.6 2 3 3 1 17 
3.5.10 0 1 0 1 19 
3.2.8 0 2 0 1 0 
7.1.5 3 2 0 1 0 
9.4.12 0 3 0 1 2 
11.5.4 2 3 0 1 0 
1.6.10 1 3 0 2 33 
5.3.10 0 2 0 2 12 
6.2.8 1 3 0 2 23 
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ID Heart Pancreas Red 
Muscle 
White 
Muscle 
ENO 3 
CONC. 
(AU) 
(tank.fish.week) 
     
7.4.10 0 2 0 2 0 
8.2.8 0 2 0 3 30 
9.1.8 0 3 0 3 29 
10.4.8 0 1 0 3 33 
9.5.10 0 3 0 3 8 
11.4.10 0 3 0 3 28 
11.6.5 1 3 3 3 21 
6.5.5 0 3 3 3 15 
2.2.6 2 3 3 3 17 
11.3.6 0 3 3 3 22 
8.1.8 0 3 3 3 26 
2.6.10 0 2 2 2 37 
6.6.10 0 2 2 2 26 
1.6.5 2 2 2 2 23 
3.6.8 0 2 2 2 19 
1.6.8 0 3 2 2 36 
5.5.4 2 3 1 1 8 
3.6.4 2 3 1 1 15 
11.2.12 0 3 1 1 26 
H3.6.6 0 2 1 1 12 
6.1.10 0 2 1 1 17 
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4.3.5 Immunohistochemical Staining 
Immunohistochemistry (IHC) was carried out using the antibodies utilised for 
western blot and ELISA results. Figure 4-8 illustrates IHC staining of a muscle 
section comprising both red and white muscle fibres using ENO3 antibody. A 
clear differential staining pattern can be observed, with little or no staining 
seen in red muscle indicating a low concentration or absence of antigen but with 
clear staining in the white muscle.
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Figure 4-8 Immunohistochemical staining of muscle probing enolase. 
Immunohistochemical staining of enolase using ENO3 antibody and subsequent 
staining with Haematoxylin. Presence of antigen is indicated by brown staining.  
 Chapter 4: Validation 142 
 
 
4.5 Discussion 
This study has provided validation for biomarker discoveries using proteomics 
previously described in chapter 3. Western blotting demonstrated that aldolase 
and enolase shared very similar profiles, whilst GAPDH abundance shows a sharp  
rise at W5pc, peaking at W6pc and then falling rapidly as described in Braceland 
et al., (2013). Enolase, using antibody ENO3 was chosen as the most appropriate 
marker of PD pathogenesis, rather than aldolase or GAPDH, due to lower 
background binding, a greater dynamic range and being its detection for longer 
in the sera. Through the use of histopathology and serum protein analysis a 
significant relationship between white muscle pathology and serum enolase 
content has been demonstrated. A serum enolase biomarker may be useful as a 
non-destructive and cost effective health monitoring tool in Atlantic salmon as it 
may detect myopathy in apparently normal fish and predict flesh quality issues 
such as bleaching of fillet and melanisation at harvest. This would allow for the 
implementation of means of reducing financial impacts incurred through 
downgrading by implementing management strategies or postponing harvest 
until these problems are rectified. 
 
In addition, enolase also holds promise in assessing the sensitivity of 
histopathological scoring systems. Semi-quantitative scoring systems such as the 
one used in this study (McLoughlin et al., 2006; Christie et al., 2007), whilst 
extremely useful in describing the extent or degree of pathology, are limited in 
a number of ways. First, due to the categorical nature of any semi-quantitative 
scoring system there will always be a level of subjectivity, as to where one 
sample is placed, and given that there will in nature always be heterogeneity 
this can lead to the reduction of accuracy. For instance, whilst there was a 
significant correlation of white muscle histopathological scores and enolase 1 
and 3 sera abundance, the level of variance between concentrations of fish 
placed in the same category (or score) was reasonably high. This was reflected 
in the fact that whilst the probability of a correlation being at p = <0.0001 the 
amount of variance explained was only 38%. Whilst this is still a reasonably high 
degree of variance being explained it is probable that the development of a less 
categorical histopathological scoring system would increase sensitivity and thus 
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accuracy. However, the use of such a system would take longer to carry out 
using more resource and require a high level of skill. In contrast, development of 
a continuous quantitative non-destructive serum based biomarker based system 
allows for the non-destructive diagnosis of white muscle pathology and 
assessment of its severity. In addition, humoral non-destructive markers can give 
an indication of the extent of pathological damage in terms of the whole 
organism rather than just in the small area sampled for histopathological 
analysis.  
 
It is important to note that currently, in salmon disease, other non-destructive 
markers of skeletal muscle myopathy are used, with the most common being 
creatine kinase (CK) (Ferguson et al., 1986; Roger et al., 1991; Yousaff and 
Powell 2012). However, the assay relies on the enzyme activity of CK which 
whilst a reliable and well established method has some disadvantages over the 
enolase ELISA described here. For example, the range of concentrations in 
healthy sera (due to a high and variable activity) is large (Ferguson et al., 1986; 
Roger et al., 1991; Yousaff and Powell 2012) thus making it hard to identify 
subtle disease associated changes on which  to base health management 
decisions. This is especially a problem when a site has an outbreak of HSMI and 
CMS where changes may be quite small and fall within the healthy range. 
Moreover, the literature thus far has only investigated total CK concentrations 
meaning the assay lacks tissue specificity as the enzyme is ubiquitous and while 
there is a muscle specific isoforms identified which can specifically be assayed 
for the issues of enzymatic activity tests still remain. 
 
Unless a biomarker is truly tissue specific, histopathology remains the most 
reliable means of identifying specific pathogenesis. Enolase in vertebrates is 
characterized as possessing three paralogs; enolase 1 (α enolase), 2 (γ enolase) 
and 3 (β enolase) (Tracy and Hedges, 2000). Enolase 2 is regarded as neuron 
specific, thus enolase 1 and enolase 3 were chosen in this study for immunoassay 
development, with Enolase 3 being laterally chosen as the best marker due to 
low interassay CV and reliability of ELISA. Both correlated exclusively with white 
muscle pathology in PD affected fish as determined by histopathology. Whilst 
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this was expected in the case of enolase 3, this specific correlation was 
interesting in terms of enolase 1 as enolase activity (via an enzyme kinetics 
assay) has been shown in heart lysate from coho salmon, Oncorhynchus kisutch 
(Landrey et al., 1978). Moreover, the isoform has been proposed as an early 
indicator of myocardial infarction in humans (Mair, 1997).  An explanation as to 
why enolase concentrations were not altered in serum of fish sampled with low 
muscle but high heart pathology could be that the amount of enolase being 
released passively by pathological damage into the humoral system is below the 
sensitivity of western blot and ELISA using this antibody. Despite this, even when 
mean pathological damage is low (0.0139) at week 3 post challenge there is a 
detectable increase from previous sampling points in enolase concentration. 
However, this may be due to the quantity of muscle when compared to heart. A 
similar issue was found by Yousaff and Powell (2012) who reported during CMS 
affected fish no significant correlation of pathological damage to the heart on 
serum creatine kinase (CK) and lactate dehydrogenase (LDH) activities while in 
the same study heart pathology in fish with HSMI significantly correlated with CK 
and LDH levels. However, this is possibly an artefact of sampling times where 
sampling has missed the effect of pathology on the proteome, with the enzymes 
leaked already being turned over. Despite this, the lack of correlation (between 
heart pathology and enolase concentration) in this current study is interesting 
and future work will aim to identify the distribution of specific isoforms of 
enolase in salmon. This would be of great use as if isoforms are found, as in 
mammals, to be tissue specific they may be used to differentiate between 
pathologies of different tissues in a non-destructive manner as is routinely 
carried out in human medicine and for other livestock species. In fact studies 
where the direct effect of specific pathogenic mechanisms on the humoral 
proteome or enzyme concentrations is distinctly limited in salmon infectious 
disease. Creatine kinase has also been studied in terms of sera levels in fish with 
PD (Ferguson et al., 1986; Rodger at al., 1991). However, the relationship 
between sera levels and histopathology was not directly investigated.  
 
In conclusion, this study has identified, through the use of commercial 
antibodies, significant correlations of enolase 1 and 3 serum concentrations with 
muscle pathology in PD. The enolase ELISA has been shown to have potential use 
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as a non-destructive health monitoring tool for this and possibly other diseases 
involving myopathy in salmon and other teleostei species. Such markers, 
currently lacking in aquaculture, may be beneficial to the industry by being an 
early stage indicator of a problem developing at a given site. Monitoring in such 
a way, may have economic benefits as early diagnosis of a disease problem may 
permit implementation of other disease management strategies such as 
functional feeds at the most optimal time. In addition, this marker may also be 
useful, due to its correlation with white muscle pathology, a means of assessing 
the sensitivity of histopathological scoring systems such as the one used in this 
study. Monitoring could also help lower the ecological impact of the industry in 
terms of farmed to wild stock disease interactions as earlier identification of 
clinical disease may lead to quicker recovery through swifter action. Future work 
on this enzyme aims to examine tissue distribution of specific isoforms and the 
establishment of a reference range of enolase in healthy salmon production site 
and change during natural outbreaks of fish disease. This will involve an 
expansion of study number (n) and the opportunity to validate this marker using 
samples from fish suffering from diseases other than PD which cause muscle 
myopathy. 
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5.1 Introduction 
5.1.1 General 
Pathological damage to tissues during disease is a major problem for the 
production of salmon by aquaculture with downgrading of fillet quality and 
reduced cumulative reduction in biomass due to chronic reduced health having a 
significant effect on the profitability and sustainability of the industry. Presently 
the most well established and reliable way of assessing pathological disease in 
fish is by histopathology. However, histopathology, compared to other means of 
assessment, is time consuming, costly, and takes a high level of expertise. 
Despite this, it remains the gold standard for diagnosis due to the limited 
number of reliable and sensitive means of non-destructive health monitoring 
available. In light of this there is a growing interest in identifying biomolecules 
which may detect pathological damage or indeed infection using non-destructive 
techniques, such as sampling of blood derived serum. 
 
5.1.2 The Discovery of a Serum Precipitation Reaction 
In the search for a means of detecting infection and disease in salmon we 
investigated the suitability of the acute phase protein ceruloplasmin (Cp) as a 
marker using Atlantic salmon serum samples from a pancreas disease (PD) trial. 
Our hypothesis was that by using the method described by Ceron et al. (2007), 
where a colorimetric assay based on the oxidation of paraphenylenediamine 
(PPD) substrate in a sodium acetate buffer is used to determine Cp activity in 
salmon serum, we could monitor the acute phase response to infection by 
salmonid alphavirus (SAV) subtype 3 (SAV3) in the experimental model described 
in Chapter 2. Using this methodology it was found that assumed Cp 
concentrations in salmon sera were several fold greater than in the serum of  
species such as man, dog and pig and yet salmon Cp was not identified in the 
salmon serum proteome (Chapter 3). This observation led to the hypothesis that 
either Cp gram for gram possesses a higher oxidase activity in salmon than any 
other thus far studied organism or there were other causes for the apparently 
elevated Cp level. However, further investigation revealed that upon removal of 
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the active substrate PPD the simple mixing of sera from salmon with PD and 
sodium acetate buffer caused a change in turbidity due to the appearance of an 
opaque precipitate, leading to change in absorbance at 550 nm and an apparent 
high activity of Cp. Furthermore this turbidity was associated with the disease 
state of the individual from which the sample was taken. This was an interesting 
observation especially since the buffer is commonly used as a base buffer for 
enzymatic/ protein assays to which functional substrates are added. Moreover, 
similar methodologies have also been used in other finfish species. For example, 
Haluzova et al. (2010) demonstrated ceruloplasmin activities rising after carp 
were treated with the pesticide Sparatakus, again with no precipitation of 
proteins being reported despite pathological damage to a number of tissues. A 
similar buffer system has also been used with an acetate buffer and sodium 
azide solution mix (plus PPD substrate) being used by Yada et al. (2004), again 
with no precipitate formation being noted in Rainbow trout. 
 
The test developed from these initial observations and described in this chapter 
has the potential to provide results at three levels. The first of these is a 
qualitative test with simple mixing of serum and sodium acetate trihydrate 
buffer and observing with the naked eye if the mixture becomes turbid or 
remains clear. This has shown to be very effective in the laboratory with no 
visible turbidity occurring when using serum samples from clinically healthy fish. 
The second level of the test is the quantitative monitoring of precipitation 
formation over a period of time using a spectrophotometer, where differential 
precipitation has been shown as an indicator not only of pathological damage to 
a given tissue but also to attain information on the extent/ severity of the 
damage. Thirdly precipitated proteins from these tests can be reconstituted in 
water and separated using electrophoresis to give a band profile relating to the 
tissues that has been damaged. We can find no evidence in the literature of any 
similar test in any species. Therefore not only does this test have huge potential 
in non-destructively diagnosing clinical disease and which tissues are damaged it 
also represents an interesting novel phenomenon in biological terms. 
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5.1.3 Aims of Study 
• To develop and validate the observed precipitation phenomenon 
• To determine correlation between pathological damage and precipitate 
formation 
• To determine whether the test can detect reduction in pathology severity 
in fish fed different diets  
• To investigate which proteins are being precipitated during PD 
• To investigate the precipitation potential of other pathologies through use 
of tissue lysates  
 
N.B. A patent application is in preparation based on the findings of this chapter. 
 
5.2 Materials and Methods  
5.2.1 Samples  
5.2.1.1 PD Cohabitation Disease Model 
Sera used in this chapter, unless otherwise stated, were obtained from the PD 
trial as described in section 2.2.1. Only samples derived from fish fed fed diets A 
and B were investigated (n = 54 each time point). 
 
5.2.1.2 Samples from Aquaculture sites and Tissue Lysates 
Samples were collected from clinically healthy salmon (n = 23), with no history 
of PD or any other viral infection, of an average weight of 3kg from an 
aquaculture production site in Ardnish (UK). Fish were killed by lethal overdose 
of anaesthetic (MS-222, Pharmaq) and blood taken in non-heparinised 
vacutainers, spun at 10,000xg for 15 minutes and serum collected and stored at -
80°C. A pool of these samples, referred to as ‘POOL A’ herein, was also used for 
inter-assay CV calculation upon development of a precipitation assay. 
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A number of tissue samples from these fish were also collected, with samples of; 
whole skeletal muscle, liver, spleen, gill, eye, brain, heart, pyloric caeca, 
kidney and head kidney all being sampled stored immediately on dry ice and 
subsequently at -80oC until processing. Lysates from these tissues were prepared 
as in section 4.2.3. 
 
5.2.2 Development and Optimization of Precipitation Assay 
In order to develop a rapid and quantifiable assay for the determination of 
precipitate formation in a given sample, an assay was developed for use on a 
spectrophotometer using sodium acetate trihydrate buffer and also for use on a 
micro-titre plate reader. The final optimized conditions for both systems are 
given and thereafter modifications used in the optimisation process, using the 
micro-titre plate system are described.   
 
The precipitate assay was performed on a spectrophotometer (Jencons 7315) as 
follows. An aliquot of 180µl 2% (w/v) bovine serum albumin (BSA) was added to 
60µl of sample before and then mixed in a cuvette with 1 ml of 0.6M sodium 
acetate trihydrate buffer at pH 5.6 was placed in the cuvette. The BSA was 
shown not to have any effect on the reaction kinetics or precipitation reaction 
but reduced the sedimentation of precipitate allowing for more reliable OD to 
be monitored. Monitoring of the OD was at 340nm with readings taken every 
second for 60 min. This methodology was used primarily in early development of 
the assay while determining optimum conditions, such as temperature. 
 
For use on a microtitre plate 15µl of sample (in duplicate) was dispensed to a 96 
well plate and placed inside the plate reader (Fluorostar Optima BMG Labtech) 
at 37°C. Sodium acetate trihydrate buffer (0.6 M at a pH of 5.6) was heated to 
37°C before addition of 245µl to each well. Absorbance (Ab) was measured at 
340nm over a 60 minute duration with readings being taken every 30 seconds. 
The change in optical density (∆340) was calculated by subtracting the first 
reading from the final. When investigating tissue lysate precipitation, conditions 
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remained the same except 230µl of buffer was added to 30µl of sample in each 
well. 
 
5.2.3 Statistical analysis 
To understand varying precipitation potential of samples and how this might 
relate to the severity of tissue damage individual ∆340 were compared to 
individual histopathological score of each tissue (2.3.2) via a general linear 
model procedure in SAS version 9.3 (SAS Institute, Cary, N. Carolina) for 
regression analysis. Through this analysis it was possible to establish any 
correlation between precipitate formation and tissue pathologies.  
 
In addition, the Pearson coefficient test was also carried out comparing ALT, 
AST, and CK scores to investigate the statistical likelihood that these enzymes 
may be part of precipitate.  This test gives the correlation coefficient (r) of two 
variables with -1 indicating absolute no correlation and 1 indicating total 
correlation. Interpretation of correlation coefficient was carried out as in 
Dancey and Reidy (2004) where strength of correlation is interpreted as in Table 
5-1. 
 
Table 5-1: Value of Pearson correlation coefficient against corresponding 
strength of correlation. 
 Value of the Correlation Coefficient Strength of Correlation  
 1 Perfect  
 0.7 - 0.9 Strong  
 0.4 - 0.6  Moderate 
 0.1 - 0.3  Weak 
0  No Correlation 
-1 Negative Correlation 
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5.2.4 Electrophoresis and Protein Spot Identification 
An observable turbidity is produced upon mixing of 0.6M sodium acetate 
trihydrate pH 5.6 buffer (SAT) and serum samples. In addition, this turbidity is 
visibly different depending on the disease status of the individual. To investigate 
the composition of the proteins forming the precipitate, separate W0pc and 
W4pc pools were created for examination with equal volumes from each time 
point. Samples of the serum pools (300µl) were added to 0.6M sodium acetate 
trihydrate buffer (1ml) and allowed to incubate for one hour in a water bath at 
37°C. The solution was then centrifuged at 10,000xg for 10 minutes and 
supernatant collected. Precipitate was washed by re-suspending in 1ml of SAT 
buffer and mixed prior to spinning at 10,000xg. This was repeated twice and 
each time supernatants removed. After the final wash the precipitate was re-
suspended in 200µl of distilled water and vortexed until proteins had gone back 
into solution. 
 
The nature of the protein in the precipitate was examined by two dimensional 
electrophoresis (2-DE) as in section 3.2.1.  In total 36 protein spots from the 
resulting 2D-E gel were excised and subjected to trypsin digestion before protein 
identification via electrospray ionisation (ESI) mass spectrometry on an Amazon 
ion trap MS/MS (Bruker Daltonics) as in section 3.2.3. 
 
One dimensional electrophoresis was also carried out using reconstituted 
precipitate formed after the mixing of sodium acetate trihydrate buffer and 
tissue lysates. This methodology is described in section 4.2.4.  
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5.3 Results 
5.3.1 Development and Optimisation of Precipitate Assay 
Assay optimization found that the kinetics, overall formation and monitoring of 
precipitate formation was dependant on a number of factors which were 
individually optimised. These were pH of buffer (Figure 5.1A), wavelength 
(Figure 5.1B and 5.1C), temperature (Figure 5.1D), and the molarity of buffer 
(Figure 5.1E). During optimisation the positive samples used were either pooled 
serum from W4pc of the infection or were muscle lysates prepared as in Section 
4.2.3. 
A range of buffers with the desired pH were prepared by titrating sodium 
acetate (0.2M) with acetic acid (0.2M) and di-sodium hydrogen phosphate (0.2M) 
with sodium dihydrogen phosphate-2-hydrate to achieve a range from pH 3.7 to 
pH8.0.  Results (Figure 5.1A) indicated that a sodium acetate buffer, pH 5.6 was 
optimal for maximizing ∆340. The optimal wavelength for detecting changing 
turbidity by precipitation was examined by assessing a range of fixed wavelength 
detection filters to establish the optimal wavelength for observing precipitate 
formation by ELISA plate reader. The 340 nm filter yielded the greatest OD 
reading (Figure 5.1B). This wavelength also gave higher absorbance using a 
spectrophotometer when compared to 550nm (Figure 5.1 C), confirming that a 
wavelength of 340nm was optimal. Figure 5.1D shows the effect of temperature 
on the spectrophotometer assay.  Increasing the temperature from 20oC to 37oC 
caused a steady increase in the absorbance at 340nm for the precipitation 
reaction.  At 45°C there was a rapid increase followed by a fall in absorbance 
due to a sedimentation effect with precipitate settling out of the solution. The 
effect of buffer molarity on precipitation carried out using a plate reader with 
60μl muscle lysate being added to 200μl buffer.  Figure 5.1E illustrates the wide 
range of molarity where precipitate is formed, although a significant drop in ∆340 
being seen when sodium acetate buffers of <0.2 M were used. From these results 
the optimal assay conditions for the serum precipitate reaction (SPR) were 
determined: 0.6M sodium acetate trihydrate buffer at pH 5.6, and reaction 
temperature at 37°C. Other factors such as buffer to sample ratio were also 
investigated and the optimum was found to be 15µl sample into 245µl buffer for 
analysis on the ELISA plate reader and 1ml of buffer being added to 240µl of 
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sample mix (60µl sample and 180µl 2% BSA) in the spectrophotometer with 
changing absorbance being monitored over a 60 minute period (∆340). 
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Figure 5.1: Optimization of precipitate assay.(A) Illustrates the effect of pH of buffer (pH 3.7 to 5.6 sodium acetate trihydrate buffer 
while pH range 5.8 to 8 is a sodium phosphate buffer) of delta OD of muscle lysate over a one hour period.
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Figure 5.1: Optimization of precipitate assay. (B) Blank corrected optical 
density of resulting precipitation reaction from the mixing of muscle lysate and 
buffer when using a range of different wavelengths 
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Figure 5.1: Optimization of precipitate assay. (C) The kinetics of muscle lysate precipitation reaction when monitored at either 340nm 
or 550nm. 
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Figure 5.1: Optimization of precipitate assay. (D) Temperature effect on the formation of precipitate, monitored at 340nm using 
muscle lysate with OD reading taken every second.
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Figure 5.1: Optimization of precipitate assay. (E) The effect of molarity on the 
delta OD (over a one hour time period) when using W6pc sera. 
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5.3.2 Quantification of the Serum Precipitation Reaction during 
Pancreas Disease  
The developed SPR assay was carried out on individual samples from the PD trial 
to investigate the changes in precipitation over time of the trial and the 
relationship with pathological damage of PD. A pool of sera from clinically 
healthy fish ‘POOL A’ and a pool of week 4 post challenge (W4pc) fish were used 
to calculate interassay %CV, which were 10.6% and 9.7% respectively (n = 25 
plates), average intra assay %CV was 7.2% (n= 25 plates. 
Figure 5.2 shows SPR measured by the mean ∆340 of serum from fish according to 
week post challenge (Wpc). There is a clear increase in precipitation of sera 
samples post W3pc, peaking at W6pc and returning to near homeostasis levels by 
W12pc. In addition, the mean result of pool A is shown with ∆340 comparable with 
healthy fish from the trial (W0pc).
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Figure 5.2: Mean ∆340 of samples by week post challenge. Serum precipitation reaction (mean + SEM) measured by change in absorbance 
over 60 minutes at 340nm (∆340) according to week post challenge (Wpc) using microtiter plate assay. In addition pool A quantified 
precipitation formation is shown. SEM bars on Pool A result indicates SE of inter assay replicates (n = 33 plates).
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Given the profile of precipitate it was thought that this may be influenced by 
general pathology of PD. Therefore, statistical analysis of individual fish ∆340 of 
samples was carried out against corresponding histopathological lesion scores. 
Precipitate reaction correlated positively with heart (p = 0.001), pancreas (p = 
<0.001), red muscle (p = <0.001), and white muscle (p = <0.001) histopathology 
scores, thus indicating that pathological damage to all tissues had a significant 
effect on the precipitate potential of serum. Pearson correlation coefficient 
scores of precipitate reaction with serum activities of AST, ALT and CK were 
0.62, 0.86, and 0.92 respectively. These moderate to strong associations further 
strengthened the hypothesis precipitation potential was dependent on the 
existence/ severity of pathological damage to tissues in fish with leakage of 
these enzymes (ALT, AST, and CK) into the humoral system causing a differential 
serum precipitate potential. 
 
5.3.3 Dietary Difference 
Given that pathological damage apparently causes the release of proteins which 
appear to be components of the precipitate described, quantified precipitation 
(∆340) results were separated by diet to establish if this novel SPR test could also 
reflect the reduction in severity of pathology to tissues and thus lower enzyme 
activities (at certain time points post challenge). Figure 5.3 shows the 
separation of results by diet through sampling time course from W0pc to W12pc. 
This analysis showed that from W4pc to W8pc that mean ∆340 was lower in fish 
fed diet B than those fed diet A indicating a lowering of severity of pathological 
damage. 
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Figure 5.3: Dietary difference in mean ∆340 of samples by week post 
challenge. Line graph of mean delta change, of each diet separately, in 
absorbance over 60 minutes at 340nm (∆340) according to week post challenge 
(Wpc). Error bars indicate standard error (SE) of the mean at each time point.  
Diet A is indicated in black and diet B with grey line. 
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5.3.4 Composition of Precipitate 
The composition of the precipitate formed by the SPR was examined by 2-DE and 
subsequent spot excision for identification of the proteins involved via 
electrospray ionisation (ESI) mass spectrometry. This precipitation was found to 
be dependent on the health status of fish. Samples from healthy fish produced 
very little visible change in turbidity thus forming a very small pellet, in 
comparison to the precipitate formed with serum from diseased fish, post 
centrifugation. Therefore, to examine the changes that occur in serum proteins 
that cause this SPR in salmon with PD, the precipitates formed from pools of 
W4pc and W0pc were compared (Figure 5.4A and 5.4B respectively). The change 
in precipitate composition was clearly visible and 36 protein spots were removed 
for identification by mass spectrometry (Table 5-2).    
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Figure 5.4: 2-DE separation of precipitate W0pc vs W4pc.The 2-DE separation 
of protein content of precipitate; proteins were separated over a pI range 3-10 
and then by mass. Spots which were excised for identification are circled and 
numbered. (A) W4pc serum (B) W0 serum
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Table5-2: Spot mass spectrometry identities. Spots excised, from W4pc 
precipitate gel, and their corresponding identities found via mass spectrometry, 
score, peptide matches and percent (%) sequence coverage. 
Spot # ID Score Matches % Seq. 
Coverage 
1 No sig. Matches - - - 
2 Complement component C9 (Q4QZ25) 185 13 13 
3 Complement Component C9 (Q4QZ25) 408 32 19 
4 Complement Component C9 (Q4QZ25) 91 4 5 
5 Serotransferrin-1 (P80426) 797 58 33 
6 Enolase 3-1 (B5DGQ6) 112 7 14 
7 Enolase 3-2 (B5DGQ7) 261 24 26 
 Enolase 3-1 (B5DGQ6) 213 20 22 
 Cathespin M (Q70SU8) 175 63 40 
8 Cathespin M (Q70SU8) 150 29 30 
9 Fructose-bisphosphate aldolase 
(B5X0T0) 
309 20 25 
 Creatine Kinase-2 (B5DGP0) 290 35 40 
 Creatine Kinase-3 (B5DGP2) 257 34 36 
10 Pyruvate Kinase (C0H8V3) 109 4 6 
11 Enolase 3-2 (B5DGQ7) 767 79 41 
 Enolase 3-1 (B5DGQ6) 635 71 39 
12 Enolase 3-1 (B5DGQ6) 583 51 41 
13 Enolase 3-2 (B5DGQ7) 596 50 29 
 Enolase 3-1 (B5DGQ6) 547 41 27 
14 Aldolase a, fructose-bisphosphate 1 
(B5DGM9) 
251 16 26 
15 Creatine Kinase-2 (B5DGP0) 400 57 42 
 Creatine Kinase-3 (B5DGP2) 340 53 42 
 Creatine Kinase (B5DGN9) 263 45 31 
16 Creatine Kinase-2 (B5DGP0) 462 63 44 
 Creatine Kinase-3 (B5DGP2) 427 60 40 
 Creatine Kinase (B5DGN9) 285 44 35 
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Spot # ID Score Matches % Seq. 
Coverage 
17 Creatine Kinase-2 (B5DGP0) 501 68 45 
 Creatine Kinase-3 (B5DGP2) 452 64 45 
 Creatine Kinase (B5DGN9) 356 56 40 
18 Creatine Kinase-2 (B5DGP0) 426 67 39 
 Creatine Kinase-3 (B5DGP2) 365 60 35 
 Creatine Kinase (B5DGN9) 191 36 27 
19 Creatine Kinase-2 (B5DGP0) 491 77 39 
 Creatine Kinase-3 (B5DGP2) 415 64 35 
 Creatine Kinase (B5DGN9) 181 44 27 
20 Aldolase a, fructose-bisphosphate 1 
(B5DGM9) 
727 60 48 
21 Glyceraldehyde 3-phosphate 
dehydrogenase (O42259) 
210 29 36 
22 Glyceraldehyde 3-phosphate 
dehydrogenase (O42259) 
251 31 48 
23 Apolipoprotein A-I (P27007) 773 129 55 
 Apolipoprotein A-I-2 (O57524) 264 55 23 
24 Apolipoprotein A-I (P27007) 1970 241 76 
 Apolipoprotein A-I-2 (O57524) 350 66 30 
25 Apolipoprotein A-I (P27007) 571 92 56 
 Serotransferrin-2 (P80429) 182 9 10 
26 Apolipoprotein A-I (P27007) 216 37 56 
27 Creatine Kinase-2 (B5DGP0) 279 57 30 
 Creatine Kinase (B5DGN9) 149 45 17 
28 Triosephosphate isomerise B 
(NP_001133174.1) 
652 60 40 
 Triosephosphate isomerase (B5DGL3) 365 18 8 
29 Triosephosphate isomerise B 
(NP_001133174.1) 
471 33 40 
 Triosephosphate isomerase (B5DGL3) 295 14 8 
30 Fructose-bisphosphate 1 (B5DGM9) 349 30 30 
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Spot # ID Score Matches % Seq. 
Coverage 
30 fructose-bisphosphate 2 (B5X0T0) 332 26 28 
31 Triosephosphate isomerase (Q70I40 ) 197 9 27 
32 Type-4 ice-structuring protein LS-12  664 33 54 
33 Apolipoprotein A-I (P27007) 149 24 52 
 Apolipoprotein A-I-2 (O57524) 131 12 23 
34 Apolipoprotein A-I (P27007) 214 52 39 
 Apolipoprotein A-I-2 (O57524) 154 16 46 
35 Creatine Kinase-3 (B5DGP0) 112 13 19 
36 Hemoglobin subunit beta (Q91473) 385 39 79 
 Alpha-globin 1 (A9YVA1) 90 5 18 
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The 2-DE gel profile of precipitate formed from diseased (W4pc) serum is much 
more complex and diverse than that of the W0pc serum. The main difference in 
the proteome associated with this differential precipitation is an increase in 
proteins (spots 6-22, 27-31, 35) that are described as intra cellular enzymes 
which are increased in the serum due to pathological damage during PD. For 
instance, a number of intracellular enzymes were identified three isoforms of 
creatine kinase, enolase, aldolase, glyceraldehyde 3-phosphate dehydrogenase, 
and pyruvate kinase. Moreover, proteomic analysis found that these proteins 
increased in serum abundance (section 3.3.4). However, there also appears to 
be an increase in apolipoprotein A1 (spot 23-25, 33, 34) complement C9 (spots 2-
4) serotransferrin (spot 5, 25) cathepsin (spot 8) and haemoglobin (36). The 
small precipitate formed with W0pc (healthy fish) sera comprises mainly 
apolipoprotein and haemoglobin (Figure 5.4B). 
 
5.3.5 Tissue Lysate Precipitation 
The correlation of SPR and the health status of the individual coupled with the 
over representation of intracellular enzymes in the precipitate whose presence 
can only be explained by pathological damage during PD led to the investigation 
of precipitation of tissue lysates, to assess the potential of the SPR test as a 
diagnostic tool of diseases of differing pathology. Figure 5.5 illustrates the ∆340 
of different tissue lysates over a 60 minute period when 30µl of lysate was added 
to230µl 0.6M sodium acetate trihydrate (pH 5.6) to per well. Average replicate 
CV was 5.3% (n=3). The graph illustrates that whilst all tissue lysates studied 
possess precipitate potential there is a difference in ∆340 between them. 
However, whilst pyloric cacae appears to form little precipitate it did not 
behave in the same manner as other tissue lysates and as soon as lysate was 
added to buffer there was an instant precipitation making it hard to quantify 
over a period of time. 
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Figure 5.5: Tissue lysate precipitation ∆340. The ∆340 over 60 minutes caused by 
precipitation of protein when using tissue lysates. Bovine serum albumin (2% 
BSA) was used as a blank. Error bars indicate standard error of mean (SEM) (n = 
8).
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This differential precipitate led to the investigation of proteins which 
precipitate from lysates from a number of tissues. After reconstitution with 
water of the precipitate pellet, 1-DE was carried out and band profile compared. 
Figure 5.6 shows these band profiles (samples 1-10) demonstrating the different 
nature of protein content of precipitate and also the unique profiles of each 
tissue type’s precipitate. In addition, W4pc precipitate (sample 11) is shown as 
reference and demonstrates that its band profile is not influenced by one tissue 
alone, again in agreement with statistical analysis. Moreover, it appears to share 
a combination of the band profiles present in heart and skeletal muscle 
precipitate with the possibility of pancreas but given this is not a distinct organ 
this is hard to ascertain. 
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Figure 5.6: 1-DE separation of tissue lysate precipitation. Protein precipitate 
(after reconstitution in water) of tissue lysate and W4pc pool precipitate 1-DE 
band profile. Corresponding tissue/ sample are as follows:M = Molecular weight 
(Mw) ladder, 1 = Liver, 2 = Spleen, 3 = Gill, 4 = Eye, 5 = Brain, 6 = Heart, 7 = 
Kidney, 8 = Head kidney, 9 = Pyloric caeca, 10 = Whole skeletal muscle, 11 = 
W4pc 
M 
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5.4 Discussion 
This study has demonstrated that a precipitation reaction occurs when serum 
from Atlantic salmon is mixed with either sodium acetate trihydrate or sodium 
phosphate buffers in the pH range of 3.7-8. The reaction is much more 
pronounced when the salmon are infected with SAV, the causative agent of PD.  
This interaction is interesting biologically as it is possible that it may be a 
salmon specific phenomenon, as despite the many applications of similar buffers 
in a number of assays for Cp in studies of many species, such an effect 
(precipitation) has not been reported.  
 
In its simplest form, observable turbidity upon addition of sera from PD positive 
salmon to the buffer, this pathophysiologal reaction has promise as a quick 
onsite inexpensive point of care qualitative test. Although precipitate formation 
does occur using healthy serum (as in Figure 5.4B), it is not visible to the naked 
eye thus making a clear distinction between sera from healthy and diseased 
salmon simple. Furthermore, a quantifiable test was also developed which has a 
potential role in diagnostic laboratories devoted to aquaculture. 
 
Through development and optimization it was found that this phenomenon is 
affected by a number of parameters such as temperature and the molarity pH of 
the buffer used (Figure 5.1). For instance, the rate of precipitation formation is 
much faster at higher temperatures and also more is formed over a given time 
when using a buffer of higher molarity, with an optimal concentration of 0.7 M. 
In addition, the precipitate leading to the quantifiable turbidity has an optimal 
absorbance at a wavelength of 340 nm. Using this optimised method the 
precipitation potential of individual samples from the PD cohabitation trial 
described was assessed with ∆340 measured from 0 to 60 minutes.  
 
Protein precipitation is a well described phenomenon where proteins become 
insoluble through a change in environment thus altering surface or charge 
characteristics. This is achieved through a number of techniques including 
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altering temperature and pH, adding metal ions, organic solvents and salts, all 
of which enable for the separation of desirable proteins (Asenjo, 1990). One of 
the most widely used methodologies for precipitating proteins is ammonium 
sulphate precipitation, where proteins are separated through the gradual 
increase of ammonium sulphate percentage. For instance, the protocol is 
commonly used to fractionate proteins in order to make samples less complex to 
then carry out purification of specific targets (Sarikaputi et al., 1991) or for 
proteomic investigation (Saha et al., 2012). However, sodium acetate trihydrate 
has never been described to be used in such a way. Moreover, it is currently 
used as a base buffer for investigation of protein activity on substrates with no 
such phenomenon being described (Ceron et al., 2007). 
 
Analysis of individual samples from the pancreas disease trial described in 
section 2.2.1 showed that there was a significant difference in SPR through the 
trial with an initial rise in precipitation potential of sera at W4pc, before its 
peak at W6pc and returning to homeostasis near levels at W12pc (Figure 5.2). 
Using a pool of clinically healthy sera collected from fish at aquaculture sites it 
was possible to validate the ∆340 results of W0 fish as not an artefact of the trial 
and facilitate the establishment of a healthy range of precipitate formation. The 
increase in precipitate and subsequent fall was shown to be influenced by all 
tissues which are affected during PD, with histopathological lesion scores from 
pancreas, heart, red and white muscle all significantly correlating with ∆340 of 
individual serum. Moreover, ALT, AST and CK, which were previously shown to 
be indicators of general pathology, appear from Pearson coefficient analysis to 
have a strong correlation with the phenomenon. Therefore, it was hypothesised 
that pathological damage by the virus caused enzymes to leak into the sera (in 
agreement with ontology and previous work) forming components of a 
precipitate due to a lower stability in the presence of the buffer than the normal 
serum proteins such as albumin and immunoglobulins.  
 
Diet had an effect on the SPR.  When these results were split according to diet 
(Figure 5.3) it was found that fish fed diet B (functional feed Biomar plus 3) had 
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lower mean ∆340 in W4pc to W8pc compared to those who were fed diet A 
control. This reduction was in the weeks post challenge where the most severe 
pathological damage was seen in tissue pathology and serum enzyme activities 
(of ALT, AST and CK) were at their greatest. The precipitate assay is sensitive 
enough to reflect differential severity of pathology, as evidenced through 
histopathology and enzyme activity, on application of a functional feed. 
Furthermore, this mean reduction in SPR was much more pronounced and 
consistent than the semi-quantitative histopathology scoring systems and 
enzyme activity assays as previously discussed (2.3.4). Having linked precipitate 
formation to pathology it was necessary to investigate the composition of 
precipitate in more detail by gel based proteomic techniques. 
 
Figure 5.4 shows the precipitate composition of SPR of diseased (W4pc) and 
healthy (W0pc) sera after it was mixed with sodium acetate buffer and after 
extensive washing and reconstitution in water, by 2-DE. A clear difference in 
complexity of precipitate was observed and 36 spots were excised for ion trap 
MS/MS identification. These excised spots are labelled in Figure 5.4A with their 
corresponding identities in Table 5-2. The vast majority of spots in identified 
that were present in W4pc precipitate but absent in W0pc were intracellular 
enzymes which are not present in high abundance during homeostasis. Indeed a 
number of them had previously been found (section 3.4.2) to be raised in serum 
abundance during PD due to pathological damage. For example, creatine kinase 
(CK), enolase, aldolase, and glyceraldehyde glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) were found in precipitate of W4pc serum likely due to 
their increasing humoral abundance due to pathological damage to tissues as 
described in chapter 3. However, precipitation is not exclusive to proteins which 
are present in serum due to damage to tissues. For instance, complement 
component 9 (C9) was found to be present in precipitate of W4pc sera but the 
protein spot was absent at W0pc though found in proteomic investigation of sera 
(section 3.4.3) rising in abundance as part of the humoral response to PD. 
Therefore, there appears to be potential for certain humoral proteins to 
precipitate and could mean diseases which do not cause extensive pathologies 
such as in PD or sub-clinical cases could also be diagnosed by this approach, 
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although it may be that the increase in released glycolytic enzymes causes the 
complement C9 to co-precipitate.  Despite this, certainly during PD pathological 
damage to the tissues is the main driving force of the SPR. In addition, the 
finding of multiple isoforms of enolase (ENO1, ENO2 and ENO3) and creatine 
kinase (CK1, CK2, and CK3) further validates GLM statistical analysis which 
indicates that the precipitate phenomenon is influenced by multiple tissue 
pathologies. While this makes the assay not specific to a given tissue as in the 
case of enolase 3 ELISA described in chapter 4, it has added power that 
precipitated proteins can be run using electrophoresis which through further 
development may give band profiles specific to a given disease and or pathology. 
It would be important to continue this research by proteomic analysis of the 
protein precipitated from all the tissue lysates and the precipitate generated 
with serum from other diseases of salmon and other finfish. 
 
Clearly the potential of this precipitation test to be used as a diagnostic tool for 
diseases of differing pathologies to PD depends on the ability of proteins found 
in other tissues to precipitate. Therefore, initial investigation focused on testing 
this ability using tissue lysates from a number of tissues using the precipitation 
assay where ∆340 was taken over a 60 minute period after mixing of lysate and 
sodium acetate buffer (Figure 5.5). This showed that all lysates had 
precipitation potential but extent of OD change was tissue dependent, although 
it is important to note that pyloric caeca behaved very differently from other 
tissue types by precipitating very rapidly (within seconds) and sedimenting 
making it difficult to monitor using the same methodology. Differing optimal 
conditions may be needed when using this tissue.  However, this difference 
indicated that different tissues possess differing concentrations of precipitatable 
protein or even different proteins which can be precipitated. If pathological 
damage to tissues leads to release of different protein from individual tissues it 
could prompt modifications of the diagnostic test as electrophoresis profiles and 
ultimately immunoassay could be used to diagnose damage to specific tissues. 
Moreover, this may identify specific markers which could be used downstream. 
Therefore, an initial investigation in which 1-DE was carried out on precipitated 
proteins from these lysates, was performed to assess this potential use. Figure 
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5.6 shows the one dimensional separation of precipitated proteins derived from 
liver, spleen, gill, brain, heart, kidney, head kidney, pyloric caeca, and whole 
skeletal muscle. While it appears many bands are shared between tissues there 
are clear observable differences. For example, there is a prominent band at 
15KDa present in heart (sample 6) that is absent in skeletal muscle (sample 10) 
precipitate. In addition to this, W4pc precipitate band profile is also shown and 
appears to share a band profile similar to both muscle and heart lysates again 
supporting previous analysis that pathological damage to all tissues has an effect 
on precipitation. Unfortunately given that the pancreas is not a distinct organ in 
salmon it was not possible to sample this, however, W4pc precipitate has some 
very low molecular weight (<10KDa) bands not present in either heart or skeletal 
muscle but are observed when using pyloric caeca (where the pancreas is found 
discreetly) which may be potential target markers of this pathology. In addition 
the bands present in W4pc precipitate challenge at around 170KDa do not appear 
in the separation of any tissues studied and thus may represent, from molecular 
weight, precipitatble components of the immune system such as C9. Future 
investigation of these band profiles by mass-spectroscopy is warranted but it 
seems from initial investigation there is potential that the SPR  is representative 
of whichever tissues are damaged thus other pathologies out with PD could be 
diagnosed by investigation of the proteins present in the precipitate. In light of 
this future work should focus on the further development of this test and its 
validation through investigation of different diseases. 
 
This discovery of the SPR with serum from salmon with PD holds promise in 
diagnosing pathogenesis and fish health assessment. It has been shown that a 
quantifiable change in SPR occurs when examining sera from PD affected fish 
compared with clinically healthy fish. In addition, this test may be used as an 
economical and rapid test for assessing the efficacy of protective/ functional 
feeds, disease trial models and vaccines in PD research. In addition, future work 
aims to assess its usefulness as an indicator of many flesh quality issues that are 
currently a problem in salmon aquaculture. 
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6.1 General Discussion 
Infectious diseases pose a great threat to the long term sustainability of Atlantic 
salmon, Salmo salar, aquaculture (Kibenge et al., 2012; Yousaf et al., 2013). 
Therefore, limiting the impact of any outbreak which may occur is paramount to 
the industry and is achieved by diagnosis of a disease problem and subsequent 
implementation of disease management strategies. However, despite recent 
improvements in diagnostic methods (Adams and Thompson, 2014) and the 
development of novel ways to reduce disease severity such as functional feeds 
(Tacchi et al., 2012) the tools available possess a number of limitations and 
there is industrial demand for non-destructive means of health assessment. 
Moreover, while there is growing evidence for the usefulness in altering diet 
composition during disease, there are very few studies which show the effects in 
terms of disease severity. Therefore, the aim of this project was to assess the 
potential of non-destructive markers of pathological damage, using a pancreas 
disease (PD) model, which could be used as part of a proactive health monitoring 
programme. 
 
Initial work focussed on establishing that the disease trial was successful in 
causing PD in the experimental population with a number of routine diagnostic 
methods carried out. Detection of SAV3 infection was performed, as described in 
Graham et al. (2011), by attempting to isolate SAV and detection of virus 
neutralizing antibodies from the sera of fish at 0, 4, and 5 Wpc. To confirm that 
fish were SAV free at the start of the experiment the viraemia of the serum was 
investigated. Reverse transcriptase polymerase chain reaction (RT-PCR) was also 
carried out with heart tissue from sacrificed fish from W2pc to W5pc to 
investigate the horizontal spread of infection. These tests confirmed that fish 
were naive pre-trial and that the virus spread throughout the population as 
anticipated. In addition to this, histopathological assessment of pancreas, heart, 
red and white skeletal muscle attained results similar to previous studies with 
the sequential pathology characteristic of PD being shown (McLoughlin et al., 
2006; Christie et al., 2007). The pancreas was the first tissue to develop lesions 
at week 2 and was also the slowest to recover, with a minority of samples 
showing that the fish had still not fully recovered by week 12. Conversely, the 
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heart pathology demonstrated an extremely quick recovery, with a peak in 
lesion severity in fish sampled in week 4 and then a rapid recovery. Moreover, 
dietary analysis found that fish fed functional feed (diet B: Plus 3 Biomar 
product) had lower pathological lesion scores at specific time points during the 
trial compared to those fed a control diet. Histopathology scores at each time 
point for all assessed tissues were compared between diets finding fish fed diet 
B had significantly lower lesion scores at specific time points during the trial, 
often when pathological damage was at its peak in heart, pancreas and red 
muscle at W4pc (p = 0.073; p = 0.0206; p = 0.0006 respectively) and W6pc (p = 
0.0288; p = 0.014; p = 0.049). There was also a significant reduction in lesion 
severity of the white muscle at W6pc (p = 0.0331). However, given that 
histopathology is destructive and the scoring system used is semi- quantitative 
the serum activities of three analytes were assayed. Creatine kinase (CK) serum 
activities have previously been investigated by Ferguson et al. (1986) and Rodger 
at al. (1991) showing that activities increase significantly during the disease. 
This was also found to be the case in this study increasing to a peak at W6pc 
before falling to homeostasis levels by W12pc. Similar profiles were also 
observed through analysis of two novel targets of aspartate transaminase (AST) 
and alanine transaminase (ALT) which had not previously been investigated in 
salmon disease. In addition, statistical analysis found that fish fed diet B 
possessed significantly lower activities at W4pc and W6pc for both CK (p = 0.011; 
p = 0.0076 respectively) and ALT (p = 0.0013; p = 0.0017 respectively. Lower AST 
activities were observed in fish fed diet B at W6pc (p = <0.001). As anticipated 
serum activities were found to be influenced by pathological damage to heart, 
red muscle, and white muscle thus not being tissue specific. Moreover, despite 
the apparent usefulness in non-destructively assessing general fish health these 
assays have a number of limitations which may impact on their application in the 
field. First, the range of concentrations in healthy sera, due to a high and 
variable activity, is large as described in the literature (Ferguson et al., 1986; 
Roger et al., 1991; Yousaff & Powell 2012) thus making it hard to identify subtle 
changes in concentrations on which  to base health management decisions  at a 
given time point. This is especially a problem when a fish farm site has an 
outbreak of HSMI where changes may be quite small and fall within this range. 
Indeed, it would appear that values (U/L) of CK are extremely high when fish are 
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affected with PD compared to HSMI. In addition, publications only report total 
CK concentration, which is ubiquitous, thus not indicating a specific pathology. 
These two issues are much more of a problem when the nature of sampling at an 
aquaculture site is considered where there is a low probability that a fish will be 
sampled multiple times over a given period. Therefore, meaning that individual 
variability cannot be easily accounted for as in other livestock species. 
Therefore, it would be useful in terms of diagnostics to have other non-
destructive targets that may add to information attained from serum analysis 
and may be more sensitive, accurate, and reliable in diagnosing pathogenesis. 
Therefore, there is a high industrial demand for non-destructive markers of 
disease which can indicate specific tissue pathologies for diagnosing clinical 
disease and also infection of infectious agents. 
 
In the search for potential targets a gel based proteomic study was carried out 
comparing the two dimensional electrophoresis (2-DE) profile of protein 
composition of pooled serum (according to week) from the nine sampling points 
from W0pc to W12pc. In total 72 spots were found to differ significantly over the 
course of the disease trial which were excised, subjected to trypsin digestion 
and proteins identified via ion trap mass spectrometry. Bioinformatic analysis of 
spot profile intensities by Hierarchical Cluster Analysis made it possible to 
understand the effect of disease progression on the serum proteome in general 
terms with a clear separation between those recorded from 0 – 4 wpc and those 
from 5 – 10 wpc. However, the clustering of W12pc with those W0pc to W4pc 
indicated by this time there was a return to near homeostasis. Further analysis 
of spot profiles were against histopathological scores of damage to specific 
tissues in order to establish if a given spots abundance change was statistically 
linked to pathology or not. In this regression generalised linear model each spot 
was regressed on the mean value of each tissue’s histopathological score at each 
sampling time point in a separate model.  Therefore, the probability that a 
protein spot increased or decreased in intensity in association with tissue 
damage as determined by histopathology was determined, with those which did 
not correlate significantly being classed as components of the humoral immune 
system. This analysis has a number of advantages in simply basing categorization 
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on ontology mainly being that it allows for the identification of potential tissue 
specific isoforms of the same protein. However, in the main, ontology and this 
analysis were in agreement. For example, complements C3 & C9, complement 
factor B, and the complement inhibitor C1 which were found to be altered in 
abundance irrespective of tissue pathologies have been previously characterised 
as part of the fish innate immune system. In addition, other well-known humoral 
components of the immune system were found to alter in abundance, such as 
hemopexin and transferrin.  However, the main focus of the project was to 
establish potential markers of pathological damage and thus these were studied 
in more detail. 
 
Potential markers identified in the study were mainly for red and white muscle, 
with few spots being correlated to pancreas and heart pathology. This apparent 
lack of biomarkers for these tissues was most likely because the abundances of 
other potential specific protein biomarkers for heart and pancreas were not 
raised sufficiently in the serum to be detected by the proteomic methodology 
used in this study. Alternatively it may be due to differential size of the tissues. 
However, there was a significant correlation between one spot (656) containing 
serotransferrin and heart pathology. This was interesting given that the protein 
is not generally thought of being present in the tissue, indeed most spots 
containing the protein correlated with pathological damage to any tissue. 
However, the protein has been synthesised in the heart of rats (Aldred et al., 
1987) and possesses transferrin receptors (Upton et al., 2003) as iron is pivotal 
to its function. Many protein spots were found to correlate with 
histopathological lesion scores of more than one tissue. For example, the spot 
abundance of creatine kinase (CK), as previously indicated by enzyme activity, 
was found to be significantly linked to pathological damage to the pancreas as 
well as red and white skeletal muscle. Indeed many proteins did not appear to 
be influenced by a single pathology rather correlating with two or more tissue’s 
histopathology scores which could identify tissue specific isoforms or be an 
artefact of the sensitivity of proteomic approach or histopathological scoring 
system’s semi- quantitative nature.  However, the most promising candidates 
were those which correlated largely with white muscle pathology, namely 
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enolase and aldolase A. Thus these were chosen for validation by other 
approaches. In addition, glyceraldehyde-3-phosphatedehydrogenase (GAPDH) 
was chosen for further investigation to test whether the finding that spots 
containing the protein did not correlate with white muscle pathology was an 
artefact of the proteomic methodology used. 
 
The ultimate aim of Atlantic salmon aquaculture is to produce flesh, comprised 
of skeletal muscle and fat, which is desirable in the market place. Whilst 
downgrading of fillet can be caused by nutritional factors, toxic myopathies, and 
muscle breakdown due to excessive exertion (Larsson et al., 2012) one of the 
most important causes is following infectious diseases which cause skeletal 
muscle myopathy. Therefore, given white muscle is the main constituent of this 
product, any reliable biomarker of its pathology would be extremely useful to 
industry in diagnosing clinical disease and as a marker of flesh quality. Arguably 
the biggest hurdle in taking potential biomarkers through a production pipeline, 
and indeed why despite much research into diseases in general very little impact 
on industry usually occurs, is the nature of validation and finding of suitable 
makers which fit the requirements of industry. In brief, for a biomarker to be a 
useful tool in diagnostics it must be accurate and sensitive for disease state, 
have low variation within a population undergoing the same stimuli and 
reproducible and consistent over time and circumstance (Moore et al., 2007). 
Moreover, if normally present in biological fluid or tissue under homeostatic 
conditions a ‘healthy range’ of analyte concentration must be established so a 
problem may be identified swiftly when out with this range. In addition, any 
diagnostic test target must also be consistent and accurate with robustness to 
biological and analytical variation. With these criteria in mind it was decided 
that enolase, aldolase, and GAPDH should be taken forward for initial validation 
of proteomic results as serum abundance of the enzymes in healthy individuals 
seemed extremely low/ not present using gel based proteomics. Initial validation 
was carried out using a number of commercial antibodies against the enzymes by 
western blotting to ensure cross reactivity and specificity. This investigation 
found that western blot band profiles, which were semi-quantified using imageJ 
(http://rsbweb.nih.gov/ij/), correlated significantly with statistical analysis 
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with general spot profiles from proteomic investigation containing these three 
enzymes. Moreover, it was shown that a signal for GAPDH was only observed at 
W5pc and W6pc and thus did not seem to correlate with any pathology. While 
this did not definitively answer the original question posed the most plausible 
explanation was that antibody sensitivity may have been low and thus any 
presence of the enzyme may have been too low for detection pre W5pc and at 
W8pc onwards. Therefore, it was ruled out for future development. In addition, 
western blotting using a commercial antibody against aldolase A showed that 
band intensities and proteomic profiles demonstrated similar profiles through 
the time course of the PD trial. Despite this, initial attempts to develop an ELISA 
for this marker were not successful due to a high level of non-specific binding, 
which to some degree can also be seen on western blots. Despite this, three 
antibodies were used in initial validation of enolase, two of which were against 
enolase 1 isoform (ENO1a and ENO1b here in) while the other was against 
enolase 3 (antibody referred to as ENO3) isoform of the protein as both of these 
were discovered by proteomics. 
 
Western blots using these three antibodies were initially carried out after one 
dimensional electrophoresis and subsequent transfer and the profiles of spots 
corresponded well with band intensities through the course of the trial. 
Moreover, it was observed that antibodies ENO1a and ENO3 had minimal non-
specific binding. Therefore, the use of these antibodies in a more sensitive and 
quantitative manner was explored through the development of an ELISA. This 
work demonstrated that while both of these antibodies were suitable for this 
platform, ENO3 much better represented the histopathological lesion scores of 
white muscle. This result agreed with ontology as in most studied species 
enolase 1 isoform is expressed in all tissue types while enolase 3 is tissue 
specific, and while this is not clearly defined in Atlantic salmon the initial 
hypothesis was that the latter would be the more appropriate biomrker. 
Subsequent work therefore focused on validating enolase 3 as muscle specific. 
To do this a section of 50 fish from the trial with varying tissue (all tissues) 
histopathological scores were chosen depending on score of different tissues and 
statistical analysis of their enolase 3 concentrations against these scores carried 
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out. From this it was found that enolase 3 concentrations only correlated 
significantly with pathological damage to white muscle. Moreover, 
immunohistochemical staining of a section of whole skeletal muscle revealed 
that only white muscle cells stained after treatment with ENO3 antibody again 
indicating that this tissue type was the only location of the enzyme isoform. 
While this study has not fully validated enolase 3 serum concentration as a tool 
for diagnosis of PD it has gone some way in doing so. Future work must attempt 
to do this, through the use of the assay in higher samples numbers. In addition, 
the dietary difference leading to alteration in serum enolase 3 concentrations 
was not established and thus must be investigated. Despite this, the ELISA 
developed has potential uses as a non-destructive health monitoring tool, not 
only for PD induced white muscle myopathy but also as a means of assessing 
flesh quality and sensitivity of histopathological scoring systems such as the one 
used in this study.  
 
Chapter five describes the discovery and subsequent development of a novel tool 
for diagnosing pathological damage to Atlantic salmon. The discovery came 
about through the attempt to use a well-established protocol in mammalian 
species, for the determination of serum concentrations of ceruloplasmin (Cp) 
using an assay where the oxidation of a substrate paraphenylenediamine (PPD) is 
monitored through time. From this study assumed levels of Cp were extremely 
high even if oxidation activity in salmon was greater gram for gram than in other 
species. Subsequent observation lead to the finding that if the oxidation 
substrate was removed completely and diseased sera was mixed with the base 
buffer commonly used in this assay, sodium acetate trihydrate, it resulted in a 
visible turbidity. This observed turbidity was found to be due to the 
precipitation of proteins out of solution and was variable, in terms of degree of 
cloudiness, being dependent on disease state (initially at a qualitative level by 
eye). Optimization of the test found that it was sensitive to a number of 
parameters, such as, temperature, molarity of buffer, pH, and wavelength of 
light used. This optimization of conditions allowed for the quantification of 
turbidity leading to the development of an assay where the change of optical 
density (∆) was represented by this phenomenon. The developed assay was then 
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used with all fish fed diet A (control) and B (Plus 3 functional feed) were it was 
found that from W4pc to W8pc that fish fed a functional feed had lower ∆340 
than those fed the control diet, indicating as with previous results that this 
functional feed lowers disease severity. This was strengthened through 
subsequent analysis which found that this differential turbidity was influenced 
by pathological damage to all tissues affected by PD, with significant 
correlations with pancreas, heart, red and white muscle histopathological lesion 
scores.  Moreover, serum enzyme activities of CK, ALT, AST were found to have 
a strong association with precipitate formation indicating that proteins which 
are leaked into the serum due to pathological damage to tissues are the main 
constituents. Subsequently, the composition of precipitate was investigated by 
gel based proteomics to investigate this further. In total 36 major protein spots 
were removed after two dimensional electrophoresis separation of precipitate 
formed after W4pc was mixed with sodium acetate trihydrate. Identification of 
the proteins by mass spectrometry found that many enzymes already discussed 
as markers of pathology, including; creatine kinase (CK), enolase, aldolase, and 
glyceraldehyde glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were found 
in precipitate with W4pc serum. However, precipitation is not exclusive to 
proteins which are present in serum due to damage to tissues. For instance, 
complement component 9 (C9) was found to be present in precipitate of W4pc 
sera, but this protein spot was absent when W0pc precipitate was separated by 
2-DE. Moroever, C9 was also found in chapter 3 by proteomic investigation of 
sera through the disease trial to rise in abundance as part of the humoral 
response to PD. Despite this, certainly during PD pathological damage to the 
tissues is the main driving force of differential precipitation In addition, the 
finding of multiple isoforms of enolase (ENO1, ENO2 and ENO3) and creatine 
kinase (CK1, CK2, and CK3) further validates statistical analysis which indicates 
that precipitate phenomenon is influenced by multiple tissue pathologies. This 
led to the hypothesis that it may be possible for tissues other than those 
affected by PD to leak proteins into serum which could be detected by the 
precipitation test described. However, clearly this is dependent on ability of 
proteins found in other tissues to precipitate. Therefore, initial investigation 
focused on testing this ability using tissue lysates from a number of tissues using 
the precipitation assay where ∆340 was taken over a 60 minute period after 
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mixing of lysate and sodium acetate buffer. All investigated tissue lysates 
possessed proteins which precipitated out of solution when added to buffer. 
Although protein precipitation by adjustment of buffer conditions is an 
established technique and has been used as an indicator of IgG in the serum of 
neonatal animals when barium sulphate has been used (Pfieffer et al., 1977), 
the precipitation of serum protein following pathological release of protein from 
tissue has not been used previously as a diagnostic test. Furthermore, when 
resulting precipitate was examined by one dimensional electrophoresis there 
appeared to be tissue specific band profiles which may represent pathology 
specific markers. Moreover, the separation of W4pc precipitate when compared 
to tissue lysate bands shared bands with those damaged during PD indicating the 
potential of this test of diagnosing pathologies of different kinds. 
 
 
6.2 Future Directions 
This project through the use of a pancreas disease cohabitation disease model 
has identified a number of novel markers of non-destructive markers 
pathological damage in Atlantic salmon and demonstrated the reduction in 
disease severity through the administration of a functional feed.  
Initial investigation into the potential of non-destructive markers of pathological 
damage focused on serum biochemistry activities of CK, ALT, and AST. However, 
there are a number of limiting factors limiting their application in industry as a 
diagnostic tool. Despite this, CK is becoming increasingly used in general health 
assessment. Therefore, future work into this test must focus on the apparent 
high activity compared to other species and try to control for this. Moreover, the 
individual and disease variability observed in literature and in this study means 
that it would be highly useful for industry wide establishment of a healthy 
reference range of CK activity so subtle changes in abundance can be identified 
as soon as possible.  
Gel based proteomics and statistical analysis identified a number of potential 
markers of pathology and immune responses to SAV infection. Following studies 
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should focus on the validation of these and try to investigate the tissue specific 
isoforms of proteins that have been potentially found. In addition, to this more 
sensitive gel free proteomic methodologies would be useful in finding more 
targets thus increasing our understanding of the pathology and pathogenesis of 
PD. Moreover, it would be interesting to attempt to see if the same proteins 
correlate to pathological damage to the same tissues during different diseases.  
 
Further development of work described in the validation of enolase should also 
be carried out in diseases of other aetiologies and investigating its use as a 
marker of reduction of fillet quality due to other myopathies. In addition, while 
it was found that healthy fish from aquaculture sites had no detectable level of 
the enzyme in their serum it would be useful for further investigation of fish at 
different ages to confirm that this is the case. 
 
The discovery of the serum precipitation test holds promise in diagnosing 
pathological damage in fish in a non-destructive manner. Moreover, this test is 
able to quantify the severity of damage to tissues which are damaged. This 
quantification of turbidity caused by precipitation and the ability to reconstitute 
precipitated proteins in water for examination by electrophoresis appears to be 
a powerful tool in diagnosing disease and illustrating which tissues seem to be 
damaged. However, much work is still to be done in order to maximize its 
potential. Firstly, the identification via mass spectrometry of unique bands that 
result from electrophoresis separation of tissue lysate precipitate may indicate 
tissue specific markers of disease. In addition, to this, the test’s usefulness in 
other diseases which differ in pathological damage to PD must be assessed. 
Clinical samples from the field must also be tested to validate this test in an 
aquaculture setting.  
 
In general the findings of this study have great potential application in being 
used in proactive monitoring schemes in industry with fish health being assessed 
non-destructively. Monitoring in such a way may have economic benefits as early 
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diagnosis of a disease problem may permit implementation of other disease 
management strategies such as functional feeds at the most optimal time. 
Moreover, these tools add to the diagnostic tools available to farm managers to 
diagnose clinical disease thus informing them on the best action to take during 
an outbreak. 
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